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Introduction
Nanoparticles-based controlled drug-delivery systems are one of the most promising tool
for human health care. In the last decades, many platforms based on nanoparticles have
been developed for diagnosis and therapy of major diseases, especially cancer. Porous
materials able to load and release drugs in a controlled manner have been widely inves-
tigated as biocompatible vectors. Ideally, a targeted drug delivery vector should be able
to target specific areas in the body and release its cargo at controlled rate when it is
needed, avoiding secondary effects due to overdose and maximizing the therapeutic effi-
ciency. Porous particles with gate-keeping mechanisms responding to stimuli such as pH,
redox potential, light-triggering, temperature, etc. have been developed but many porous
carriers still rely on diffusion to release the encapsulated drugs.
Among these platforms, silica NPs provide many advantages, such as highly controllable
size and shape, high drug payload, low toxicity, and excellent biocompatibility. They
dissolve in physiological conditions and their degradation products, namely orthosilicic
acid, can be easily excreted through kidneys. Mesoporous silica NPs have a porous
structure with pores diameters from 2 to 50 nm and can bond active biomolecules and
drugs by physical adsorption or covalent binding.
However, a detailed understanding of the behavior of mesoporous silica nanoparticles in
biological environments is needed to push the technology towards a clinical standard.
In particular, dissolution of mesoporous silica NPs, influences their biodurability, their po-
tential toxicity and their drug release kinetics and should be investigated deeply to predict
nanoparticles fate in vivo. Attention should be paid to carefully identify the parameters
that affect the dissolution of particles such as surface area, size, and surrounding media.
Indeed, these studies should be designed to mimic the relevant in vivo environment.
In this thesis we propose a study of mesoporous silica degradation in biological relevant
conditions realized through in situ ellipsometry on model thin films, in complex media
containing proteins and in dynamic flow.
Ellipsometry provides the thickness and the optical constants of the analyzed thin film and
ix
can follow their evolution during dissolution process. The structure of mesoporous silica
nanocarriers is reproduced on thin films which, because of their plane interface can be
studied by ellipsometry. Nevertheless, ellipsometry can’t be performed in opaque liquids
so we use two different setups for transparent buffer-solutions and for real biological fluids
such as serum and blood. In the latter case we employ a setup for total internal reflection
ellipsometry (TIRE), able to work in opaque fluids.
The thesis is organized in five chapters as illustrated in the figure above.
Chapter 1 aims to present the state-of-the-art regarding drug delivery systems based on
nanoparticles, discussing biocompatibility and toxicity, targeting mechanisms and in vivo
degradation. Particular attention is brought on mesoporous silica nanoparticles and their
biomedical applications, which are the focus of this work. Chapter 2 reviews sol-gel
chemistry and nanostructuration methods, along with all the techniques involved in the
preparation and characterization of mesoporous silica thin films and extensively employed
in this thesis. A detailed study on dip-coating deposition technique was carried out
since the good control of the layer thickness is fundamental for degradation experiments
reproducibility, and it is reported in Chapter 3.
Chapter 4 describes the ellipsometry technique and the total internal reflection mode
(TIRE) employed for analysis in biological fluids. We discuss the design and optimization
of TIRE setup, which we propose to couple with a microfluidic channel to perform dissolu-
tion experiments in flow conditions. Results are presented and discussed in Chapter 5 in
which dissolution rate of silica at 37 ◦C are reported for several physiological fluids. First,
a general model for mesoporous silica dissolution is proposed and parameters affecting
x
dissolution such as surface area and porous structure are discussed. Finally, the influence
of protein adsorption and liquid flow rate on mesoporous silica dissolution kinetics are
highlighted.
xi
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Chapter I
Nanocarriers for targeted drug
delivery
I.1 Nanotechnology for health care
Probably one of the biggest innovations brought by nanotechnology is its application
to medical science: Nanomedicine, which has radically changed the way we approach
medicine. In the lecture "There’s plenty of room at the bottom" given by Richard Feynman
in 1959 at Caltech [1], which is usually referred to as the origin of nanotechnology, there
were the first revolutionary ideas of nanomedicine. In his speech Feynman considered the
possibility that patients may in the future swallow the surgeon, and talked about designing
and manipulating very small robots to be introduced into the human body for repairing
altered cellular processes or for healing injuries. Feynman pointed out that the biological
systems and the cellular mechanisms work on very tiny scale and he said:"Consider the
possibility that we too can make things very small, which does what we want, when we
want - and that we can manufacture an object that maneuvers at that level". At that
time all of this was just imagination, but with the technical advances of the 1970s and
the 1980s nanotechnology moved the first steps. A very important technical progress
was the invention of the scanning tunneling microscope which allowed, for the first time,
the visualization of individual atoms. Latterly, significant technical advances as atomic
force microscopy, atomic layer deposition and nanocrystal synthesis made nanotechnology
evolve quickly and the first nanomaterials appeared, along with their applications.
The understanding of molecular and supramolecular world developed with nanotechnol-
ogy allowed to unravel the complexity of biointeractions, and the possibility to create
devices for imaging and manipulation of biological structures became real. A major-
1
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ity of biological processes occur at the nanoscale: DNA, proteins, antibodies, lipids and
self-assembled structures made of these building blocks are nanosized materials. Under-
standing the relation between the structures and the properties of these nanomaterials is
mandatory if we want to be able to successfully fight against diseases and injuries, given
that biology uses nanostructures to manage cellular processes.
Figure I.1 – Nanoparticle drug delivery systems and the related scales.
Nowadays we produce many artificial nanostructures able to interact with complex, self-
assembled biological nanosystems, allowing the manipulation of biological processes.
Nanofibers and nanopatterned substrates are used to produce biomimetic scaffolds [2, 3]
where cells spread and proliferate to form bone tissue [4], muscle [5] or epithelial tissue [6].
Solutions of nanoparticles have been used as tissue glues or as hemostatic materials to
stop internal bleeding [7–9].
Many diseases, including cancer, are associated with alteration in cellular metabolic path-
2
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ways which produce specific signals, for example circulating biomarkers. Detecting these
signals is crucial for rapid and early diagnosis which, until now, has been limited by the
lack of biosensors capable of probing the concerned zone. Nanomaterials can interact
with biological signals through their chemical, optical or magnetic properties, becoming
a powerful tool for in vivo diagnostics. Several types of nanoparticles are being used for
imaging and labeling, because they can be detected with different techniques exploiting
their peculiar properties such as fluorescence, optical absorption, magnetic force or Raman
scattering. A commonly used imaging technology rely on magnetic resonance (MRI) and
allows to monitor magnetic nanomaterials in living tissues. These nanoparticles are gener-
ally made up of a magnetic core, often in iron oxides Fe3O4 or γ-Fe2O3 or metals, and an
hydrophilic surface coating [10–14]. Fluorescent nanoparticles are also extensively used
for cells imaging. They can consist in polymeric [15,16] or silica particles [17,18], labeled
with fluorophores, or surface-stabilized quantum-dots [19–22]. Moreover, nanoparticles
are noninvasive and avoid tissue disruption and consequent complications.
The key feature of nanoparticles for imaging and diagnostics is that their properties de-
pend on their size and size can be easily tuned during synthesis. Furthermore the surface
of nanomaterials can be engineered to control immunoreaction, biodistribution and cel-
lular uptake or to make them interact with specific biomarkers, for example conjugating
a precise antibody on the surface to target the antigen.
I.2 Nanomedicine and Drug Delivery
Nanoparticles are powerful therapeutic and diagnostic tools, in particular they can be
used as drug delivery carriers, improving the effectiveness of healing treatments. In fact,
conventional drugs are administered systemically and distributed to the whole body: lack-
ing specific targeting, they are largely degraded and excreted before reaching the diseased
tissue. The inability to establish which organs are concerned by the drugs effects is one
of the main limitations of medicine. In cancer treatment, for example, the therapeutic
agent needs to be delivered to individual tumor cells in sufficient quantity to be effective
but without harming healthy cells. This is indeed the biggest challenge of anticancer
therapies: delivering drugs to the pathological areas and confine them there, which allows
exploiting their therapeutic effect while limiting detrimental side effects due to overdose.
Reducing the uncontrolled dispersal of drugs all over the body, targeted delivery keeps
drug concentration in the therapeutic window, maximizing its efficacy, with no need to
inject high doses of therapeutics which bring adverse reactions.
3
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The key characteristic of nanovectors is their versatility. They are multicomponent sys-
tems which can be designed to accumulate preferentially in some parts of the body. They
can include biosensors which target some specific cells and integrate stimuli responsive
drug release mechanisms to deliver the drug only under specific environmental conditions.
If the particles need to be used as diagnostic tools they have to show peculiar magnetic
or optical properties, while if they are supposed to be drug carriers they have to be able
to host their cargo, either by covalent bonding or, in the case of porous particles, by
absorption in the pores.
Figure I.2 – The design of nanoparticles for biomedical applications involves numerous aspects: composi-
tion, size and shape can be tuned to control physical properties and biodistribution; the surface chemistry
can make NPs stealth, to avoid accelerated clearance by the immune system (with PEGylation for exam-
ple) and can modify the particle surface charge to improve stability and cell uptake; the functionalization
with specific ligands allows targeted delivery and drugs can enhance their stability and solve solubility
problems through bonding/encapsulation in NPs. Image reported from [23]
Over the past few decades, many nanoparticle platforms have been exploited as drug
delivery vehicles, belonging to a wide range of materials such as polymers [24,25], metals
4
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[26] and ceramics [27].
Figure I.3 – Growth of the number of publication with keywords ’drug delivery’ and ’nanoparticle’. Data
from Web of Science.
The number of publications concerning nanoparticles employed as therapeutic vectors
is spreading (figure I.3), and, to date, 50 nanopharmaceuticals have been approved by
US FDA (Food and Drug Administration) and are available for use in clinical practice,
while even more are being tested in clinical trials [28]. Most of them are previously
existing drugs encapsulated in nanoparticles and, in the majority of cases, they rely on
passive targeting through EPR effect, which involves nonspecific accumulation in diseased
tissue (see section I.4.1). Nanoparticles used in approved nanodrug formulations or under
evaluation in clinical trials currently include liposomes, polymers, micelles, nanocrystals,
metals/metal oxides and other inorganic materials, proteins and dendrimers (figure I.4).
A huge part of nanopharmaceutical approved or in clinical trials is made by anticancer
and antimicrobial nanodrugs. However, there are also formulations being developed for
autoimmune conditions, psychiatric disorders, anesthesia, arthritis, metabolic disorders,
ophthalmic conditions, and others (see table I.1).
Most of the formulations approved haven’t demonstrated improved efficacy or targeting
compared to the free drug, but they have shown reduced toxicity. In the case of cancer
therapy, which is still the main field of application for nanodrugs, the chemotherapeutic
agents are often insoluble in water and they require toxic solubilizing excipients, as in
the case of paclitaxel. The dose of such chemotherapeutics has to be limited to avoid
systemic toxicity, necessarily reducing their efficacy. Encapsulation in nanoparticles offers
5
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Figure I.4 – Types of nanoparticles in A. approved nanodrugs and B. nanoformulations currently in
clinical trials. Adapted from [29]
a viable solution to administrate higher doses of hydrophobic drugs without employing
toxic agents, thus many chemotherapies have been approved as nanoformulation and
more are in clinical development. Abraxane (nab-paclitaxel, Celgene) is a formulation of
paclitaxel conjugated to albumin nanoparticles and was approved by the FDA in 2005 for
metastatic breast cancer. It has now been indicated as treatment also for other cancers.
It is more tolerable than conventional paclitaxel, because of the absence of toxic solvents
and can be administered to patients at a considerably higher dose, increasing its efficacy.
The first approved nanodrug was Doxil (doxorubicin hydrochloride, Janssen) in 1995, to
treat Kaposi’s sarcoma. It showed reduced cardiotoxicity compared to the free drug and
nowadays it is employed also to treat breast and ovarian cancer [29].
Anyway, the number of nanodrugs which survives clinical development is still small, be-
cause often they are unable to demonstrate a significant improvement in efficacy and be-
cause improved toxicity could be achieved employing other drugs with simpler production
processes. For example, liposomal formulations of cisplatin (L-NDDP, SPI-77, lipoplatin,
and Li-PlaCis) proved to be less toxic than free cisplatin but brought no benefit in terms of
efficacy. Since other less nephrotoxic platinum alternatives (such as carboplatin) already
exist, there was no further development of liposomal cisplatin [30].
In fact, research on nanotherapeuticals is flourishing but the transition from academia to
production lines is still very poor. There are multiple obstacles and challenges in bringing
drug delivery nanocarriers to the market, which can be resumed in three main groups:
safety and toxicity issues, production and cost issues and regulation problems.
6
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Safety and toxicity issues
To avoid unpredictable side effects, characterization of nanomaterials in biological envi-
ronments is mandatory. There is a huge amount of data concerning polymers, liposomes
and micelles (which is the reason of their dominance in nanodrugs available for use in
clinical practice), but the problem with nanoparticles is that for every new formulation
(change of size, charge, shape, surface coating) new tests are necessary. Moreover, NPs
can interact with many different organs and living tissues, triggering potentially harmful
responses. Thus, the analysis of the interactions between nanoparticles and biological
systems is a very long process, which needs many tests for every modification of the ma-
terial employed. This procedure can’t be avoided and results in a huge amount of time
and money to bring the product on the market.
Regulation issues
One of the greater problems is the lack of standard protocols to characterize nanodrugs
and their toxicity, which causes a spreading of informations difficult to compare. Stan-
dards for characterization have yet not been defined but major efforts have been made.
The US Nanotechnology Characterization Laboratory (NCL), in collaboration with FDA
has published guidelines on nanomaterials characterization that include some standards
to evaluate their toxicity [31].
Nanotherapeutic products are currently regulated within a conventional regulatory frame-
work but they need additional expert evaluations about their safety and efficacy, because
of their structural complexity.
From the regulatory perspective, the main challenges concern the applicability of current
methods and tools to assess characterization and biodistribution of emerging nanothera-
peutics, particularly related to their and impact on the living systems. A huge work needs
to be done to obtain classifications of converging technologies and to define critical prod-
uct characteristics predictive of product performance in vivo (e.g. size , shape, surface
chemistry and porosity). Therefore, both the EMA (European Medicines Agency) and
the FDA constantly update their guidelines to evaluate nanomaterials, in the attempt to
shape a safe and efficient regulatory framework for nanotherapeutics.
Production and cost issues
One of the factors that limits the commercialization of nanodrugs is that the production
costs of nanoparticles for biomedical use are very high. In fact, their synthesis is often
7
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challenging and made of multiple steps to fulfill all the requirements needed. They have
to be stable enough to be processed further and to be stocked in large quantities and their
synthesis must avoid toxic reagents which traces can be harmful in their final application.
They have to be biodegradable and biocompatible, and they need to be masked from
the immune system through a surface coating (usually made of hydrophilic polymers,
or lipids). Then, if they are used for diagnostics they need special optical, magnetic or
thermic properties, which often depends on size. Thus, the NPs size distribution during
the production process must be very narrow. If they serve as drug carriers they need to
charge an high quantity of load and possibly a mechanism to release it in a controlled
way or in special conditions.
Moreover, NPs production process needs industrial infrastructures which include a nanochar-
acterization laboratory (for physical, chemical, and biological characterization of nanoma-
terials intended for medical use), a pilot line to scale up laboratory preparation of nanoma-
terials, according to industrial and regulatory standards, and a coordination with clinical
organizations to perform pre-clinical tests. Compared with conventional formulations,
the control of nanomaterials often presents greater scientific and technical challenges,
to achieve reproducibility from batch to batch with respect to particle size distribution,
charge, and porosity and to have the product stable enough to be stocked and to re-
move undesired nanostructures. This implies very high fabrication costs which needs to
be justified by an important benefit over conventional formulations to have the product
commercialized.
In fact, the nanodrugs currently available are all very simple formulations, often made
of polymers, micelles or liposomes, which avoid further steps of surface coating to mask
them from the immune system, and they rely on passive targeting through EPR effect,
not bringing any ligand to target specific cells. This avoid delicate functionalization steps
and expensive reagent such as anti-bodies. More the architecture of the nanoparticle
is complex and more is production is expensive and complicated. This means that to
be produced and sold it has to be very efficient in his task. To date, NPs based on
active targeting (specific binding of a ligand on the NP surface to a receptor on the cells
surface) haven’t shown an important gain in therapeutic effects compared to conventional
drugs, but the latest trends in approval and clinical trials of nanodrugs saw an increasing
percentage of active targeted nanoparticles [29]. One example is is SGT-53 (SynerGene
Therapeutics), which contains an antitransferrin antibody fragment that binds with a
transferring glycoprotein receptor on cancer cells and it is being studied for the treatment
of solid tumors and metastatic pancreatic cancer [32].
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I.2.1 Multifunctional NPs
Figure I.5 – The growth in the number of publications (vertical axis scale on the right) and number
of citations per year (vertical axis scale on the left), concerning theranostic platforms which combine
diagnostic and therapeutic properties in a single nanoparticle-based system. Data from Web of Science.
In the last years another important research trend is the development of multi-functional
nanoparticles which can integrate multiple functions such as diagnosis, imaging, targeted
delivery and controlled release in one individual platform. Such efforts to combine diag-
nostic and therapeutic capabilities into a single agent are commonly defined with the term
"theranostics" and represent a very active research field which counts currently around
1000 publications per year (figure I.5).
An overview on multi-functional nanoparticles is given in figure I.6 and extensively dis-
cussed in a review by Bao et al. [33] recently. Such theranostic platforms include very
often inorganic functional components such as metals, metal oxides or semiconductors.
They have peculiar optical, magnetic and plasmonic properties which can be easily tuned
controlling their size and shape.
Gold nanoparticles, for example, are good contrast agent for optical imaging but they
can also be used for photo-thermal therapy, so one can visualize exactly where nanopar-
ticles are accumulated and treat the area thermally [34,35]. Gold nanoparticles owe they
peculiar optical properties to localized surface plasmon resonance, which absorbs light at
specific frequency. The light absorbed is mainly emitted by gold nanoparticles as scattered
light, which makes them suitable tools for optical imaging, while the remaining energy is
converted into heat. For in vivo application, the absorption frequency should be within
9
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Figure I.6 – Schematic representation of multifunctional nanoparticles for drug delivery and diagnostics.
They can be designed as a combination of an inorganic nanocrystal and a coating layer which can in-
clude (a) mycelles or liposomes, (b) mesoporous silica, (c) layer-by-layer assembly and (d) surface grafted
moieties. Reproduced from [33]
the optical transparent window of human tissues (between 650 and 1300 nm) so light can
penetrate deep into the tissue without being rapidly attenuated. Luckily the absorption
spectra of gold nanoparticles is tunable with their size and shape [36] and can be shifted
from the visible to the near infrared region, allowing the use of gold nanostructures for
in vivo imaging and photo-termal therapy [37]. These nanoparticles can also be loaded
with drugs and provide the combined effects of chemotherapy and thermal therapy in one
singular platform. To date, the FDA has not yet approved any gold-based nanodrugs,
but they are under evaluation as delivery vehicles for the extremely toxic antitumor agent
TNFα. In the clinical trials they demonstrated reduced toxicity but they were rapidly
cleared by the reticuloendothelial system, to date a new nanoformulation of gold NPs con-
jugated with PEG is being developed to deliver TNFα (Aurimune, from CytImmune) and
has been found to decrease clearance rate and improve accumulation in tumors through
10
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EPR effect.
Not every type of nanoparticle is naturally multi-functional, as gold nanoparticles are, but
often they are composites in which each part brings a different functionality. For example,
it is common to find core-shell structures in which an inorganic core is encapsulated into
a mesoporous silica shell or into a lipid bilayer or a biopolymer coating. In this case the
inorganic core is used for imaging, due to his physical properties, while the coating layer
allows including drug molecules, fluorescent tracers and targeting ligands. Moreover the
nanoparticles surface can be engineered to provide biocompatibility and stability.
Iron oxide NPs have been studied in numerous clinical trials as contrast enhancement
reagents for magnetic resonance imaging (MRI). However, FDA-approved iron oxide
nanoparticles are employed as iron replacement therapies for the treatment of anemia
associated with chronic kidney disease (CKD). Some of them are reported in table I.1.
These formulations are made by an iron oxide core, coated with hydrophilic polymers (e.g.,
dextran, sucrose), and provide a slow dissolution of the iron, allowing administration of
large doses without exceeding free iron levels in the blood.
Superparamagnetic iron oxide nanoparticles (SPIONs), particularly iron oxide and mag-
netite have been used as non-targeted contrast agents for MRI. Some SPION drug formu-
lations have received FDA approval, such as Feraheme (ferumoxytol, AMAG Pharmaceu-
ticals), even if it is currently indicated mainly as an iron substitute therapy for anemia
condition associated with CKD. However, this nanoformulation is also being studied as
an imaging agent in numerous clinical trials [32]. SPIONs can be also used for hyper-
thermia treatments, thanks to the energy that they release when excited in a magnetic
field and several SPIONS are currently being investigated as hyperthermia agents against
tumors, showing promising clinical results. For example, Nanotherm (MagForce AG) is
a formulation of SPIONs coated with aminosilanes for local hyperthermia treatment of
glioblastoma tumors. It is injected directly into the tumor, and heated through the appli-
cation of an alternating magnetic field. The tumor microenvironment reaches in this way
a temperature of 40-45 ◦ C and cell death is provoked. Nanotherm is currently awaiting
FDA approval.
Among silica-based systems, Cornell Dots (C Dots) are fluorescent core-shell silica nanopar-
ticles that are being developed at Cornell University as a diagnostic and therapeutic tool
for cancer treatment. They have a silica core labeled with a near-infrared organic dye
surrounded by a pure silica shell, which is coated with polyethylene glycol (PEG). Com-
pared to free dye equivalents in solution, the C Dots are 20 to 30 times brighter and
they showed improved photo-stability. They were originally designed as diagnostic tools
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to map tumors, however they showed ability to induce cancer cell death in vitro when
cancer cells are in a state of nutrient deprivation, while high concentrations were well-
tolerated under normal conditions. When administrated to mice, tumors also reduced.
They are undergoing human clinical trial since 2010. [38] The same research group at
Cornell University is developing mesoporous C dots to host drugs, and C-dots conjugated
with antibodies to target specific cancer cells [39, 40].
Organic nanoparticles have been widely explored as well, constituted by polymers, pro-
teins, dendrimers or lipids, especially liposomic systems.
Liposomes are lipid vesicles with a large aqueous center in which they can host hydrophilic
compounds, while hydrophobic molecules can be embedded in the lipid bilayer; they carry
drugs across biological barriers overcoming cellular uptake and improving biodistribution,
being suitable vectors for many kinds of drugs [41, 42]. FDA approved many formula-
tions where drugs are encapsulated in liposomes and they showed improved stability and
bioavailability (see table I.1).
Polymeric nanoparticles are also widely investigated as nanocarriers because of their good
stability in vitro and in vivo and the possibility to easily graft multiples molecules and
ligands on their surface, making them very versatile. Moreover, they’re usually made up
of biodegradable polymers such as poly(lactic acid) (PLA), poly(glycolic acid), poly(ε-
caprolactone) and their copolymers, avoiding problems of toxicity; poly(ethylene glycol)
(PEG), poly(ethylene oxide) PEO, and poly(propylene oxide) (PPO) are also used to
synthesize nanoparticles which have great biocompatibility [43–45]. Polycyanoacrylate
nanoparticles have proved themselves effective for brain delivery [46,47].
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Table I.1 – List of nanodrugs approved by US FDA and available for clinical practice [29]
Trade name
(Manufac-
turer)
Generic name Indications Benefit of NP*
Liposome NPs
Curosurf (Chiesi
USA)
Poractant alfa Respiratory distress
syndrome
Increased delivery
with smaller volume,
decreased toxicity
Doxil (Janssen) Doxorubicin
HCl liposome
injection
Karposi’s sarcoma,
ovarian cancer, multi-
ple myeloma
Increased delivery to
disease site, decreased
systemic toxicity
Abelcet (Sigma-
Tau)
Liposomal am-
photericin B lipid
complex
Fungal infections Decreased toxicity
Depodur (Pacira
Pharmaceuticals)
Liposomal mor-
phine sulphate
Postoperative analge-
sia
Extended release
Marquibo (Spec-
tral Pharmaceuti-
cals)
Liposomal vin-
cristine
ALL Increased delivery to
tumor site, decreased
systemic toxicity
Onivyde (Ipsen
Biopharmaceuti-
cals)
Liposomal
irinotecan
Pancreatic cancer Increased delivery to
tumor site, decreased
systemic toxicity
Visudyne(Bausch
and Lomb)
Liposomial
verteporfin
Ocular histoplasmo-
sis, myopia
Increased delivery to
site of diseased vessels,
photosensitive release
Vyxeos(Jazz
Pharmaceuticals)
Liposomal
daunorubicin
and cytarabine
AML Increased efficacy
through synergis-
tic delivery of co-
encapsulated agents
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Trade name
(Manufac-
turer)
Generic name Indications Benefit of NP*
Polymer NPs
Adagen (Leadiant
Biosciences)
Pegademase
bovine
SCID Longer circulation
time, decreased
immunogenicity
Adynovate
(Shire)
Antiemophilic
factor, pegylated
Hemophilia Greater protein stabil-
ity, longer half-life
Cimzia (UCB) Certolizumab pe-
gol
Crohn’s disease,
rheumatoid arthritis,
psoriatic arthritis
Longer circulation
time, greater stability
in vivo
Copaxone (Teva) Glatimer acetate Multiple sclerosis Controlled clearance
Eligard (Tolmar) Leuprolide ac-
etate and poly-
mer
Prostate cancer Longer circulation
time, controlled
payload delivery
Mircera (Vifor) Methoxy
polyethylene
glycol-epoetin
beta
Anemia Greater aptamer
stability
Pegasys (Genen-
tech)
Pegylated IFN
alpha-2a
Hepatitis B, Hepatitis
C
Greater protein
stability
Plegridy (Biogen) Pegylated IFN
beta 1-a
Multiple sclerosis Greater protein
stability
Renvela; Renagel
(Genzyme)
Sevelamer car-
bonate; Seve-
lamer HCl
CKD Longer circulation
time and therapeutic
delivery
Zilretta (Flexion
Therapeutics)
Triamcinolone
acetonide
Osteoarthritis knee
pain
extended release
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Trade name
(Manufac-
turer)
Generic name Indications Benefit of NP*
Micelle NPs
Estrasorb (No-
vavax)
Micellar estradiol Vasomotor symptoms
in menopause
Controlled delivery
Nanocrystal NPs
Avinza (Pfizer) Morphine sulfate Psychostimulant Greater drug loading
and bioavailability
EquivaBone
(Zimmer Biomet)
Hydroxyapatite Bone substitute Mimics bone structure
Emend (Merck) Aprepitant Antiemetic Greater absorption
and bioavailability
Invega Sustenna
(Janssen)
Paliperidone
palmitate
Schizophrenia,
schizoaffective dis-
order
Slow release of low-
solubility drug
NanOss (RTI
Surgical)
Hydroxyapatite Bone substitute Mimics bone structure
Rapamune
(Wyeth Phar-
maceuticals)
Sirolimus Immunosuppressant Greater
bioavailability
Ritalin NA (No-
vartis)
Methylphenidate
HCl
Psychostimulant Greater drug loading
and bioavailability
Tricor (AbbVie) Fenofibrate Hyperlipidemia Greater bioavail-
ability, simpler
administration
Zanaflex
(Acorda)
Tizanidine HCl Muscle relaxant Greater drug loading
and availability
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Trade name
(Manufac-
turer)
Generic name Indications Benefit of NP*
Inorganic NPs
Dexferrum
(American Re-
gent)
Iron dextran Iron deficiency in
CKD
Increased dose
Feraheme
(AMAG Pharma-
ceuticals)
Ferumoxytol Iron deficiency in
CKD
Prolonged, steady re-
lease with less fre-
quent dosing
Ferrlecit (Sanofi-
Aventis)
Sodium ferric glu-
conate complex in
sucrose injection
Iron deficiency in
CKD
Increased dose
Protein NPs
Abraxane (Cel-
gene)
Albumin-bound
paclitaxel
Breast cancer, pancre-
atic cancer
Greater solubility,
increased delivery
to tumor, decreased
toxicity
Ontak (Eisai) Denileukin difti-
tox
Cutaneous T-cell lym-
phoma
Targeted T-cell speci-
ficity, lysosomal es-
cape
* Compared with conventional formulations
ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; CKD = chronic
kidney disease;
HCl = hydrochloride; IFN = interferon; SCID = severe combined immunodeficiency
disease.
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I.3 Biocompatibility and Immunoreaction
For using nanoparticles as nanomedicine tools they need to be stable in vivo and to have
good biocompatibility. A surface coating of polymers or lipids is usually an effective way
to avoid particles aggregation and fast dissolution, providing them stability in biological
media [14,48–51]. Hydrophilic polymer such as poly(ethylene glicol) (PEG) can constitute
a protective shell for nanoparticles and lower the non-specific adsorption of proteins,
hindering the organism immunoreaction and thus insuring longer circulation times.
I.3.1 Accelerated Blood Clearance
In order for a drug delivery device to achieve its goals, it must remain in the bloodstream
long enough to reach its therapeutic target, but nanoparticles undergo immune recognition
due to their relatively large size: they have the same dimensions as viruses, against which
our immune system developed a very effective defense. The phenomenon of accelerated
blood clearance (ABC) is responsible of fast elimination of nanoparticles from bloodstream
and it is due to a rapid uptake of NPs by macrophages of the reticuloendothelial system
(RES). The macrophages of the RES remove nanoparticles from the circulation through
phagocytosis, but they can identify them only through specific proteins, called opsonines,
bonded or adsorbed onto the particle surface. The opsonines are blood proteins which
start to bind very quickly to every particle injected in the bloodstream, in a process called
opsonization, which triggers recognition by the phagocytes and following elimination.
Once internalized by the macrophage, the nanoparticles are rapidly cleared through the
liver within few hours. Thus, masking the nanoparticles to avoid opsonization is critical
to enhance nanocarriers blood circulation times.
I.3.2 Making stealth nanoparticles
The simplest strategy to overcome this problem is to play on the size of NPs. In fact,
particles bigger than 200 nm are removed very efficiently by the RES, and colloids smaller
than 6 nm are quickly cleared through the kidneys. So, in order to be retained as long as
possible, the size of nanocarriers can range from 6 to 200 nm, with an optimum between
50 and 100 nm, which is also the size range to exploit the EPR effect to reach diseased
tissues, as described in section I.4.1. The anisotropy of the nanoparticles is another pa-
rameter playing a role in the kinetics of cellular uptake process. It has been observed that
a little anisotropy can promote the cellular uptake while a strong anisotropy can facilitate
renal clearance [52].
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The mentioned properties are important to extend circulation times of NPs but they are
not sufficient to retain the carriers in the bloodstream long enough to reach their target
cells. Some surface engineering needs to be performed to hide the nanoparticles from the
immune system.
One widely used method to slow down opsonization is covering the nanoparticles with
molecules which reduce the hydrophobic and electrostatic interactions between opsonines
and the particle surface. These coatings are usually made up of long hydrophilic polymer
chains, the most employed being PEG (poly ethylene glycol) and PEG-containing copoly-
mers, which demonstrated their effectiveness in minimizing blood protein adsorption and
extend the circulation time of nanoparticles [53–55]. The results are promising but still a
huge amount of nanoparticles accumulates in the liver and doesn’t target the tumor. An
interesting strategy to improve the targeting is to cover the nanoparticles with PEG and
then add cationic polymers containing amine moieties: the particle remains hydrophile
but gains a positive surface charge which favors its interaction with cellular membranes
and its subsequent uptake, as described in section I.4.1. However the synthesis needs to
be properly tuned to avoid a too high charge density which would destroy the cellular
membranes and reduce the circulation times of nanoparticles. This type of coating has
been tested in vivo by Meng et al., showing a significant improvement in targeting tumors
in comparison with a simple PEG coating [56].
I.4 Targeting strategies
The innovation about nanocarriers is the possibility of reaching injured tissue, such as
cancer cells, avoiding healthy tissues and the ability of releasing cytotoxic molecules only
where they are needed. This allows the formulation of drugs that couldn’t be employed in
conventional chemotherapy because either highly toxic or insoluble in water, for example.
The goal of medical research on drug delivery devices is to make them passively or ac-
tively target tumors or diseased tissues. The two approaches are detailed in the following
sections.
I.4.1 Passive targeting
In order to improve the preferential accumulation of nanoparticles in tumors, one strategy
is to take advantage of the existing differences between pathological and healthy tissues.
Tumors show leaky blood vessels, presenting many large fenestrations (from 100 nm to
several hundreds of nm) due to fast and defective angiogenesis (the formation of new blood
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Figure I.7 – Nanoparticles can reach tumors through Enhanced Permeation and Retention effect (EPR),
exploiting the leakiness of angiogenic blood vessels, in an approach called passive targeting. Besides,
nanocarriers can identify their target cells through ligand-receptor interactions, through an active targeting
approach. Image reproduced from [57]
vessels from existing ones) typical of pathological processes. The leakiness of tumor vas-
culatures is due to the rapid proliferation of endothelial cells and the lack of pericytes; this
condition enhances vessels permeability allowing nanoparticles and large macromolecules
to pass into tumors. Moreover, nanoparticles are retained in the cancer because of tumors
inefficient lymphatic drainage, while in normal tissues macromolecules are cleared by the
lymphatic system through the constant drainage of the extracellular fluid. The interstitial
fluid is thus renewed very often and the solutes and colloids contained in it are recycled
to the circulation. In tumors, this important lymphatic function is defective and the
extracellular fluid is retained, along with the nanoparticles and macromolecules within it.
Molecules smaller than 6 nm are able to diffuse back to the blood circulation but bigger
objects accumulate. This phenomenon is referred to as enhanced permeation and reten-
tion effect (EPR) and it is the main responsible of passive accumulation of nanoparticles
in tumors.
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The EPR effect greatly depends on the physicochemical properties of nanocarriers, such
as size, shape, charge and surface chemistry. In the first place, a high blood concen-
tration of nanoparticles is important to ensure extravasation into tumors and prevents
the eﬄux back to the blood stream. Consequently, it is mandatory to extend circulation
times of nanoparticles, hiding them from the immune system through stealth coatings
which decrease their interaction with opsonins and consequently delay their uptake by
macrophages (see section I.3.2).
The size of the nanovectors is a crucial parameter to have an efficient accumulation
in tumors through EPR effect: the average fenestration in tumor blood vessels being
around 100 nm, nanoparticles bigger than this cut-off usually are not able to penetrate in
tumors. Among nanoparticles which are smaller than 100 nm, the larger ones diffuse in the
tumors more slowly than smaller ones but if their size is below 6 nm they undergo rapid
renal clearance, being not suitable for drug delivery application. The rapid elimination
through the kidneys of small-size imaging probes have been demonstrated, showing poor
accumulation in the main organs and a clearance of more than 50% of the injected dose
within 24h. Many contrast agents used for MRI or CT imaging or the near-infrared dyes
used for optical imaging have dimensions in this range (< 6 nm) and are rapidly cleared via
the kidneys [58, 59]. Thus the optimal size of nanoparticles for tumor targeting through
EPR effect is between 6 and 100 nm. Furthermore, not all the tumors have the same
permeability and knowing the specific tumor biology is important to design an effective
nanocarrier. For example, if the tumor is hyper-permeable, NP of 30, 50, 70 or 100
nm show similar distributions, however only particles smaller than 70 nm can efficiently
penetrate and accumulate in poorly permeable tumors [60]. It is important to remind
that not only cancer is concerned by EPR effect, in fact there are other pathologies which
show similar characteristic to tumor vasculature, such as cardiovascular conditions.
Thus, size is for sure a very important parameter, but the nanoparticles shape may also
play a role: spherical objects will not interact with the surrounding environment the same
way as rod-shaped or disc-shaped particles. In fact, it has been observed that nanorods
tumor distribution kinetics differs from biodistribution of their spherical counterparts:
nanorods with an aspect ratio of 10 show similar blood circulation profiles compared to
spherical nanoparticles with equivalent hydrodynamic radius, however they extravasate
in tumors 4 times faster. Moreover, they diffuse deeper in the cancer [61], even if they
could penetrate cells less efficiently, as discussed in section I.5.3. In many biological
processes the shape and the deformability of nanosized objects are crucial to ensure the
proper working of the whole system, therefore these parameters need to be considered
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when designing a drug delivery device, in order to maximize its effectiveness.
Surface charge have a significant impact on all the nanoparticles biointeractions, partic-
ularly on protein adsorption and cellular uptake of nanocarriers. Indeed, several studies
seem to confirm that positively charged nanoparticles are internalized much faster than
neutral or negatively charged ones [56,62] despite their shorter blood circulation times [63].
Such an effect could be related to the negatively charged character of cell membranes,
which favors adhesion and up-take of positive nanoparticles.
The discovery of EPR effect paved the way for future cancer therapy, however we still
need to understand the importance of many parameters to be able to entirely exploit it.
For example, EPR shows a big variability between patients and its effectiveness greatly
depends on tumor biology and microenvironment. Besides, EPR effect increases the
accumulation of drug nanocarriers in tumors but not necessarily improves their ability to
penetrate inside cells. In order to enhance the affinity of drug delivery vehicles for their
targeted cells, the surface of NPs is modified with targeting ligands in the so-called active
targeting approach, presented in the next section.
I.4.2 Active targeting
Although passive targeting serves as basis for nanocarriers drug delivery, it still suffers
lack of control. For this reason, many efforts have been made to design nanocarriers
which can selectively bind to target cells. In order to achieve this goal, nanoparticles
are functionalized with molecules called ligands, which bind to specific receptors onto the
cell surface: through ligand-receptor interactions nanovectors find their target cells and
bind to them. Once bound, nanoparticles are quickly internalized by cells and release
their cargo. Commonly employed ligands include macromolecules such as antibodies,
nucleic acids, proteins, sugars, peptides and small molecules such as vitamins. Their
target molecules, often also called receptors, can be proteins, lipids or sugars located on
the surface of cells. Actively-targeted NPs have increased affinity for their target cells but
they need to be in their proximity to interact with them, so this type of NPs still relies
on EPR effect to reach the tumors and need to be designed to have long blood circulation
times. Active targeting doesn’t change much the biodistribution of nanomaterials but
increases the NPs uptake, enhancing therapeutic efficacy.
In order to be effective, this strategy needs to target receptors or antigens which are over-
expressed on the surface of target cells in comparison with normal cells. For example,
folate receptor (FR) is a membrane receptor over-expressed on the surface of many cancer
cells including lung, brain, breast and ovarian cancer cells, while it shows limited expres-
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sion on healthy cells, on which it is poorly accessible from the bloodstream. The ligand
used to target FR is Folic acid (FA, also called vitamin B9 or folate), a nutrient required
for cell proliferation and involved in the biosynthesis of nucleotides. Cancer cells prolif-
erate very fast and they need nutrients to maintain their fast-growing metabolism, thus
they overexpress receptors for nutrition as FR and Transferrin receptor (TfR). Folic acid
and transferrin (a protein which delivers iron to cells) have been bound to nanocarriers
outer surface improving intracellular delivery in vivo [64, 65].
Ligands are often linked to the surface of NPs through covalent bonds which can be per-
formed directly on the surface (Gold NPs reaction with thiols) or on functional groups
specifically added to improve the reactivity of the material (e.g. OH and NH2 on inor-
ganic NPs). The density of ligands on the surface of nanoparticles greatly affects their
affinity for targets and thus, their uptake rate. Multiple ligands can show cooperative ef-
fects: once a ligand binds to its substrate, the subsequent binding of the adjacent ligands
are thermodynamically favored. Moreover, the multiple interactions of NPs with the cell
force a local concentration of the receptors which triggers the wrapping of the cellular
membrane, beginning nanoparticles internalization (see section I.5.3). Nevertheless, high
density of ligands not always improves the cellular uptake, in fact the surface decora-
tion with ligands changes the properties of NPs: surface charge and hydrophobicity are
modified, and hydrodynamic size is also different. This alteration modifies the biodistribu-
tion and circulation times, in some cases improving the macrophage clearing. Therefore,
the ligand density has to be properly tuned to optimize the efficacy of actively-targeted
nanocarriers and its influence on the nanoparticles in vivo interactions has always to be
considered.
An interesting approach to this issue is given by Ashley et al. [14] encapsulating a porous
silica nanoparticle in a lipid bilayer through liposome fusion, creating a so-called photo-
cell (figure I.8). In this configuration, the outer surface is dynamic and, when one ligand
identifies its target and binds to it, the other ligands can migrate on the lipid bilayer to
maximize the exposure to cell receptors. With this method, the advantage of multiple
cooperative binding is retained employing a small density of ligands, avoiding the com-
plications linked to the presence of many ligands on the surface. The protocells charged
with Doxorubicine (a widely employed anti cancer drug) proved themself very effective,
they target tumors much better than liposomes-Doxorubicine systems and they are less
toxic to healthy cells.
Many antibodies have been studied as targeting ligands but they face some important
limitations which narrow their application in vivo. First of all, they are large macro-
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Figure I.8 – Representative design of a functionalized protocell, constitued by a mesoporous silica core
(blue in figure) and a lipid bilayer outer shell. Tumor-targeting ligands (peptides or proteins, such as
recombinant human scFvs) can be conjugated to functional groups on the surface of the protocell lipid
bilayer. The mesoporous core can host a wide variety of cargos such as chemotoxins, genes, siRNA,
aptamers or imaging agents. Polyethylene glycol can be conjugated on the surface (green coil) to enhance
circulation times. Image reproduced from [66]
molecules of about 150 kDa and their size complicates conjugation, especially on small
nanoparticles, besides they increase the hydrodynamic radius of the NPs remarkably.
Moreover, their physiological role is to recognize antigens and signaling them to immune
cells or macrophages to be cleared from the bloodstream, so they compromise circulation
times of NPs. Other proteins, such as transferrin (Tf) [67], have been used as targeting
ligands because of their three-dimensional shape, which provides them high affinity with
specific substrates but, as antibodies, they also enhance the size of NPs because of their
bulky nature. Moreover, their tertiary structure being modified, they can lose the affinity
for their target after conjugation. Smaller molecules as peptides have also been studied
as targeting ligands. In this case they doesn’t impact much on the nanoparticles size and
they have simpler three-dimensional interactions. The most used are peptides contain-
ing the sequence RGD (arginine-glycine-aspartic acid) which bind to integrine receptors
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overexpressed on angiogenic endothelial cells. Another family of ligands is represented
by short, single-stranded oligonucleotides (DNA or RNA) but, if their specificity is high,
their stability in biological environment is easily threaten by nucleases. On the contrary,
small molecules such as folic acid have good stability and small size and they overcome
many of the limitations previously described. Nevertheless, small molecules ligands are
limited in number, because the screening process to identify new efficient affinity ligands
for interested substrates are long and difficult. The most used ligands of small size are
folic acid to target folate receptor (FR), triphenylphosphonium (TPP) to target mitho-
condria and several carbohydrates to target lectins (cellular membrane proteins). To
conclude, actively-targeted nanoparticles are under evaluation and some formulation are
already in clinical development, they still face many restraints but they could open the
path for a more efficient therapy of many diseases, allowing optimization of drug delivery
and limitation of side effects.
I.5 In vivo degradation and toxicity
Nanomaterials have unique characteristics due to their size and in the last decades they
have been employed in a wide range of applications such as electronics, coatings, batter-
ies, optics, composites, cosmetics, paints, medicine etc. The human and environmental
exposure to nanomaterials have reached a level which makes mandatory to assess its pos-
sible hazard to human health. When employed in medicine, nanomaterials are designed
to follow specific routes, mainly they are injected in the blood circulation. Anyway,
nanoparticles produced on an industrial scale for applications other than medicine can
also reach the human body, via the airways, through ingestion or passing through the
skin. Because of their high surface-to-volume ratio, materials at the nano scale are very
reactive and interact with living systems and this makes it necessary to understand not
only the nanomaterial dynamics but also the surrounding environment, because nanopar-
ticles properties are modified when introduced in a biological system. Nanotoxicology
studies became necessary, given the exponential growth of nanotechnology, to prevent a
harmful, unregulated use of nanomaterials. Evaluation of the in vivo hazard of nano-
materials is still at an early stage but key factors involved in nano-bio interactions have
been identified in the last years, along with the main mechanisms of toxicity including
protein misfolding, production of reactive oxygen species and cellular membrane damage.
A quick overview is given in the following sections about nanoparticles pathway within
the body and how the biological environment reacts to NPs presence.
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I.5.1 The nano-bio interface
When a nanomaterial comes in contact with biological components, a complex dynamic
interface is formed: the interactions with biomolecules modify the forces which usually
control nanoparticles in colloidal suspension, for their part, nanomaterials interfere in
biomolecules reactions and functions, causing a great impact. The interface between
nanomaterials and biological systems is influenced by many parameters including physic-
ochemical characteristics of the nanoparticles and properties of the suspending media,
besides membrane and biomolecules interactions. What makes the characterization of
this interface so difficult is that many parameters are involved and it’s not simple to sepa-
rate their contributions; considering that the nanoparticle properties such as size, shape ,
surface charge, porosity, surface roughness, crystallization and surface hydrophobicity are
all important characteristic to determine interaction at the bio-interface. Moreover chem-
ical composition and surface functionalization have of course a huge impact. The liquid
media is equally important to shape the interface: its ionic strength, pH and the presence
of biological macromolecules (e.g. proteins) control the NPs aggregation and dissolution,
furthermore ions and macromolecules can adsorb onto the surface of the nanoparticles,
changing their hydrodynamic radius and surface charge, promoting or hindering agglomer-
ation and modifying the forces acting on particle-medium interface (electrostatic repulsive
forces and attractive Van der Waals forces).
Modeling the nano-bio interface presents one more difficulty: the system is not at steady-
state. It evolves continuously, due to the presence of cells which actively interact with
the NPs through binding, uptake, production of proteins and ions transfers. The inter-
nalization of NPs trough ligand-receptor identification and membrane wrapping further
complicates the interactions involved and expose NPs to a different environment inside
the cell.
When it comes to the interface between biological systems and nanomaterials all of this
must be considered to make this field evolve and to perform a safe use of nanomaterials. A
nanoparticle entering a biological medium is not the same object that in synthesis solvent.
Its surface is modified and the forces through which it interacts with the medium and the
other particles completely depend on this new state.
I.5.2 Protein corona
Physiological fluids, such as blood and interstitial fluid, contain a complex mixture of
proteins, so when nanoparticles enter a physiological environment they are rapidly coated
by proteins which adsorb on their surface, forming what is known as "protein corona".
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The corona modifies the size, surface chemistry and aggregation state of the nanomaterials
dramatically, shaping them as they will be "seen" by cells and biological interfaces. It is
formed of an inner layer of strongly bound proteins, called hard corona, and an outer
layer of weakly adsorbed protein in fast exchange with the environment, known as soft
corona. It is this new hybrid object (nanoparticle + protein corona) which determines
transport kinetics and interactions of nanomaterials in a biological environment.
Figure I.9 – Schema of protein corona formation on a nanoparticle surface. The corona formation is a
kinetic (k) and thermodynamic (K) process which depends on the surface characteristic of the nanopar-
ticles, such as functionalization and charge. It exist an inner layer of strongly bound proteins and an
outer layer of adsorbed proteins which exchange rapidly with the environment. Serum proteins commonly
observed in NP coronas are shown: serum albumin, immunoglobulin G1 (IgG1), alpha-2 macroglobulin
(A2M), and apolipoprotein A-1 (apoA1). Reproduced from [68].
Physicochemical properties of the nanoparticles, such as surface functionalization, charge
and size influence the composition and evolution of the protein corona which, in turn,
controls particle’s bioactivity, determining their interaction with cells, targeting activity
and circulation times [69, 70]. Size in particular defines the curvature of the surface
which is responsible for the adsorbed protein amount and composition, smaller particles
generally showing higher protein adsorption, due to their bigger curvature, which decrease
steric hindrance between adsorbed macromolecules [69,71]. Surface charge is also relevant
for the adsorption of biomolecules, but it will never avoid completely the formation of
protein corona, as demonstrated by Qiu et al. using nanoparticles differently charged:
the positive ones adsorbed a greater amount of protein in comparison to negative ones
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but a corona is formed around all the systems investigated [72].
Protein corona is a dynamic interface which exchanges over time with the surrounding
environment; in a first time, higher-abundance protein with fast kinetics are adsorbed
preferentially on the NP’s surface, to be displaced later by lower-abundance proteins with
higher affinity. Understanding the evolution of protein corona in vivo is critical to obtain
effective and non toxic nanocarriers. Corona composition also depends on the biological
fluid investigated; in blood, human serum albumine (HSA) and fibrinogen are the main
components, no matter particle size or material, because they are the most abundant
blood proteins. Anyway, they seem to be in great part on the soft corona, in fact when
washed and centrifuged, NPs show a very different corona, where the amount of HSA is
drastically reduced and there is an enrichment of apolipoprotein A-I and antithrombine-
III, both low abundance proteins, as reported by Kokkinopoulou et al. [73] and an high
amount of immunoglobulins. Binding to immunoglobulins leads to particle opsonization
and phagocytosis.
Anyway, when particles are internalized by cells they are exposed to a different environ-
ment in comparison with bloodstream, and their corona can undergo modification. There
are several studies, well discussed in the review of Feliu et al. [74], and the majority
of them showed that even passing though different biological environments, the protein
corona keeps a stable fingerprint of the first fluid encountered. It has been demonstrated
that protein corona can hinder the aggregation of nanoparticles, stabilizing them in bio-
logical media [70,75] and it can influence dissolution rates of nanocarriers and drug release
kinetics, as reported by Shahabi et al. in the case of mesoporous silica particles [70], where
drug release rate has been found lower in presence of protein corona, probably due to a
diffusion barrier formed by the protein layer, which act as a sort of protective shell. The
presence of protein corona has to be considered when designing a targeted nanocarrier,
the layer of biomolecules could indeed shield the ligands bound on the surface, limiting
the access to them, moreover proteins could compete with the interaction between ligands
and receptors [76,77].
On the other hand, particles have reverse effects on biomolecules which can be harmful,
and it’s important to understand this type of interactions to design safe nanoparticle
drug delivery systems. In fact, binding to nanoparticles can affect the structure and
function of proteins, they can unfold and be denaturated by the contact with the particle’s
surface, losing their function such as enzymatic activity, with catastrophic effects on
cellular methabolism, and they can also undergo fibrillation due to the contact with
nanomaterials [78,79]. The modification of protein structure is one of the main mechanism
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of toxicity associated with nanoparticles in vivo.
The so-called "biological identity" of nanoparticles controls all the particle’s interactions in
vivo and strongly depends from many parameters, that’s why, to be relevant, characteri-
zation of nanomaterials should be done within the investigated biological medium and not
in cell culture medium or buffers, which usually have a much lower protein ratio, produc-
ing a significantly different protein corona and, consequently, different bio-interactions. In
fact, despite many studies, it is still very difficult to predict the behavior of nanoparticles
in vivo starting from their intrinsic properties, because when NPs enter physiological envi-
ronments their physicochemical properties critically change and the system’s complexity
doesn’t allow easy representative modeling.
I.5.3 Cell uptake
For particle uptake to occur, the free energy at the interface must be lowered enough to
overcome the resisting forces which inhibit the internalization. These forces include the
stretching of cellular membrane, the diffusion of receptors until the binding site and the
hydrophobic exclusion of polar moieties. Particle adhesion depends on specific (ligand-
mediated) and nonspecific binding interactions with the cellular membrane, which can,
subsequently, wrap around the particle in a process called receptor-mediated endocytosis
and start the particle uptake, as illustrated in figure I.10. In order to start the process
of internalization, a critical number of ligand-receptor interaction must be achieved, and
receptors need to migrate through the membrane towards the binding site, in a process
that has its own diffusion rate constant, with an optimal value to achieve wrapping. Then,
the energy released from these cooperative interactions must be enough to overcome the
folding and stretching of the membrane around the particle.
The nanoparticle properties such as surface charge, hydrophobicity and size influence the
nonspecific interactions with the membrane, and it has always to be considered that these
characteristics change once particles enter in a biological environment, as highlighted in
section I.5.2. Surface coatings can optimize nonspecific interaction to favor particles up-
take, for example adding positive charges to be attracted by the negative charged domains
on the cell membrane, anyway this strategy has to be properly tuned because positive
charged particles are identified and eliminated faster by the macrophages. The role of
surface charge is mainly linked to the corona formation before internalization, in fact it
controls the amount of protein which adsorb more on less strongly on the nanoparticle
surface. When cells interact with NPs the latest are already covered with proteins and
their surface change has been modified, in some cases inversed. So, if positive charges
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Figure I.10 – For particle uptake to occur, specific and nonspecific interactions must decrease the free
energy at the contact site to overcome resistive forces such as ligands diffusion and membrane stretching.
Clathrins are protein components that mediate energy-dependent uptake of particles and are activated
when the first receptors bind to ligands. Nanoparticles are represented as red spheres with attached
ligands (yellow dots). These ligands bind to membrane receptors (Y-shaped), triggering the membrane
wrapping and the particle uptake. Reproduced from [80]
remain accessible, they will favor interaction with the cellular membrane which often
exposes negative charged functions, otherwise the NPs are probably internalized prefer-
entially because of their higher amount of protein on the surface. In fact, as highlighted
by Qiu et al., positively charged particles have a wider protein corona and they show
higher uptake ratio even if their surface charge after adsorption is inversed [72].
Size affects the cellular uptake greatly, and it exists an optimal size of nanoparticles to
have efficient wrapping, which depends on ligand density (receptor-mediated uptake) and
surface characteristics (non-receptor-mediated uptake). Generally speaking, bigger parti-
cles require huge receptors movements to reach a sufficient number of interactions, so the
receptors diffusion kinetics can be very slow, at the same time, for little NPs it is more
difficult to reach a critical number of interactions to trigger membrane wrapping, and
sometimes they agglomerate to form bigger objects before being internalized. This have
been investigated on Gold NPs, which show an optimum size around 50 nm, while smaller
(14 nm) and bigger (74 nm) nanoparticles have slower uptake kinetics, besides their total
amount inside cells is reduced in comparison to 50 nm particles [81–84]. Shape can also
favor or hinder internalization: for example long rod-shaped particles with high aspect
ratio, such as carbon multi-walled nanotubes (MWCNTs) can be difficult to incorporate
for cells, causing inflammation; a shape effect have been observed for Gold NPs too,
showing that, with the same surface chemistry, high aspect ratio nanoparticles have lower
uptake ratio in comparison to more symmetrical shapes [72]. Nevertheless, asymmetric
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nanoparticles with moderate aspect ratio showed a more effective internalization and a
faster uptake kinetics than spherical particles according to Bartneck et al., suggesting that
a moderate anisotropy can help cellular uptake but a too high aspect ratio can interfere
with it [52]. These contrasting results demonstrate that every single system studied is
pretty peculiar and because of the many factors involved in bio-nano interactions it is
difficult to extrapolate a general rule. It is important to identify the tunable properties
of nanoparticles which can play a role in their biological interactions and test them when
studying a new system.
The other actor of the uptake process is important too: not every cell reacts in the same
way to the nanoparticle presence. Macrophages and leucocytes are cells dedicated to the
removal of infectious diseases and foreign organisms and they are much more efficient
in the uptake process than any other cell of the body. Even at very low nanoparticle
concentration, the 95% of macrophages internalize NPs while just the 1% of HeLa can-
cer cells showed uptake, the particle internalization being 80-100 times more efficient in
phagocytes than in cancer cells [52]. Thus, on every evaluation made on a drug delivery
system, the tests should be made on the targeted cells because the response between
various cellular lines can be very different.
I.5.4 Biodegradation
Once drug delivery nanocarriers have fulfilled their purpose, they need to be eliminated
from the body, and this is a delicate step, because during the biotransformation they
could produce toxic molecules. Generally, organic components such as liposomes, pep-
tides, poly (lactic acid) (PLA) and its copolymers, are completely biodegradable and they
are degraded and excreted through standard metabolic pathways, with almost no toxicity.
Other materials, such as quantum dots (CdS, ZnS) or Cu and Ag oxides and complexes,
form soluble cations (Ag+,Zn2+,Cd2+,Ni2+) which have high cellular toxicity because
they interfere with cellular metabolism. For this reason, for the moment, they are studied
in many research laboratories but don’t find many real applications in the nanomedicine
field. There are also some materials, particularly sol-gel SiO2 and iron oxides (FexOy)
which form soluble non toxic species (silicate oligomers and iron complexes) eliminated
through metabolic pathways without damaging for the cells. Some nanomaterials, includ-
ing TiO2 and Gold NPs, are not soluble in biological conditions and they can be excreted
via exocytosis and renal clearance only if their size is small enough. Otherwise, they
accumulate in the tissues and they can generate high toxicity. Carbon materials such
as carbon nanotubes are potentially biodegradable through enzyme oxidation but often
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they contain high amounts of toxic metals, due to their production process, which cause
serious level of toxicity.
Oxidative stress
One of the most important mechanism of toxicity of metal oxides nanoparticles is the
production, during their biodegradation, of reactive oxygen species (ROS) leading to a
condition called oxidative stress. Reactive oxygen species are free radicals containing
oxygen, they are produced in small quantities by cells, some of them act as cellular
messengers in redox signaling and they are also employed by the immune system to kill
pathogens. Usually, cells are perfectly able to balance the production of ROS with the
presence of antioxidant defenses, nevertheless when there are too many ROS (coming
from an external agent, such as nanoparticles, or because a cellular process is altered)
cells are not able to neutralize them or repair the damages efficiently: this situation is
what is known as oxidative stress.
ROS are dangerous because they react with proteins, lipids and DNA, modifying their
structure and leading to severe alterations of cellular processes. They can damage the
membrane lipids impacting physiological functions and eventually causing cellular death.
Moreover, ROS activate redox sensitive transcription factors involved in inflammatory
response, so when the antioxidants such as glutathione (GSH), are not able to remove all
the ROS species, inflammation takes place before apoptotic pathways and cell necrosis
would eventually be triggered by very high levels of oxidative species.
There is an interesting study conducted by Zhang et al. screening the toxicity of several
metal oxides nanoparticles: from a few sets of data, taken on independent tests, results
that a group of metal oxides is highly toxic for cells while others are safe materials [85].
All these metal oxides are theoretically able to produce ROS during their biodegradation,
but only a few interfere with biological redox processes, among these toxic oxides there
are TiO2, Ni2O3, Cr2O3, Co3O4, Mn2O3, CoO, CuO and ZnO. Except the last two
materials mentioned, all the other oxides have something in common: the energy of their
conduction band lies in a range between -4.12 and -4.84 eV, which is exactly the gap of
redox potential of the main oxidation-reduction pairs in cellular processes.
Basically, almost all the redox reactions involved in cellular metabolism are associated
to a redox potential ranging from -4.12 to -4.84 eV and the metal oxides which have a
conduction band in this energy span can exchange electrons and in this way interfere with
redox cellular signaling. Other oxides such as SiO2, Al2O3, ZrO2, Fe2O3, Fe3O4 and CeO2
don’t show toxicity due to interference in redox processes and they have conduction band
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placed to lower or higher energies respect to the redox biological active range. There are
two oxides which resulted highly toxic even if the energy of their conduction band is out
of the critical range: ZnO and CuO. These materials don’t owe their toxicity to the redox
reactions disturbance but to their high solubility in biological media: they produce cations
which easily pass the membranes and enter cells. A high concentration of cations inside the
cell alters completely the proton pump activity and causes inflammation, ROS production
and mitochondrial damage, which makes ZnO and CuO highly cytotoxic materials.
There are still many aspects of nanomaterials toxicity largely unclear but nanotoxicology
is gaining increasing importance, given the growing employ of nanomaterials in many
applications: development of a regulation to limit human exposure to harmful levels of
nanomaterials is necessary. The therapeutic use of materials at the nanoscale is slightly
different and it requires another regulation, which balances the therapeutic effect with
potential risks.
I.6 Mesoporous Silica Nanoparticles
Amongst inorganic nanoparticles for drug delivery, particular attention must be given
to mesoporous silica nanoparticles (MSNs). These nanomaterials have a silica matrix
with a periodically ordered porous structure showing pores diameters from 2 to 50 nm.
The advantage of this type of material is its large surface area (500-1000 m2/g)which
allows huge quantities of drugs to be loaded into the particles. Silica nanoparticles are
especially suitable for nanomedicine application because they can be easily prepared in
large amounts following several protocols, they are chemically stable in air and can be
simply functionalized on the surface using well-known silane chemistry. Furthermore,
as long as it is made by sol-gel processing, silica is generally recognized as safe and
the products of silica degradation, namely orthosilicic acid, are excreted from the body
through the renal system.
In recent years many mesoporous silica materials have been synthesized, with different
structures, and many efforts have been made to develop them for biomedical application
since the first report of MSNs as drug delivery vehicles in 2001 [86], which have been
reviewed in two excellent works by Lin et. al. [51] and Argyo and al. [87].
I.6.1 Synthesis
Mesoporous silica is obtained from a solution containing silica precursors (typically sili-
con alkoxides) and a structuring surfactant: the molecules of surfactant undergo a self-
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Figure I.11 – Schematic representation of the synthesis process of mesoporous silica. Adapted from [88].
assembling process in which they create micelles and silica precursors place themselves
around the formed micelles, interacting with the outer hydrophilic part. The alkoxides
hydrolysis/condensation takes place and a shell of silica is formed around the micelles,
which have arranged themselves in a liquid crystal phase. Once the surfactant is re-
moved by washing or thermal treatment, a material with pores of accurate size, shape
and organization is obtained, as illustrated in figure I.11.
Yanagisawa et al. described in the early 1990s the synthesis of mesoporous materials
through intercalation of long-chain alkyltrimethylammonium cations into the layered sil-
icate kanemite [89]. Later, calcination removed the organic species, yielding a porous
material where the silicate layers condensed and converted in a silica three-dimensional
structure with nanoscale pores. Unfortunately, there were no further characterization
data available and the results of Yanagisawa et al. didn’t have the regard they deserved.
Few years later, researchers at Mobil Corporation synthesized mesoporous silicate/aluminosilicate
using surfactant templates and obtaining very uniform pore sizes [90, 91]. These materi-
als, named MCM (Mobil Composition of Matter), are known as the M41S family which
includes materials with three different mesophases: lamellar (MCM-50), cubic (MCM-48)
and hexagonal (MCM-41) I.12.
These synthesis were based on the electrostatic interaction between the cationic surfac-
tants and silicates which leads the cooperative self-assembly. Afterwards, Pinnavaia’s
group described a method based on hydrogen-bonding interactions, to obtain mesoporous
silica with neutral amines as a template [92] and shortly after, the first synthesis using
non-ionic block copolymers as structuring agents was reported [93]. These materials,
templated with non-ionic surfactants, are known as MSU-X (X = 1–4 depending on
the nature of the hydrophobic part of the template: alkyl, alkylaryl, block copolymer,
or Tween,respectively) and are the subject of an extended review by Prouzet and Bois-
sière [94]. The successful synthesis of 2D-hexagonal SBA-15 silica, templated with neutral
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Figure I.12 – The M41S family of mesoporous materials, including MCM-41 where the mesophase have
a 2D-hexagonal structure, MCM-48 (cubic) and MCM-50 (lamellar). Reported from [97].
copolymers just followed [95,96].
Amongst the most common materials employed for therapeutic vectors there are MCM-41
and SBA-15 materials, in which self-assembled micelles of templating surfactant drive the
pores ordering in an hexagonal arrangement. Particles from 50 nm to 2 µm of diameter
have been obtained, with pores ranging from 2 to 6 nm (MCM-41) or from 4.6 to 30 nm
(SBA-15). The surfactant micelles are cylindrical, arranged in an hexagonal structure
around which silica condensate. Once the templating surfactant is removed, through
calcination or solvent extraction, it leaves well-aligned cylindrical pores parallel to each
other (see figure I.12).
MCM-41 and SBA-15 nanoparticles are known for a long time but many progresses have
been made to control size and shape of pores and particles, and other synthesis methods,
including sol-gel processes, have been studied to obtain mesoporous silica nanoparticles.
Sol-gel methods, for example modified-Stöber process, allow a fine control on particle size
and pores structure tuning the reaction parameters such as temperature, time, pH and
concentration. In the Stöber method, silicates such as tetraethyl orthosilicate (TEOS)
and tetramethyl orthosilicate (TMOS), are added to an aqueous solution of alcohol and
ammonia, in which the hydrolysis reaction replaces alkoxides groups with hydroxyl groups.
Usually, the silanol groups undergo successive condensation reactions producing siloxane
bonds (Si-O-Si) and forming polysiloxanes discrete particles. These particles grow and
successively aggregate into chains then into networks and eventually evolve into a gel.
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(a)
(b) (c) (d)
Figure I.13 – Transmission electron micrographs of (a) silica mesoporous vectors (Adapted
from [98]. Copyright 2012 American Chemical Society.)(b) MCM-41-type nanoparticles
(Adapted from [99]. Copyright 2011 American Chemical Society.), (c) micrometer-sized
SBA-15 material (Adapted from [100] Copyright 2012 Wiley-VCH.), (d) colloidal MSNs
with worm-like pore structure (Adapted from [87]. Copyright 2014 American Chemical
Society.)
However, under the basic conditions of Stöber process, gel times are long enough for
particles to reach a critical size which stabilizes them through electrostatic repulsion effects
before gelation can occur. Monodisperse spherical particles of SiO2 are obtained, their
size depending on the reactants concentration, solvent polarity and temperature [101,102].
Adding surfactants as cetyl trimethylammonium bromide (CTAB), or other molecules
forming micelles, to the reaction mixture leads to mesoporous particles. The inorganic
phase condenses around the micelles which act as a template, once the organic components
are removed, a porous structure is obtained. This process is efficient only if there are
attractive interactions between the micelles and the inorganic phase, for this reason, in
the conditions of Stöber method, only positively charged molecules are valuable templates.
Size and structure of the pores depend on the templating material and its concentration.
An excess of water and the pH neutralization quench the growth of nanoparticles and the
time between the hydrolysis and the neutralization can be modified to tune the particles
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size, as reported by Fowler et al. [103]. An overview of the main reported synthesis of
NPs by templating techniques using surfactant micelles is given in table I.2.
For mesoporous nanoparticles the template removal is a very critical step: in fact, during
high temperature treatment particles can condensate and aggregate irreversibly, resulting
in very poor dispersion in aqueous media. Particles aggregation can be an issue even if
the surfactant is removed by solvent extraction, because of subsequent cycles of washing
and centrifugation, especially on smaller particles. Some methods to avoid aggregation
during the surfactant removal step have been elaborated , including dialysis and liquid-
phase calcination, in which particles are suspended in high boiling organic solvents and
heated at high temperature to degrade the templating agent [112,114]. Nevertheless, the
majority of the studies done on MSNs stability and dispersity are conducted in water,
which is not representative in case of biomedical applications. In fact, as discussed in
sections I.5.1 and I.5.2, when particles enter in biological environments they find high
ionic strength conditions and proteins which adsorb on their surface, modifying to a great
extent their aggregation state. Studies on long-term stability of MSNs in physiological
conditions are necessary to exploit them as drug delivery carriers, and lately some reports
of such type started to appear [115–120].
I.6.2 Toxicity
The hazard for human health represented by silica particles needs to be discussed deeply,
given the wide exposure to this material and the growing importance of silica nanoparticles
in nanomedicine. In fact, some toxicological studies qualifies silica as safe, but it is well
known that a serious disease such as silicosis is provoked by silica nanospheres. Thus,
here will be discussed the main factors which can lead to silica toxicity for humans.
If silicon dioxide, also known as silica, corresponds uniquely to the chemical formula
SiO2, it exists in several forms with different structures, either crystallines or amorphous.
There are several polymorphs of crystalline silica among which the most known and most
abundant is quartz. With the exception of stishovite, in all its crystalline forms silica
shows tetrahedral SiO4 units in which a central atom of silicon is coordinated with four
oxygen atoms. The SiO4 tetrahedra share vertices and can arrange themselves in different
structures with variable silicon-oxygen bond lengths and Si-O-Si angles. Moreover, silicon
dioxide exists in amorphous forms including silica glass and colloidal silica.
About human toxicity of silica particles, in the literature there are many variable results
obtained in studies which consider different silica structures, particle size and dose but
all the investigations agree that the main toxicity mechanism for SiO2 is the induction
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of oxidative stress through production of reactive oxygen species (ROS). As discussed in
section I.5.4, an high level of ROS cause citotoxicity through several processes. Looking
more in detail the possible paths of ROS generation for silica particles, can be useful to
consider the different forms of the material.
In the case of quartz has been evidenced that on the cleaved planes of the crystals are
generated some Si−O· and Si· radicals which react with H2O, O2 and CO2 to form
ROS such as OH·,O2· causing acute inflammation. Decreasing the surface reactivity,
for example masking silanol groups, leads to a reduction of ROS formed and a critical
inhibition of in vivo toxicity [121].
Addressing the problem more deeply, Ghiazza et al. compared the toxicity of particles
of quartz, silica glass and colloidal silica shaped in spheres of similar dimensions (0.5-
5 µm) and equivalent surface area (4-5 m2 · g−1) [122]. They found a similar level of
cytotoxicity on macrophages for quartz and silica glass, pointing out that crystallinity
is not the source of surface reactivity, given that silica glass is a complete amorphous
material. On the other hand, sol-gel amorphous colloidal silica showed no toxicity in all
the independent tests evaluated and when analyzed with electron paramagnetic resonance
(EPR) it didn’t display surface radicals, which are generated from both silica glass and
quartz according to EPR spectra. Through reaction with H2O2 quartz and silica glass
produces OH· radicals while sol-gel silica did not. This process is often associated with
particles toxicity and can take place in lysosomes, starting the production of ROS from
silicon or silanol surface radicals. Thus, what is the difference between amorphous silica
glass and amorphous silica obtained through a sol-gel process which makes the former
toxic and the latter safe for human health? It is necessary to analyze the silica production
process and its implication in the final structure of the material.
In fact, different amorphous silicas can be obtained through a few procedures, employing
high temperatures or mild temperature processes. Among the colloidal silicas synthesized
at low temperatures there are the ones obtained through silicate precipitation and silicas
produced through hydrolysis of silicon alkoxides, including mesoporous silica materials.
Some high temperature processes also produce amorphous silica particles, in particular
silica glass, pyrolitic silica and smoked silica. In the high temperature procedures, the
materials are cooled down quickly, freezing within them metastable structures. On the
contrary, during sol-gel processes the material has enough time to arrange reaching local
energy minima.
A study carried out by Zhang et al. [123] investigated the cytotoxicity of pyrolitic silica and
Stöber sol-gel silica, finding out through fluorescence microscopy that they accumulate on
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different parts of the cells: pyrolitic silica mainly bound to the cell membrane while Stöber
silica are localized within the cells. They also confirm that sol-gel amorphous silica is not
cytotoxic, but pyrolitic silica show toxicity through oxidative stress mechanism. Also in
this case, EPR analysis show high amount of surface radicals in the case of pyrolitic silica
and a much smaller amount for Stöber silica. The difference between these two different
materials is in the structural organization at a small scale. Raman spectroscopy can
provide informations on the various oligomers present in the material structure and when
applied to silica particles obtained with high temperature process shows a characteristic
peak associated with high strained siloxanes cycles including three silicon atoms. This
peak is absent from the Raman spectra of all the silica materials produced through low
temperature methods.
So, it seems to exist a correlation between the presence of highly strained cyclic structures
which are easily cleavable and the generation of surface radicals which causes the toxicity
of silica nanoparticles. These strained cycles are formed because of the fast cooling and
are present all over the bulk material, so they generate radicals progressively, along with
silica dissolution.
Thus, some silica materials have a high surface reactivity which make them dangerous
sources of surface radicals and, subsequently, of reactive oxygen species, capable to damage
cells through oxidative stress. Silica nanoparticles obtained through sol-gel process showed
almost no cytotoxicity because of their low surface reactivity. Nevertheless, even sol-gel
silica particles can reach a certain level of toxicity depending on size, surface charge
or anisotropy ratio, for the reasons discussed in section I.5 and reported by Quignard
et al. [124]. Porosity can also influence the cytotoxicity of silica nanoparticles, in fact
if mesoporous silica has more surface area, a porous particle exposes much less silanol
groups to the interaction with cells. This makes mesoporous silica particles less reactive
than equivalent dense particle and consequently, safer [125].
I.7 Hybrid organic-inorganic mesoporous silica particles
The versatility of silica nanoparticles is one of their most attractive characteristic, which
turns them in powerful tools. In fact, the silica scaffold can be functionalized with many
different organic moieties, creating hybrid organic-inorganic materials with peculiar prop-
erties [126,127]. External surface functionalization improve colloidal stability and protect
nanoparticles from degradation, moreover it can enhance biocompatibility or supply cell
targeting moieties or even pores gating moieties, which can release the pore’s content
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under specific stimuli. Moreover, functionalize the inner pore surface can increase the
interaction with the cargo, sometimes even providing a covalent binding site, raising the
stability of the therapeutic agent and controlling the delivery kinetics. Making the pore
walls hydrophobic [128] will increase their affinity for nonpolar compounds, while lining
them with hydrophilic moieties will favor the adsorption of polar substances or metal
ions [129,130].
I.7.1 Functionalization through post-synthetic grafting
Figure I.14 – Post-synthetic grafting to functionalize silica surface. Reproduced from [126]
Functionalization of silica nanoparticles usually follows two main approaches: post-synthetic
grafting or co-condensation. The former method employs alkoxysilanes which react with
the silanol groups of silica surface in a condensation reaction, forming Si-O-Si links.
The most used alkoxysilane to functionalize silica nanocarriers include 3-aminopropyl
triethoxysilane (ATPS), 3-mercaptopropyl trimethoxysilane (MPTS), and various PEG-
silanes. The first two allow for easy links with other broadly used moieties such as
maleimides and isothiocyanates, while pegylation is widely used to improve biocompati-
bility and circulation times of nanoparticles in vivo (see section I.3).
It is possible to functionalize both the external surface and the inner pore surface, per-
forming the grafting reaction on a material with empty pores; this leads to a reduction
of the material porous volume and, in case of very bulky grafting molecules, can induce
pore blocking.
On the other hand, it is also possible to functionalize only the external surface of the
nanoparticles, removing the template which occupies the pores just after the grafting
reaction. With this method, and carefully avoiding template extraction by the reaction
mixture, the pores are sealed to the diffusion of grafting species and the functionalization
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takes place only on the nanoparticle outer surface. An example of the latter method is
given by Mal et al. [131], who grafted coumarin at the pore openings of MCM-41 silica,
then removed the templating surfactant by extraction and inserted cholestane molecules
in the pores. Irradiation with UV light at 310 nm induce coumarin photodimerization
and the dimers act as closing gates obstructing the pores; however irradiating with light
at 250 nm causes photocleavage of the dimers, allowing access to the pores, from which
cholestane can be released. They manage to create a photochemically controlled gating
system for tunable uptake and release.
In many cases controlled release systems involve gatekeepers, which are bulky molecules
or nanoparticles sealing the pore entrances, attached to the particle surface through cleav-
able linkers. When exposed to certain stimuli the links break, unlocking the pore access.
Following the same principle, hosted drug molecules can be linked to the pores surface
with covalent or coordinative bonds, which can be cleaved to trigger cargo release by
competitively binding molecules or reducing/oxidating agents. Platforms which react to
many different external triggers, such as temperature [132, 133], pH [134] or redox re-
actions [135, 136], have been developed. Bein and co-workers employed an interesting
method of selective functionalization of the inner and outer surfaces of MSNs, involving
multi-step co-condensation and resulting in bi-functional nanoparticles with an onion-
shell structure [137].
I.7.2 Co-condensation
Another path to obtain hybrid silica materials is the simultaneous condensation of corre-
sponding silica and organosilica precursors. The co-condensation of alkoxysilanes ((RO)4Si)
and trialkoxyorganosilanes of the type (R′O)3SiR leads to materials in which organic
residues (-R) are anchored to the pore walls [138–141]. Using this method, organic moi-
eties have usually a more homogeneous distribution than in post-grafted materials and
there’s no risk of pore blocking. However, the content of organic functionalities in the
matrix affects the mesoscopic order, leading to completely disordered materials when it is
too high, thus organic content is usually kept below 40%. In fact, increasing proportion
of (R′O)3SiR in the reaction mixture promotes homocondensation reactions instead of
co-condensation reactions with the silica precursors, changing the reaction kinetics and
influencing the material structuring process. Obviously, the removal of templating agents
should be carried out carefully, to avoid the degradation of organic moieties, thus solvent
extraction is usually chosen instead of calcination.
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(a) Co-condensation (b) PMO synthesis
Figure I.15 – Co-condensation method to obtain hybrid organo-silica, and its development to obtain
periodic mesoporous organosilica materials (PMO) employing organic bridged precursors of the type
(R′O)3SiRSi(OR′)3. PMO have organic moieties inside the silica walls, while using non-bridged precursors,
such as (R′O)3SiR the organic moieties are just anchored on the silica pore walls. Images reproduced
from [126]
Following the same approach it is also possible to obtain periodic mesoporous organosil-
icas (PMOs): a new class of mesostructured hybrid materials which have the organic
bridges integrated in the silica network, not just anchored on the pore walls [142]. PMO
materials are synthesized through hydrolysis and condensation of bridged precursors of
the type (R′O)3SiRSi(OR′)3, forming the structure reported in I.15b.
I.8 Conclusions and perspectives
Over the last 15 years, there has been extensive progress toward developing size-controlled,
multi-functional nanoparticles for biomedical applications. Several materials have been
tested and platforms which can perform more functions in the same time (diagnostic and
therapy, for example) have been developed.
Despite the impressive progresses in this field, multiple reviews have highlighted the need
for in vitro and in vivo studies examining biodistribution of NPs and their biodegrada-
tion in physiological conditions. These informations would help the design of efficient
nanocarriers, capable of reaching their target without harming healthy tissues and being
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degraded and excreted with no issue of toxicity.
Nevertheless, even if many encouraging results have been presented, the bio interactions
still need to be deeply investigated, in fact many data are collected in media that are
far too different from real biological environments, giving informations of limited utility.
On the other hand, in vivo experiments are often expensive and many parameters play a
role, making difficult for scientist to evaluate single contributions. A good way to solve
this issue is to perform in vitro experiments in conditions as close as possible to biological
ones, in order to obtain important informations which would make us able to predict
in vivo behavior of nanoparticles, limiting the expensive animal tests and inserting each
behavior in a general scheme, capable to guide nanomedicine researches.
The work conducted in this thesis follows this idea, focusing on the interaction between
mesoporous silica materials and biological environments. In particular, the study ad-
dresses the silica degradation process in physiological conditions and the parameters which
can have an influence on it.
The main goal of this study is the development of a new and rapid technique for in
situ analysis of the interface between materials and biological fluids, capable to follow
the degradation dynamics of therapeutic vectors and their drug release profile in real
biological media (serum, blood). In particular, we want to explore the dynamic nature of
bloodstream, which can affect the mechanisms of protein adsorption, particle dissolution
and drug release. To do so, ellipsometric analysis has been chosen to follow in situ
kinetics on 2D therapeutic vectors stack models. Ellipsometry is the ideal method since
it is fast, it can differentiate several layers of a stack and can be performed in liquid media.
Nevertheless, it works on thin films either than particles, so it is necessary to reproduce the
composition and the structure of the nanocarrier on a thin film. Through this approach
it is possible to address phenomena which are difficult to assess in colloidal systems.
The only difference between nanoparticles and films systems is their surface curvature,
which is important in the phenomena of protein adsorption, but its contribution can be
investigated later while important detailed informations can be obtained about the silica
bio-interfacial structure and its dynamics using in situ studies on films. The aim is to
develop a method which can be employed with a large amount of materials, to study
nearly any kind of therapeutic vector, but for the fine tune of the technique we started
employing a well-known class of nanocarriers: the mesoporous silica nanoparticles.
Thus, we produced mesostructured porous silica and hybrid organo-silica thin films and
we performed surface functionalization to provide a PEG-exposing surface (reported in
Chapter II).
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In parallel, we developed a special setup to perform in situ ellipsometry with non transpar-
ent fluids, willing to perform analysis in blood. We built a microfluidic cell and coupled it
to the sample, in order to monitor the flow influence on silica stability (Chapter IV). This
step of the project has been technically challenging, we had to find the best configuration
to work, being careful to not modify the analyzed surface during fabrication step. It is a
very complex system with many limitations which came from the ellipsometry technique,
the microfluidic cell fabrication and coupling and external factors such as temperature
control all over the setup parts.
Once the setup has been built, we analyzed mesoporous silica stability in phosphate
buffered saline solution. This step was necessary as reference to evaluate the influence of
proteins and cells on silica dissolution and it was also mandatory to compare our tech-
nique with well-established methods to ensure that it will be accurate and reproducible.
Employing phosphate buffered saline as medium, we performed analysis through an ellip-
sometric standard static liquid cell.
We could then slowly enhance the complexity of the system, adding proteins in solution
and then performing the analysis employing serum and blood as liquid media. Through
the setup developed we could finally look at the influence of flow on dissolution kinetics
in complex media (Chapter V).
The main steps of the project are summarized in figure I.16.
We developed a tool which can simulate a great amount of structures of therapeutic
vectors and evaluate their interface dynamics in biological media, obtaining data which
can be easily compared when the experiment condition are similar. The versatility of
the technique allows the exploration of many different conditions, relevant for different
applications (therapeutic vectors for cancer or lung diseases or kidney diseases). Being
able to quickly compare materials response for a given environment is crucial to bring
drug delivery nanocarriers on the market. Only in this way the fast development of new
efficient nanovectors, optimized for their function, will be possible.
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Figure I.16 – Scheme of the project developed during the thesis and its main steps.
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Chapter II
Mesostructured sol-gel silica thin
films
II.1 Sol-gel chemistry of silicates
The sol-gel method enables the processing of glasses and ceramics starting from molecular
precursors, in mild conditions (pressure, temperature) and in presence of solvent. It is
based on inorganic polymerization of molecular precursors, which are usually metal alkox-
ides of general formula M(OR)x, where M is metal and R is an organic group (alkyl, aryl).
The precursors undergo hydrolysis in presence of water and two hydrolyzed molecules
can link together in a condensation reaction, building a larger molecule and releasing a
molecule of water or alcohol.
This process can continue and build huge inorganic polymers into linear chains or three
dimensional structures, depending on the monomers functionality, turning the solution
of molecular precursors into a sol, that is a colloid in which the dispersed phase has
dimensions between 1 and 1000 nm. Depending on the nature of the precursors and on
the synthesis conditions (pH, concentration, temperature), the colloid can be constituted
of discrete particles or extend into a continuous polymer network, in the latter case it is
called a gel. Gelation can also be produced by fast evaporation of the solvent, as it happens
during the processing of films or fibers. Gels continue to condense after their formation,
during a period called aging and undergo shrinkage during drying by evaporation. The
resulting dried gel is called xerogel and is usually amorphous and porous. To obtain a
non porous material, the xerogel needs to be heated enough to cause sintering, during
this thermal treatment many materials also crystallize.
Concerning silicates gels, their synthesis is usually made through hydrolysis and conden-
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sation of silicon tetra-functional alkoxides employing a mineral acid (e.g. HCl) or a base
(e.g. NH3) as a catalyst. Alkoxides groups (OR) undergo hydrolysis producing silanol
groups (Si-OH) which condense forming siloxane bonds (Si-O-Si) plus the by-products
water or alcohol in the following reactions:
Hydrolysis
≡ Si−OR + H2O 
 ≡ Si−OH + ROH
Water condensation
Alcohol condensation
≡ Si−OR + HO− Si ≡ 
 ≡ Si−O− Si ≡ + ROH
alcoholysis
Water condensation
≡ Si−OH + HO− Si ≡ 
 ≡ Si−O− Si ≡ + H2O
Hydrolysis
Usually condensation starts before hydrolysis is complete, thus silanols can react with
other silanol groups or with alkoxides groups. Silicon alkoxydes and water are not miscible
and a mutual solvent such as alcohol is used as reaction medium, but alcohol is not
only a solvent, it can participate in the alcoholysis and condensation reactions. The
nomenclature employed has been taken from Brinker and Scherer [102].
The pH is a very important parameter in silica polymerization: in basic solutions particles
grow forming stable sols, while in acid solutions or in presence of flocculating salts they
aggregate in chains and subsequently in a tridimensional network, forming a gel. The
particles don’t aggregate at basic pH in absence of salt because their surface silanols
are ionized, making the particles mutually repulsive. The most employed precursors for
silica sol-gel synthesis are: tetraethyl orthosilicate (TEOS) and tetramethyl orthosilicate
(TMOS). In order to insert some organic function in the silica network or to reduce the
precursor functionality, some organoalkoxysilane of the type (RO)3SiR′ or (RO)2SiR′2 are
used, where R′ is a nonhydrolyzable substituent (e.g. (3-Aminopropyl)triethoxysilane
(APTES), (3-Mercaptopropyl)trimethoxysilane, (3-Chloropropyl)triethoxysilane).
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Figure II.1 – Sol-gel silica precursors.
II.2 Mesostructuration
Mesoporous silica thin films can be prepared by evaporation induced self-assembly (EISA),
in this method the solvent evaporation causes the spontaneous association of inorganic
precursors and surfactants present in solution into an organized structure.
In the case of thin films, solution is deposited onto a substrate through Chemical Liquid
Deposition methods such as spin-coating and dip-coating (this method will be discussed
deeply in the next chapter). To obtain mesoporous materials, surfactant are added to silica
precursors in solution: they will assemble in liquid crystals phases forming the template
around which the inorganic network will condensate. In fact, during deposition, the fast
evaporation of volatile components (solvent, H2O, HCl) increases the concentration of
inorganic precursors and surfactant molecules, triggering the formation of micelles, when
surfactant concentration reaches the critical micellar concentration (CMC) (figure II.2).
In a polar solvent micelles have an hydrophobic core and an hydrophilic outer part, while
in a non polar solvent the configuration is inversed. When concentration exceeds CMC and
depending on the system characteristics, surfactants can assemble in different lyotropic
phases (some are reported in figure II.2) and form periodically ordered structures with
different symmetries (figure II.3) [143,144].
Hybrid silica-surfactant mesophases spontaneously co-assemble during EISA process, and
the removal of the organic structuring agent leaves periodic mesoporous silica solids,
with pore sizes ranging from 1 to 30 nm, depending on the surfactant employed and
on the processing parameters. The structuring agents are classically ionic surfactants,
such as CTAB (Cetyltrimethylammonium Bromide, [(C16H33)N(CH3)3]Br) or nonionic
amphiphilic molecules which aggregates in micelles, bi-layers or liposomes to minimize
the exposure of their insoluble domains (hydrophilic or hydrophobic) in a given solvent.
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Figure II.2 – Micellar structures: A) sphere, B) cylinder, C) planar bilayer, D) reverse micelles, E)
bicontinuous phase, F) liposomes. Reproduced from [144]
Figure II.3 – Some possible structures of ordered mesoporous materials, including (a) 2d-hexagonal
with cylindric pores (p6mm), (b) bicontinuous cubic (Ia3¯d), (c) face-centered cubic (Fm3¯m) with spheric
pores, (d) body-centered cubic and (e) lamellar phase. Reproduced from [145]
These templating agents usually give pore size from 1.5 to 10 nm, depending on the
molecule nature and on the presence of species which can swell the micelles to enlarge their
size. The structure of the mesophase depends on the packing properties of the surfactant,
which result from several parameters such as the steric hindrance of the hydrophobic
chain, the polar head volume and charge and the volume ratio between polar and apolar
part of the molecule.
Amphiphilic block copolymers are also used as templating agents, being able to self-
assemble in different morphologies and allowing pore sizes up to several tens of nanome-
ters, due to the dimensions of the macromolecules which form large micelles. Diblock
(AB) or triblock (ABA) copolymers are generally used, in which A represents a hy-
drophilic block (often polyethylene oxide(PEO) or polyacrylic acid (PAA)) and B, a
hydrophobic block (polystyrene (PS), polypropylene oxide (PPO), or polyvinylpyridine
(PVP). Pluronic F127 (PEO106PPO70PEO106) and Pluronic P123 (PEO20PPO70PEO20)
or smaller diblock copolymers like Brij58 (C16H33 –PEO20) are commonly used.
Silica-based mesoporous materials have been obtained using CTAB-like surfactants [146–
148], nonionic amphiphilic molecules (mainly alkyl amines and alkyl poly(ethyleneoxides))
[92,93,149] and block copolymers [150].
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As extensively studied by Brinker et al. [143], during the deposition of a thin layer from a
solution, the increasing surfactant concentration drives self-assembly of silica-surfactant
hybrid micelles and their further organization into liquid crystalline mesophases. The
kinetics of inorganic polymerization and template organization should be adapted in or-
der to obtain an organized hybrid mesostructure. In fact the interaction between the
inorganic and the organic components should be fast, and the surfactant organization
has to be faster than mineral condensation. Hence, it is essential to fine-tune the reac-
tivity of the inorganic precursors playing on concentration, pH and temperature and to
control the interactions between inorganic precursors and surfactants (H-bonding, elec-
trostatic interactions) to generate a well-defined hybrid interface. Changing the initial
alcohol/water/surfactant mole ratio leads to different final mesostructures.
Nevertheless, the solution composition is not the only parameter influencing the for-
mation of different mesophases. Grosso et al. [147] reported a modulable steady state
(MSS), which lasts some minutes after the evaporation, very important to determine the
final mesostructure of inorganic thin films. In fact, in this state the mineral network is
still weakly condensed and volatile species (H2O, EtOH) equilibrate between the envi-
ronment and the film deposited, affecting the organic-inorganic interface curvature and
forming different mesophases depending on their concentration. Being able to control
relative humidity or solvent relative vapor pressure during the MSS gives control on the
mesostructure organization.
Aging and/or thermal annealing stabilize the structure and condense the inorganic net-
work. High temperature thermal treatments or solvent extraction are employed later to
remove the surfactant. The whole process of thin films mesostructuration by EISA during
dip-coating deposition is summarized in figure II.4.
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Figure II.4 – Mesostructuration of thin films during dip-coating: the initial sol is isotropic, then the
evaporation triggers the surfactant self-assembly to form micelles (C ≥ CMC), stabilized by the inorganic
network which condenses around them. In the MSS the network isn’t stiff yet and exchange H2O and
solvent with the environment, varying the organization of mesostructures. In the case of silica, after
some minutes the inorganic network is strongly condensed and the mesostructure is fixed. Reproduced
from [147]
II.3 Dip-Coating
Sol-gel derived thin films are applied on the substrates by Chemical Liquid Deposition
(CLD) techniques and the conditions employed during this step determine the structure of
the layer, as discussed previously. In fact, during deposition, inorganic condensation and
self-assembly take place, triggered by the fast evaporation of the solvent. Moreover, the
deposition conditions influence the final thickness of the film (this aspect will be detailed
in the next Chapter). One of the most widely used techniques of CLD is dip-coating.
The dip-coating technique is the simplest method to deposit a thin layer from a solution:
the substrate is immersed into the liquid and then retrieved vertically at constant speed,
causing the deposition of a layer of solution. The physical chemistry involved in this
process is pretty complex and have been deeply investigated.
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A first model was proposed by Landau and Levich [151] in 1942 for newtonian and non-
volatile systems, taking into account the balance between the adhesion of the fluid to the
substrate and the viscous drag induced by gravity. Other studies have been conducted to
enlarge the application field of Landau-Levich model to more complex systems, such as
sol-gel ones. In these systems the forming layer undergoes continuous polymerization at
increasing rate due to the fast solvent evaporation, experiencing a dramatic increase of
the viscosity due to non-volatile components concentration.
This technique has been the object of an extensive investigation which is reported in the
next chapter. In fact, in the context of this project, it was necessary to properly master
the thickness of the silica layer in order to mimic the structure of therapeutic vectors
and to easily compare dissolution data. While performing dip-coating to obtain sol-gel
silica thin films, we noticed severe reproducibility issues and we decided to address them
with a dedicated study, discovering an important influence of the surrounding atmosphere
during the dip-coating process, on the films final thickness.
II.4 Surface functionalization
In order to reproduce the structure of particle nanocarriers on thin films as close as
possible, it is necessary to functionalize their surface. In fact, silica nanoparticles are
almost never introduced in the body as they are, but they often carry different types of
surface moieties, as seen in chapter I. In particular, grafting a hydrophilic polymer on the
surface is a widely used functionalization for biomedical devices.
Nanoparticles for drug delivery are very often covered with poly(ethylene glycol) (PEG)
because of its ability to prevent protein adsorption, hiding the particles from the immune
system [152]. Moreover, PEG is biocompatible and not toxic, and it has shown ability
to greatly improve the in vivo half-life of nanoparticles. Thus, many processes have been
developed to create PEG-exposing surfaces. On gold, PEG is usually grafted through
thiols binding [153], while on silica and silicon substrates, organosilanes such as amino-
or mercapto-trimethoxysilane are employed [154,155].
If pegylation through organosilanes is common on silica nanoparticles, we experienced
difficulties in performing it on silica thin films. In fact, either in vapors or in solution we
never obtained an homogeneous layer of polymer on the surface. When a surface modifi-
cation was evident on the silica films, it was always very irregular and full of defects across
the substrate. Thus we turned toward surface-tethered polymers obtained by a controlled
grafting-from technique, such as atom-transfer radical polymerization (ATRP). In the
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literature there are some works discussing the growth of polymer brushes on a substrate
from aqueous solutions [156,157]. Nevertheless, in our case, water could not be the solvent
of reaction, because mesoporous silica films dissolve fast in aqueous environment. Thus,
we investigated the optimal conditions to perform ATRP on mesoporous silica thin films,
grafting pegylated polymer brushes onto the surface.
The work presented here on surface functionalization has been conducted in collaboration
with Dr. Juan Martin Giussi and Dr. Omar Azzaroni and performed at Instituto de
Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Universidad Nacional de
La Plata – CONICET, La Plata, Argentina.
II.4.1 Atom-transfer radical polymerization
Atom-transfer radical polymerization is a form of living polymerization, that is a reaction
in which the chain growth proceeds in absence of chain termination and chain transfer
reactions. Usually the rate of chain initiation is fast compared to the rate of chain prop-
agation, resulting in a constant chain growth rate and a very low polydispersity index
(chain lengths are all very similar). Living polymerizations are important in materi-
als synthesis because they offer polymers with a well controlled molecular weight and
dispersity. Living polymerizations can be anionic, cationic or ring-opening polymeriza-
tions. Recently, starting from the 1970s, have been developed several methods of living
polymerization which use free radical chemistry. Living radical polymerization is usually
defined as controlled radical polymerization (CRP) because chain termination pathways
are minimized but not completely absent [158].
CRP methods are based on developing a dynamic equilibrium between an active prop-
agating radical and a dormant species. In ATRP dormant species are alkyl halides and
propagating radical undergoes an activation/deactivation process with a persistent radi-
cal, which cannot propagate. More in details, the active radicals are generated through a
reversible redox reaction catalyzed by a transition metal complex (Mn −Y/Ligand where
Y can be the counterion or another ligand) undergoing a one-electron oxidation. The oxi-
dation of the metal complex causes the abstraction of an halogen atom X from a dormant
species R-X, generating a radical R·. This reversible process has its own activation and
deactivation rates with associate constants kact and kdeact respectively. Polymer chains
grow from R· through addition of monomers, similar to a free radical polymerization,
with rate constant of propagation kp. Termination reactions occurs in ATRP, mainly
through radical coupling, however under appropriate conditions only a few percent of the
polymer chains undergo termination and these radical polymerizations behave as nearly
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living systems. Typically, less than 5% of the total growing chains terminates during the
initial stage of polymerization.
This process generates oxidized metal complexes, X−Mn+1, as persistent radicals, mean-
ing that they don’t self-terminate and they don’t propagate. In fact, the persistent radicals
do not react among themselves, but they may couple with the propagating radicals R· in
the reverse process (deactivation reaction). On the other hand, R· do not only react with
the oxidized metal complex but they also undergo irreversible self-termination through
coupling with another R·. Hence, any occurrence of the self-termination of the active
radicals induces an excess of the persistent species, which increases continuously as time
passes. Therefore, the reaction of the propagating radicals R· with the persistent radicals
is more and more favored compared to the self-termination, becoming highly dominant.
A scheme of ATRP mechanism is reported in figure II.5.
Figure II.5 – General scheme of atom-transfer radical polymerization, mediated by a transition metal
complex Mn −Y/Ligand and a dormant species R-X where X is an halogen atom.
A successful ATRP will have a small contribution of terminated chains, but also a uniform
growth of all the chains, which is accomplished through fast initiation and rapid reversible
deactivation. ATRP needs several components: monomer, an initiator with a transfer-
able halogen and a catalyst, which is a transition metal complex. Typical monomers
are styrenes, methacrylates, methacrylamides, and acrylonitrile. Each monomer has its
own atom transfer equilibrium constant Keq for its active and dormant species, which
determines the polymerization rate (Keq = kact/kdeact). If the equilibrium constant is too
small, polymerization will not occur or will occur very slowly . In contrast, too large Keq
will lead to a a high radical concentration and consequent large amount of termination.
In these conditions a high amount of deactivating metal complex is present, which shifts
the equilibrium towards dormant species, making the polymerization slower.
Initiators should provide a fast initiation and, because transfer and termination reactions
are negligible, the number of growing chains will be constant and dependent on the
initiator concentration. In ATRP, alkyl halides (RX) are typically used as initiators with
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the halide group being bromine or chlorine, to assure a rapid and selective migration
between the growing chain and the transition-metal complex. Iodine can also work well
for acrylate polymerizations but fluorine is not used because the C-F bond is too strong
to undergo homolytic cleavage.
The key component of ATRP is probably the catalyst. The metal center should have
affinity toward a halogen and its coordination sphere should be capable to selectively
accommodate a halogen atom upon oxidation. Various rhutenium and iron complexes
have been successfully employed in ATRP, as well as nickel, palladium and copper com-
plexes [158].
II.4.2 Growing PEGylated polymer brushes on silica thin films
Amethod to create protein resistant surfaces based on poly(oligo(ethylene glycol) methacry-
late brushes (p(OEGMA)) was presented by Chilkoti [159] and extended by Brown and
co-workers [160]. These brushes exhibit the same surface properties than self-assembled
monolayers containing ethylene glycol moieties, being also mechanically and chemically
robust. Moreover, through ATRP it is easier to grow co-polymers feeding mixed monomers
for polymerization. In this way, it will be possible to introduce on the brushes specific
binding sites. We applied the procedure reported by Brown, testing the better conditions
for our system. The target density is a brush of a few tens of nm, capable to strongly
change the surface properties of the silica layers. The difficulties are: performing the
reaction in a solvent different than water and avoiding the pore blocking. In fact, usually
this procedure is carried on in water, but mesoporous silica undergoes fast dissolution in
aqueous environments, so it is mandatory to find another solvent. Ideally, the polymer
brushes are grown on the surface leaving the porosity accessible, but this is not an easy
result to obtain. The initiator is grafted on amine moieties, that are uniformly dispersed
in the silica matrix. Thus, they are also present onto the pore surface; polymer brushes
may grow in the pores and, if they are long enough, they can block the access to the
porous network. Probably the easiest way to avoid pore obstruction is to have very short
brushes (few nm) which can still provide peculiar surface properties to silica without
blocking the pores.
Initiator grafting
As initiator α-Bromoisobutyryl bromide has been chosen, to be grafted on amine moieties.
Thus, the choice was either to post-functionalize silica with (3-Aminopropyl)triethoxysilane
(APTES) introducing amine groups or co-condensate APTES and TEOS and obtain hy-
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Figure II.6 – Scheme of the growth of pegylated polymer brushes on a silica surface exposing amine
moieties. a) In a first step the atrp initiator reacts with the amines on the surface, forming the sites from
which polymerization, catalyzed by a metallic complex, will start. b) Polymer brushes are grown from
acrylates monomers, bringing poly (ethylen glycol) as side chains.
brid silica bringing amines. Because post-functionalization with APTES could lead to
pore blocking in the mesoporous silica material, we chose to employ co-condensation in
order to obtain hybrid mesoporous silica exposing amine moieties. The employed sol
composition is reported in table II.1 and samples were dip-coated on silicon or glass sub-
strates (2 mm·s−1, RH=35 %, T=21◦ C) to obtain mesoporous layers of about 120 nm
of thickness. Hexadecyltrimethylammonium bromide (CTAB) was used as templating
agent. After deposition the films were stabilized 1 night at 130 ◦C and washed in Ethanol
to remove the templating surfactant.
Table II.1 – Composition of mesoporous hybrid silica sol.
Molar ratio TEOS APTES HCl H2O Ethanol CTAB
Hybrid silica 0.85 0.15 0.09 5 40 0.14
The ATRP initiator α-Bromoisobutyryl bromide is grafted on the surface of silica films
in anhydrous conditions, it is thus important to dry glassware and samples in oven at
57
Chapter II. Mesostructured sol-gel silica thin films
120 ◦C for 15 minutes before starting the reaction. Under nitrogen flow, samples are
placed in anhydrous tetrahydrofuran (THF) and triethyl amine is added, to activate the
substitution and neutralize the formed HBr. The initiator α-Bromoisobutyryl bromide
is added at 0 ◦C and under N2 flow. The samples are then kept under nitrogen at r.t.
overnight. The work-up is done the day after, scavenging residual radicals by adding
30 mL of ethanol and then washing the samples in ethanol. The static contact angle of
water on the surface passes from θ = 15◦ before the reaction to θ = 49◦ after the initiator
grafting.
Table II.2 – Experimental conditions of α-Bromoisobutyryl bromide grafting on 30 cm2
of total surface.
MW (g/mol) mmol g d (g/mL) mL
α-Bromoisobutyryl bromide 229.90 15 3.448 1.86 1.86
Triethyl amine 101.19 15 1.518 0.726 2.10
THF anhydrous 60
The success of the grafting reaction has also been confirmed by the presence of Br centers
on the surface through X-ray photoelectron spectroscopy (XPS) analysis (figure II.7b and
II.8g). The peak of bromine (3d orbital level), centered at 70.4 eV, appeared after the
grafting reaction, while it was absent in the aminated silica analysis (figure II.7a). The
second bromine peak, centered at 68.3 eV is attributed to bromide ions Br-, which are
formed during the analysis. Bromine peaks show spin orbit splitting, as every orbital
level except 1s does. For 3d orbital level, two possible spin states are possible (j = 3/2
and 5/2) and they have different binding energies. The 3d3/2 and 3d5/2 doublet has a 2:3
peak area ratio.
After the grafting reaction, the Br/N ratio, obtained from XPS data, is 0.48, meaning
that the reaction takes place on half of the amine moieties. This could be due to the fact
that not all the amines were available for the grafting reaction, some may be embedded
in the silica walls or not accessible because of closed pores. Moreover, amines grafted on
silica surface can interact through hydrogen bonding with -OH group and the proton can
eventually be transferred on the amine, forming a ion pair NH+3 SiO−. This two forms of
the amine groups are most probably in equilibrium, as reported by Graf et al. [161] but
anyway, they are not good nucleophiles for the reaction with α-Bromoisobutyryl bromide,
because their lone pair of electrons is involved in the interaction with silanols.
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(a)
(b)
(c)
Figure II.7 – XPS survey spectra of hybrid aminated silica (a) pristine, (b) after the α-Bromoisobutyryl
bromide initiator grafting, and (c) after ATRP reaction using PEGMA as monomer. The atomic percents
reported include carbon, thus they contain an error which is due to contamination by adventitious carbon.
In fact, a thin layer of carbonaceous material is usually found on the surface of every air exposed sample.
The contribution of this contamination layer can’t be removed and it is not constant for every sample,
thus we will mainly employ atomic percent ratio between elements to compare samples, and not absolute
atomic percent.
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(a) Carbon 1s (b) Nitrogen 1s
(c) Carbon 1s (d) Nitrogen 1s
(e) Carbon 1s (f) Nitrogen 1s
(g) Bromine 3d (h) Bromine 3d
Figure II.8 – Lorentzian distribution fitting curve of C1s and N1s peaks for thin films of (a-b) hybrid
aminated silica, (c-d) α-Bromoisobutyryl bromide grafted silica, and (e-f) silica with PEGMA brushes.
The bromine Br3d peaks of (g) α-Bromoisobutyryl bromide grafted silica and (h) silica grafted with
PEGMA brushes are also reported.
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Surface initiated polymerization
The ATRP was catalyzed by a copper complex with 2,2’-dipyridyl (bipy) as ligand. The
polymerizations were carried out in methanol or in mixtures of methanol and water with
a percentage of water not higher than 20% v/v. Three methacrylate monomers, car-
rying poly(ethylen glycol) as side chain have been tested. We used both poly(ethylen
glycol) methacrylate and its methyl ether, obtaining very similar results. In the case
of poly(ethylen glycol) methyl ether methacrylate, two different molecular weights (MW
= 500 and MW = 950) have been investigated, because chain length may influence the
grafting density and the length of the brushes. In fact, longer chains can have a huge
steric hindrance which favors shorter brushes and a lower grafting density. The structure
of monomers and initiator employed are reported in figure II.9.
Figure II.9 – Molecular structures of the monomers (a-c) and the initiator (d) employed in the atrp
reactions to graft pegylated polymer brushes on silica surface.
61
Chapter II. Mesostructured sol-gel silica thin films
Monomer was dissolved in solvents (70 mL) at room temperature and degassed by passing
a continuous stream of dry N2 through the solution whilst being stirred (30 min). To this
solution was added in succession bipy (1.65 mmol), CuIICl2 (0.07 mmol) and CuICl (0.7
mmol) to form the catalyst complex. The addition of a small amount of Cu(II) halides
at the beginning of the polymerization reduces the proportion of terminated chains and
helps fast establishment of the atom transfer equilibrium [158]. After every addition, the
mixture was further stirred and degassed with a stream of dry N2 for 15 min. Sepa-
rately, initiator coated samples (10 cm2 each) were sealed in Schlenk tubes, degassed (5 ·
high-vacuum pump/N2 refill cycles) and kept under N2 atmosphere. The polymerization
solution was then syringed into each Schlenk tube, submerging each sample completely.
After various polymerization times the samples were removed, washed with methanol,
then with ethanol and dried.
Polymerizations under different conditions were carried out following the above procedure,
changing the monomer, reaction times and solvent. The different experimental conditions
used are listed in table II.3 and are referred to throughout the text. A scheme of the
surface initiated polymerization was given in figure II.6.
Table II.3 – Experimental conditions of ATRP reactions, for 30 cm2 of total surface
Monomer Solvent Time (hours) Thickness (nm) θ(◦)
DEGMA ME* MeOH 1.5 1-2 44
DEGMA ME MeOH 24 35 39
DEGMA ME MeOH/H2O 80:20 1.5 1-2 39
DEGMA ME MeOH/H2O 80:20 24 60 39
PEGMA ME (500 MW) MeOH 24 - 49-50
PEGMA ME (500 MW) MeOH 72 - 49-50
PEGMA ME (500 MW) MeOH/H2O 80:20 72 10 35-41
PEGMA ME (950 MW) MeOH 72 - 49-50
PEGMA ME (950 MW) MeOH/H2O 80:20 24 5 22-27
PEGMA (500 MW) MeOH/H2O 80:20 72 1-5 41
* ME= Methyl ether.
The reaction times control the length of the polymer brushes: using DEGMA methyl
ether as monomer, we observed that after 1.5 hours the reaction didn’t produce a uniform
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monolayer of polymer on the surface, even if brushes started to grow.
In fact, the contact angle θ decreases in comparison to the sample with only the initiator
grafted (θ = 49-50◦) but it’s not possible to establish the thickness of the brushes by
ellipsometry because they are probably very short (1-2 nm) and these values are in the
range of thickness fluctuation of the sample. Performing the reaction for longer times
(24h) the brushes grow more and ellipsometry measured their thickness as more or less 35
nm. In this case θ further decreased to 39◦. Adding a percentage of water in the solvent
helps the polymerization, giving longer brushes for the same reaction time.
Using PEGMA methyl ether as monomer the mixture methanol/water as solvent became
mandatory. In fact, in this case the catalyst-monomer complex is not stable in methanol
and a green precipitate of copper salts is observed at the bottom of the Schlenk tubes at
the very beginning of the reaction. Thus, polymerization does not occur in this solvent.
Adding the 20% of water the polymerization takes place with no issues, covering the silica
surface with polymer brushes with length between 5 and 10 nm. When the monomer
employed had a lower molecular weight the brushes grew longer, while increasing MW
leads to shorter brushes but a more hydrophilic surface (contact angle passes from θ =
35-41◦ to θ = 22-27◦), as summarized in table II.3.
Contact angles were consistent with that reported in literature for ethylene glycol coated
surfaces [160] and very similar to values of ethylene glycol monolayers [153]. In fact,
employing PEGMAmethyl ether with MW= 950, the contact angle on the surface reaches
the smaller values obtained for ethylene glycol monolayers (θ = 22-27◦ compared to θ =
22-25◦ for the monolayers). Using the other monomers we found θ values around 40◦,
observing a clear dependence on molecular weight of monomer for reactions performed in
the same conditions. In particular, comparing PEGMA methyl ether polymerizations we
noticed a decrease in static contact angle for higher MW.
The XPS analysis (figure II.7 and II.8) confirms the successful grafting of the polymer
brushes. The C/Si ratio passed from 1.30 (hybrid aminated silica sample, figure II.7a) to
1.62 after the initiator grafting (figure II.7b) and reaches a value of 21.1 after the ATRP
reaction (figure II.7c). Looking at the carbon signals (figure II.8) we can see an important
increase of the C-O bond peak centered at 286.3 eV, after the ATRP (figure II.8e), due
to the PEG chains. The other peaks of carbon are those of C-C (284.9 eV) and of C=O
(288.2 eV). All these moieties are present in initiator-grafted and PEGMA-grafted silica
samples. Nevertheless, we can observe them even in the pristine aminated silica sample,
which should show only the C-C functionality. This is due to an inevitable contamination
by adventitious carbon. In fact, every sample which has been exposed to air, even for
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very short times, presents a thin layer of carbonaceous materials. This layer is known as
adventitious carbon and generally includes a variety of hydrocarbons species with small
amounts of both C-O and C=O bonds (286.3 and 288.2 eV, respectively), producing a
main peak of C-C bonds at 284.9 eV. In our case, the contribution of this contamination
layer to the carbon signal can’t be separated from the sample contribution. A reference
sample without carbon can’t be used to evaluate the contamination percent because it
can’t be assumed constant for every sample. Thus, to compare different samples it will
be used an atomic percent ratio between elements and not absolute atomic percents.
The ratio between carbon and silicon increased so abruptly after the polymerization that
it’s not possible to doubt about the increased presence of carbon atoms on the sample. It
has to be pointed out that XPS is a surface technique and it gives information on the first
10 nm below the surface. With a polymeric surface layer of some nm, silicon atoms are
masked and the amount of silicon seen by the instrument results much lower than before
the polymer grafting.
It is also interesting to observe the nitrogen signal (figure II.8b, II.8d and II.8f). In the
hybrid aminated silica sample and in the initiator-grafted sample (figures II.8b and II.8d
respectively) the N signal presents two peaks: the main one is the primary amine NH2
signal at 400 eV. There is also another peak, centered at 402 eV which is attributed to hy-
drogen bonded or protonated nitrogen, as already reported [161]. Aminosilane molecules
may form hydrogen bonds with silanol groups while bending down toward the surface
and they may undergo protonation, being in a tautomeric equilibrium as illustrated in
figure II.10. This chemical state of nitrogen originates the signal observed at 402 eV.
When the amines become hindered by the presence of the polymer brush, we observe the
disappearance of this peak (figure II.8f).
Figure II.10 – Free amines from aminosilane groups can form an hydrogen bond with surface silanol
groups, establishing a tautomeric equilibrium between the hydrogen bonded nitrogen and the protonated
nitrogen. Reproduced from [161].
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From atomic force microscopy (AFM) II.11 and scanning-electron microscopy (SEM) II.12
images we can see a smoother surface when polymer brushes have grown compared to
bare silica surface.
Figure II.11 – Atomic force microscopy images of: a) Mesoporous silica exposing NH2 moieties, before
polymer growth b) Surface coated with polymer brushes, PEGMA methyl ether MW 500 c) surface
coated with polymer brushes, PEGMA methyl ether MW 950. These images have been obtained in
tapping mode in nitrogen and the analysis has been performed by Catalina von Bilderling, researcher at
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Universidad Nacional de La
Plata – CONICET, La Plata, Argentina.
Figure II.12 – Scanning electron microscopy images of: (a-b) Mesoporous silica exposing NH2 moieties,
before ATRP reaction (c-d) Mesoporous silica surface coated with polymer brushes, PEGMA MW 500.
Thus, we can infer that p(OEGMA) brushes could have blocked the pores, at least in the
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superficial layer of the silica film. This hypothesis has been confirmed by Environmen-
tal Ellipsometric Porosimetry (see section II.5.2 below), in which the surface-PEGylated
samples doesn’t show the typical curve of mesoporous materials, their pores remaining
unaccessible to water vapors (figure II.13). Anyway, by transmission electron microscopy
(TEM) we can see pores in these functionalized thin films, meaning that the film con-
served its mesostructure. This is a great result, demonstrating that the little quantity
of water we had to add in the reaction mixture didn’t alter the mesostructure through
dissolution. Anyway, we aren’t able to say if the polymer brushes only block the pores
on the surface of the sample, but not through its overall thickness or if the pores are
completely full, because the optical contrast on carbon atoms is poor in TEM analysis
(figure II.14).
Thus, when analyzing the dissolution of these hybrid silica films (chapter V) we must also
consider a barrier effect to water penetration, due to the occluded pores on the surface.
This effect will overlap the contribution of polymer brushes functionalization, but it was
not possible to eliminate it. In fact, to avoid blocking the pores it would be necessary to
graft polymers only on the external film surface and not on the inner surface of pores.
Thus, ATRP initiator should be grafted only on the external surface, carrying out the
reaction with pores still full of surfactant, to minimize the possibility of grafting inside
the pores. These procedure could take months to be optimized and, because it was not
the main subject of this work, we didn’t develop it any further.
For future perspectives, it would be interesting to obtain similar PEGylated silica thin
films, functionalized only on the external surface. Then, it will be possible to study how
much of the brushes impact on dissolution is due to the reduction of exposed surface,
caused by the pore blocking.
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Figure II.13 – Refractive index at 632 nm of a PEGMA-coated silica film vs P/P0 of water for the
adsorption-desorption cycle. The steep change of refractive index associated with capillary condensation
is absent, meaning that pores are not accessible to water vapors.
Figure II.14 – Transmission electron microscopy images of: (a-b) Mesoporous silica exposing NH2
moieties; (c-d) Mesoporous silica coated with polymer brushes, PEGMA MW 500. The PEGylated
sample appears still mesostructured.
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II.5 Thin films characterization
II.5.1 Variable Angle Spectroscopic Ellipsometry
The refractive index and the thickness of final films were measured, after the stabilizing
thermal treatment, by spectroscopic ellipsometry performed on a UV-IR (193 1690 nm)
variable angle spectroscopic ellipsometer (VASE) M2000DI from Woollam. Measurment
were performed at an incidence angle of 70◦, and the data analysis was performed with
the CompleteEASE software.
Ellipsometry is an optical technique based on the fact that a polarized light wave change
its polarization state when reflected by a surface. This change depends from the optical
properties of the reflecting material, which can be extrapolated from the ellipsometric
measurement, along with its thickness. This can be done through an optical dispersion
model of the analyzed film, whom parameters are varied to match as closely as possible
the experimental data. For dielectric transparent materials, the most common employed
model is a Cauchy dispersion, described by the equation:
n = A+ B
λ2
(II.1)
where A and B are the variable parameters and n is the refractive index. This is the
model employed, during ellipsometric analysis, to describe the silica and hybrid silica
films prepared in this thesis, deposed on silicon or glass substrates.
The basis of ellipsometry and its mechanism will be extensively treated in chapter IV.
II.5.2 Environmental Ellipsometric Porosimetry
Environmental Ellipsometric Porosimetry (EEP) is a characterization technique for thin
porous films which has gained more and more importance. It monitors in situ gas sorp-
tion within the film, through which it is possible to evaluate open porosity, pore radius
distribution and the film backbone refractive index [162,163].
Thin porous films cannot be considered as a completely homogeneous material, in fact they
alternate the backbone material with empty volume (pores). Therefore, Effective Medium
Approximations (EMA) models can be applied to calculate the porous volume of the layer.
EMA treats the optical layer properties as a mix of the properties of its constituents,
considering the respective volume fractions. The Bruggemann-EMA is frequently used,
which allowed the determination of the relative volumetric fractions fA and fB of two
materials A and B of known dielectric constants ˜A and ˜B within a volume unit of
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Figure II.15 – Experimental setup employed in environmental ellipsometric porosimetry, reproduced
from [162]
measured dielectric constant ˜. This equation is very accurate for a two component
system:
fA
˜A − ˜
˜A + 2˜
+ fB
˜B − ˜
˜A + 2˜
(II.2)
Thus, the dielectric constant of the porous film ˜ is measured by ellipsometry under dry
air atmosphere: the dielectric function in the pores ˜A equals to the one of dry air and
the walls have a known ˜B, previously measured on a dense film of the same material.
The porous volume Vp of the mesoporous thin layer is determined with the Bruggerman
EMA by fitting the volumetric fractions of air fA and of the matrix fB within the meso-
porous film. Flowing wet air in the atmosphere, water adsorbs in the pores forming a
multi-layer coverage, until water capillary condensation. The Kelvin equation:
RT ln P
P0
= −γVL cos θG
rm
(II.3)
where P/P0 is the partial pressure, assumed equal to atmospheric relative humidity RH,
gives the value of P/P0 for which water condenses inside the pores, in a process called
capillary condensation. When P/P0=1 the pores are completely full of liquid water. In the
Kelvin equation γ is the surface tension, VL is the molar volume of water, θ is the wetting
angle and rm is the curvature radius of the liquid/vapor interface. G is a geometric factor
accounting for the pores shape, it has a value of 2 for a sphere and 1 for a cylinder. The
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geometric factor can be calculated also for elliptic pores, knowing their anisotropy factor,
as reported by Boissière et al. [162].
Figure II.16 – Representation of sorption isotherms and scheme of respective situation in the pore
system. The capillary condensation corresponds to phase 3. Adapted from [163].
In a smaller pore rm is small, so P/P0 is small, in fact capillary condensation happens
first in smaller pores. It is to mention that the measured radius rm is not exactly equal
to the pore radius since the capillary condensation occurs only after the adsorption of a
water layer completely covering the pore walls. The thickness t of this deposit can be
measured on non-porous samples of the analyzed material. And the pore radius r can be
calculated as follows: r = rm + t.
The evolution of film refractive index n and thickness d as a function of the environ-
mental relative humidity (RH =P/P0), are measured by EEP. In this way the capillary
condensation pressure P/P0 is measured and the pore radius distribution can be obtained.
Registered isotherms will present hysteresis, meaning that two different values of P/P0
are associated with adsorption and desorption.
Hysteresis is originated from the fact that the interface curvature is not the same at
adsorption and desorption, in fact, after capillary condensation a liquid meniscus is formed
inside the pores, and it has a different curvature compared to the starting adsorbed layer.
Thus, the desorption curve is shifted towards smaller P/P0.
Another reason that causes hysteresis in the porosimetry curves is that in many cases
the access to larger pores is limited by smaller pores and they are not drained until the
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Figure II.17 – Evolutions of refractive index n of CT130, CT450, F450 films as a function of P/P0
of water adsorption-desorption cycle. All the films reported are mesoporous silica films, templated with
CTAB (CT130 and CT450) or with Pluronic F-127 (F450). They have been thermally treated at 130 ◦C
or 450 ◦C, as indicated in their identification name.
desorption condition of the bottleneck is met. Then both the neck and the large pore
are rapidly emptied. From the desorption isotherm it is thus possible to obtain the pore
radius of the restrictions that access the larger cavities, also called bottlenecks.
The condensation into pores induces capillary forces, which trigger a shrinkage of the
film network during adsorption and desorption, both reversible. Based on these data
the mechanical properties of the porous film network can be calculated, as reported by
Boissière et al. [162].
From EEP data it is possible to obtain surface area values using a t-plot analysis (figure
II.19). In fact surface area S can be obtained from the measurement of slopes β of the
t-plot curve, with equation II.4.
Stot = Sext
βtot
βext
(II.4)
External surface area is known. This method had an uncertainty (about 20-40%) because
the βext value is always very small for films and thus difficult to measure with a good
accuracy. Anyway, it is a good option to estimate total surface area when geometric cal-
culation from the total mesoporous volume and mesopores dimensions is not possible. In
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Figure II.18 – Evolution of film thickness of a mesostructured silica film, as a function of P/P0. The
capillary contraction due to condensation and the relaxation due to water desorption are clearly visible.
fact, this calculation required the knowledge of the mean number of connections between
pores and when several pore environments exist or when the porous network hasn’t an
ordered structure, it can’t be used. The values of t at each partial pressure P/P0 have
been previously measured by ellipsometry on a dense silica layer.
Figure II.19 – Plot of the adsorbed water volume as a function of water layer thickness t (in angstroms).
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II.5.3 Small-angle X-ray scattering (SAXS)
Grazing incidence small-angle X-ray scattering has been performed on silica thin layers to
check their mesostructures. The GI-SAXS experiments have been performed by Pierre-
Antoine Albouy, researcher at Laboratoire de Physique des Solides, Université Paris Sud
(Orsay, France).
The mesostructuration of thin films obtained through Evaporation Induced Self Assem-
bly depends on several chemical and processing parameters, as previously explained (see
sections II.2 and II.3). In a very detailed study, Grosso et al. analyzed the mechanisms
involved in the mesostructuring process during EISA, performing SAXS experiments in
situ [147]. They pointed out that the final mesostructure is achieved during the modulable
steady state (MSS) where the film is exchanging volatile components with its environment
before fixing its composition. So, the initial chemical composition of the sol is one of the
parameters which defines the final material mesostructure, along with temperature and
vapor pressures around the sample during deposition. In fact, these two processing pa-
rameters modulate the content of volatile species (water, ethanol) in the wet film during
its equilibration with the environment.
Thus, at a given temperature, playing on precursor/surfactant ratio and relative humidity
during the deposition step, one can obtain different mesostructures in a reproducible way.
For the silica thin layers studied in this thesis, we had a Pm3n cubic structure on pure
silica films obtained with TEOS as silicon precursor and CTAB as templating surfactant,
with a molar ratio CTAB/Si = 0.14 (figure II.20 a). These films were dip-coated at 26
◦C with a relative humidity of 30-35 % in the atmosphere. The obtained structure is
consistent with the results reported by Grosso et al. in their study [147].
In the same processing conditions (T = 26 ◦C, RH = 30-35 %) the hybrid silica films,
obtained through co-condensation of TEOS and APTES (molar ratio 0.85:0.15) with
CTAB as template, self-organize in disordered structures (figure II.20 b). The system of
TEOS/Pluronic F127, with a molar ratio F127/Si = 0.005, dip-coated at T = 26 ◦C and
RH = 35-40 % forms a p6m 2D-hexagonal structure (figure II.20 c).
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Figure II.20 – Saxs patterns and the related mesostructures obtained: a) Mesoporous silica, CTAB
templated, CTAB/Si molar ratio = 0.14 b) Hybrid mesoporous silica exposing NH2 moieties, CTAB
templated, CTAB/Si molar ratio = 0.14 c) Mesoporous silica, Pluronic F127 templated, F127/Si molar
ratio = 0.005. The films have been obtained by dip-coating from solution at 26 ◦C and 30-35 % relative
humidity for CTAB systems and 35-40 % RH for Pluronic F127 system.
II.5.4 Scanning-electron microscopy (SEM) and Transmission Electron
microscopy (TEM)
The SEM images presented in this thesis are made on a Hitachi SU-700 operated by Mr.
David Montero, research engineer at the Institut des Matériaux de Paris Centre from the
Université Pierre et Marie Curie (Paris, France).
The TEM images are made on a Cryomicroscope Tecnai spirit G2, operated by Mr.
Patrick LeGriel, at Laboratoire Chimie de la Matière Condensée de Paris from Université
Pierre et Marie Curie.
II.5.5 X-ray photoelectron spectroscopy (XPS)
In order to study the chemical composition of thin films surfaces, XPS has been performed
on samples. The XPS experiments have been performed by Christophe Méthiviers at
Institut des Matériaux de Paris Centre (IMPC) from the Université Pierre et Marie Curie
(Paris, France) on a spectrometer by Omicron Scienta.
Kinetic energies of electrons are measured through an Argus hemispheric analyzer. The
XPS analyses were carried out using a monochromatic Al K(α) source (1486.6 eV, 300 W).
XPS probes the surface of the sample to a depth of 5-10 nanometres, and has detection
limits ranging from 0.1 to 0.5 atomic percent depending on the element. The instrument
was calibrated to give a binding energy (BE) of 103.3 eV for the Si 2p corresponding to
Si in SiO2 samples. An electron gun (1 eV, 5 mA) was used on all specimens as charge
neutralizer system. Peak fitting of XPS spectra was performed with CasaXPS.
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Study of dip-coating deposition
process
Dip-coating from solution is a widely used method to deposit both organic and inorganic
thin films onto various substrates. With this liquid-coating process, a homogeneous layer
is easily spread onto the substrate surface and the solvent evaporation leads to the for-
mation of a solid film with good control of its structure and thickness. In this thesis we
always used dip-coating as deposition technique since it is simple and it was previously
extensively studied in our laboratory, to control several important parameters.
Nevertheless, we often noticed a lack of reproducibility in certain conditions, particularly
when exploiting a withdrawal speed regime so-called "capillarity regime" (it will be de-
scribed later in this chapter). Particularly, we noticed important thickness fluctuations
of films deposited at the same temperature and humidity. Thus, we decided to conduct a
systematic study, in parallel with the main subject of the thesis, to address this issues and
understand their origins. The results of this study are reported in this chapter and have
been published recently [164]. The mastering of the technique was required to prepare
thin mesoporous silica layers of very well controlled thickness, which will be shown in
next chapters. The effect of solvent relative pressure around the meniscus on final thick-
ness was deeply investigated, identifying some parameters which can affect it. We found
that the solvent evaporation rate is not constant but strongly depends on the geometric
configuration of the dip-coating experiment. The first part of the chapter is dedicated to
a general study of physico-chemical phenomena involved, while the last part is focused
on exploiting the effect of solvent relative vapor pressure to provide a very good control
on layer thickness or to obtain giant thickness gradient profiles.
We carried on this investigation for various solutions (of sol gel or polymer) and found that
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they all stick to a general common trend. The as-dipped sol-gel films were then stabilized
by thermal treatment and the final thickness h0 and refractive index n were measured
by spectroscopic ellipsometry. Polymer films and colloid films were not thermally treated
before measurement.
III.1 Fundamentals of dip-coating
The first description of draining and dragging phenomena involved in dip-coating was
published in 1942, for polymeric systems, by Landau and Levich (LL) [151], who built a
theoretical model to describe the film formation mechanism and predict the final thick-
ness in certain conditions. They find that the thickness of the layer deposited depends
on the withdrawal speed u at which the substrate is retrieved from the solution. Nev-
ertheless, the LL model can’t apply to every system. For example, whenever solvent
evaporation is taking place, several critical parameters, assumed constant in LL model,
may change with time (like rheological properties and surface tension) due to the increase
of concentration of non-evaporating components. For this systems, including colloidal sus-
pensions and polymeric solutions, exist two distinct behaviors: at low withdrawal speeds
(u< 0.1 mm · s−1) the thickness of the final layer deposited h decreases with u until a
minimal value, whereas at high withdrawal speeds (u> 0.5mm · s−1) the thickness start
to increase again, as showed in figure III.1.
In the low dragging speed deposition regime (so-called capillarity regime, CR) solvent
evaporation significantly affects the deposition process, its rate E becoming a critical
parameter that radically influences the deposited film thickness, while in the high speed
regime (so-called draining regime) this parameter is negligible and the film formation
follows the LL theory.
A global, semi-empirical model giving a satisfactory description of the dip-coating process,
covering a broad withdrawal speed range (from 0.001 to 10 mm · s−1) was published by
Faustini et al. [165], combining in a single equation the contributions of both capillarity
and draining effects:
h0 = ki
(1
u
E
L
+Du2/3
)
(III.1)
where ki and D are constants characteristic of the solution, L is the width of the deposited
layer, and u is the withdrawal speed. This model matches very well with experimental
results, as reported in figure III.1.
At low withdrawal speeds, solvent evaporation takes place at the liquid meniscus, which
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Figure III.1 – Plot of the thickness versus withdrawal speed (log-log scale) for a thin sol-gel film
deposited by Dip-Coating. Experimental points match with the thickness predicted through equation
III.1 for a wide span of withdrawal speeds. Inside the plot: schemes of the meniscus region for both
capillary (left) and draining (right) regimes which dominate the dip-coating process at slow and fast
withdrawal speeds, respectively. Adapted from [166]
is continuously fed through capillary rise from the solution. In this capillarity regime
no solution dragging is involved, and the film thickness is directly related to the solvent
evaporation rate E. Capillarity regime can be very useful in the case of high surface ten-
sion solutions because it avoids dewetting problems, otherwise encountered using draining
regime; moreover, it enables deposition of thick films from highly diluted solutions, which
can be interesting if species to deposit cannot be dissolved or dispersed in high concentra-
tions. At high withdrawal speeds the final thickness is mainly dependent on the viscous
drag and the film formation is well described by the Landau-Levich model. At intermedi-
ate speeds, both regimes of film formation are overlapping, summing their contributions.
The speed range of this intermediate domain strongly depends on both solution compo-
sition and processing conditions such as temperature.
Thus, to resume: in the dip-coating process 3 different speed ranges exist, in which the film
formation follows different speed dependencies: capillarity regime concerns low speeds and
draining regime, in which is valid the Landau-Levich model, takes place at high speeds,
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while they combine into a third regime at intermediate speeds. The boundaries of these
three regions are not fixed but shift, depending on the system examined.
III.2 Irreproducibility issues
Figure III.2 – (a) Glass substrate coated with a single anti-reflective layer; various positions on the
sample for which transmission and layer thickness have been measured are reported. (b) Dip-coating
conditions: the liquid level inside the container decreases during the process because of substrate dragging.
Withdrawal speed used: 0.3 mms−1. (c) Transmission spectra taken at different distances from the top
edge of the coating layer. (d) Thickness profile of the sample.
All the cited theoretical models assume that the processing conditions do not change dur-
ing coating. Anyway, conditions may not be identical over the entire substrate surface,
and thickness non-uniformity is often noticed on the samples, for example when relatively
large surfaces have to be covered.
As an example, in figure III.2 is shown a glass substrate coated with a mesoporous methy-
lated silica-based anti-reflecting layer, made by a dip-coating process at constant temper-
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ature and withdrawal speed (T= 22 ◦C, u=0.3 mms−1). The solution composition is
reported in table III.1. After deposition, samples were cured at 450 ◦C for 10 min.
The transmission spectra along the sample point out that, the intensity of transmitted
light changes, which means that the anti-reflective layer thickness is not uniform from
the top to the bottom of the sample. By measuring the film thickness at several heights,
we evidenced that the coating layer becomes thinner when the distance from the top
increases. This behavior has been noticed quite often: layer thickness decreases along the
sample with distance from the top.
We think that this is mainly related to the variation of the level of the solution with respect
to the reservoir top limit during withdrawal. Retrieving the substrate lowers the liquid
level, changing the evaporation conditions along the substrate due to vapor confinement.
Other evidence of such an effect is reported in figure III.3 where the variations of thickness
with respect to the withdrawal rate are plotted for a TiO2 sol gel solution prepared under
similar conditions but with different reservoir geometries or filling levels. One can notice
that filling the container at various levels or using different containers could lead to
very different thicknesses of the final film obtained. Thus, these processing parameters
seem to have a strong impact on the amount of material deposited, causing thus very
significant thickness non-homogeneity. Because the reservoir geometry and filling level
mainly influence the local vapor pressure governing the evaporation rate, we chose to
investigate the influence of solvent relative vapor pressure in the atmosphere on the final
layer thickness. It is known that the relative solvent vapor pressure during film formation
can impact the material structure [167,168], but until now, the effect of a solvent-enriched
atmosphere on the amount of material deposited was never extensively investigated.
The purpose of this work is to give an overview of the phenomenon and its mechanisms
to be able to better handle and control the dip-coating process. Several systems were
investigated to obtain dense TiO2 or mesoporous SiO2 films from ethanol-based sol gel
solutions, porous SiO2 films from water-based colloidal solution, and PS PEO copolymer
films from THF solution.
The TiO2 solution was prepared with a molar ratio of 1:55:10 TiCl4/EtOH/H2O and
used fresh. The experimental investigation was performed using dense titania as a model
system since the film formation mechanisms are well-known and titania thin films are
widely employed for many applications. Dip-coating was performed at 26◦C and RH <
5%.The final films obtained were cured at low temperature (130 ◦C) to stabilize them,
keeping an amorphous structure in order to avoid uncontrolled crystallization followed
by > 50 nm surface roughness, not suited for ellipsometric analysis [169]. All TiO2 films
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Figure III.3 – Scheme of the dip-coating method and plot of the thickness versus withdrawal speed (log-
log scale) when the dip-coating is performed with different reservoirs (curves A-C) or the same reservoir
but different level of liquid (curves C1-C3) for a TiO2 solution in EtOH. The reported graphs are the
fits obtained from experimental data points (reported in figure III.5) following equation III.1. The data
points were acquired at 0.5 cm from the top of the film.
analyzed had a refractive index at 700 nm between 1.985 and 2.020.The thickness values
were obtained by using a regular beam (3 mm) that allows the thickness fluctuation
(typically 7%) due to stick and slip phenomena in the capillarity regime to be averaged.
The mesoporous SiO2 solution was prepared using tetraethyl orthosilicate (TEOS) as
inorganic precursor and hexadecyltrimethylammonium bromide (CTAB) as template sur-
factant. TEOS and CTAB were added to EtOH and in the end was added the aqueous
acidic solution (pH = 2 by HCl addition); the molar ratio used is reported in table III.1.
The solution was stirred at room temperature for 72 h before use. Dip-coating was per-
formed at 26◦C and samples were stabilized at 130◦C for 1 hour.
The PS-b-PEO polymer solution was prepared in a concentration of 3.33 g/L using THF
as solvent. PS-b-PEO (polystyrene-b-poly(ethylene oxide)) had Mn = 16400, Mn = 36400
Mw/Mn: 1.06. Dip-coating was performed at 40◦C.
A ludox silica nanoparticle suspension, named HS40, was purchased from Aldrich. The
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original stock of colloidal suspension was diluted 10 times with water. Dip-coating was
performed at 40◦C.
The refractive index and the thickness of final films were measured, after the stabilizing
thermal treatment, by spectroscopic ellipsometry at an incidence angle of 70 ◦C on a
UV-IR (193 1690 nm) variable angle spectroscopic ellipsometer (VASE) M2000DI from
Woollam , and the data analysis was performed with the CompleteEASE software.
Table III.1 – Molar composition of solutions.
Molar ratio TEOS MTEOS TiCl4 EtOH HCl H2O F127 CTAB
Anti-reflective
(fig. III.10 a-c)
0.5 0.5 - 40 0.006 5 0.006 -
Anti-reflective
(fig. III.10 d)
0.5 0.5 - 20 0.007 4 0.006 -
TiO2 - - 1 55 - 10 - -
Mesoporous SiO2 - - 1 40 0.009 5 - 0.14
III.3 The role of solvent relative vapor pressure
Analyzing figure III.3 we can see that the curve of film thickness versus withdrawal speed
shifts between different experiments, meaning that, for the same experimental conditions
and the same speed, we obtain films with different thicknesses. The gap in thickness is
huge in the ultra-low speeds regime and is progressively reduced with increasing speeds.
The factor responsible for this behavior is likely to be the partial vapor pressure of the
solvent in the atmosphere, originating from the solution evaporating from the reservoir
and from the deposited layer. In fact in the capillarity regime the film thickness is directly
related to the evaporation rate while for faster speeds this parameter has minor impact.
To investigate this hypothesis, we performed a first set of dip-coating with an ethanol-
based TiO2 sol gel solution in which the dip-coater atmosphere was progressively enriched
with ethanol, employing the gas injection system described in figure III.4.
Briefly, dry air was bubbled into hot ethanol at 50 ◦C to be saturated with the solvent
vapors and then passed through cold ethanol at 25 ◦C before entering in the dip-coater
chamber. After the passage in ethanol at ambient temperature, the solvent-saturated
air was mixed with dry air in different proportions, regulated by mass flow controllers,
and injected within the dip-coater. The passage in EtOH at ambient temperature is
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mandatory to avoid the condensation of solvent in the tubes and within the dip-coater
chamber, which cause severe irreproducibility issues. Moreover, it is important to control
the temperature of ethanol throughout the experiment and keep it constant (in fact when
a higher flow of hot EtOH-enriched air passes through the second tank, it heats up
the solvent quickly). The temperature of ethanol was checked before and after every
experiment, using an ice-bath when necessary to keep it at 25 ◦C. A total air flux of
2.5 L/min is maintained during the deposition process; otherwise, especially for slow
withdrawal speeds, the ethanol relative vapor pressure in the atmosphere changes too fast,
leading to irreproducible results, since the chamber is not a hermetically closed system
but communicates with the external environment. The experimental points obtained are
presented in figure III.5, from these data we draw the curves of figure III.6.
Figure III.4 – Experimental apparatus used to perform dip-coating with increasing solvent vapor pres-
sure.
From the ratio between dry air and EtOH-enriched air, we inferred the ethanol relative
pressure injected into dip-coating chamber. The relative vapor pressure values reported in
figure III.6 are values related to the air injected in the chamber; they are not the effective
ethanol vapor pressure values of the atmosphere within the chamber. In fact, probably
full saturation in EtOH (100%) is never reached because the system is not perfectly sealed
and exchanges always some air with the outside. All of the experiments were performed
with a reservoir filled to the top with solution.
Plotting the thickness versus withdrawal speed by equation III.1, we can see a shift of the
point of minimum thickness toward lower withdrawal speed values with increasing solvent
vapor pressure, as shown in figure III.6, going from a minimum thickness of 62 nm in dry
air until 29 nm when injecting EtOH-saturated air. There is a linear correlation between
minimum thickness and solvent partial vapor pressure increase, as reported in figure III.6.
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Figure III.5 – Plot of the thickness versus withdrawal speed (log log scale) for different solvent vapor
pressures injected in the dip-coater chamber (the data points were acquired at 0.5 cm from the top of the
film). From these data we draw the curves of image III.6.
As expected, the influence of higher vapor pressure atmosphere is stronger in the cap-
illarity regime where the thickness of the deposited layer is directly proportional to the
evaporation rate E [165]:
h0 = ki
1
u
E
L
(III.2)
The evaporation process of a solution could be a complex phenomenon to discuss because
it is influenced by several parameters. In the most simple case for which no convection
is involved, the evaporation rate E of a solvent can be described following the Hertz
Knudsen equation ( eq.III.3) [170,171]:
E = Aα(KT )−1/2(P ∗(T ) − Pamb) (III.3)
whereA is the evaporation surface area, T is temperature, α is the sticking coefficient of
a gas molecule onto the surface, and K is a constant including the molecular mass, the
Boltzmann constant, and a numeric prefactor. Both α and K are determined by solvent
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Figure III.6 – Plot of the thickness versus withdrawal speed (log/log scale) for different solvent vapor
pressures injected in the dip-coater chamber (the data points were acquired at 0.5 cm from the top of the
film.). Dashed lines are the theoretical trends, which are not possible to verify because dewetting from
substrate surface occurs at speeds smaller than 0.1 mm s−1 for high values of EtOH vapor pressure. To
have a clear image, we report here just the curves fitted with equation III.1 from experimental data points
reported in figure III.5. On the right are shown evolutions of the minimal thickness hmin, the critical
withdrawal speed uc (at which hmin is obtained), and the solution deposition rate E/L (from equation
III.1) versus solvent vapor pressure injected into the dip-coater chamber.
characteristics. Equation III.3 shows that E depends on the difference between the solvent
saturation vapor pressure P ∗ at the temperature of the solution and its relative vapor
pressure in the gas phase Pamb. Including E in equation III.2, we obtain:
h0 = ΓAT−1/2(P ∗(T ) − Pamb)
1
u
(III.4)
where Γ combines all of the previously described constant factors. By increasing the
solvent relative vapor pressure in the atmosphere Pamb, the evaporation rate E is reduced,
and, as it is evident from equation III.4, the thickness of the deposited layer h0 will be
smaller. The surface of the interface A which, in our case, is the surface of the liquid
meniscus at the contact with the substrate, also plays a role in the kinetics of evaporation.
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As a direct consequence, every parameter which can lead to a different shape of the
meniscus, such as the reservoir geometry, the contact angle between the substrate and
the solution, and the distance of the sample from the reservoir’s edge, will also influence
the evaporation rate and, consequently, the film thickness.
In the draining regime, the system quickly reaches the equilibrium thickness, meaning
that the variations in viscosity and surface tension, caused by the presence of solvent
vapors in the atmosphere, are small and that the evaporation process is slower than the
time needed for the layer deposition. Thus, the contribution of E is negligible and the
film formation follows the Landau-Levich model, in which final thickness is related only
to withdrawal speed u by equation III.5.
h0 = kiDu2/3 (III.5)
The effect of higher ethanol relative vapor pressure in the atmosphere can easily ex-
plain the behavior observed in real experimental conditions, reported in figure III.3. In
fact, changing the reservoir shape and dimension leads to a modification in the shape of
meniscus, which is the surface of the interface, directly affecting evaporation rate and,
consequently, layer final thickness h0. On the other hand, lowering the liquid level in-
side the container places the meniscus in an atmosphere richer in solvent vapors (Pamb is
higher), decreasing evaporation rate E and leading to thinner films.
We notice a huge thickness fluctuation along samples linked to the meniscus position
during dip-coating process, which can be explained as an effect of solvent relative pressure.
When the liquid meniscus is above the container, the evaporation speed is controlled by
the relative solvent vapor pressure within the dip-coater; as soon as the meniscus is
positioned within the solution’s container, the relative solvent vapor pressure increases,
following a gradient from the external edge toward the inside. In such an experimental
situation, the Pamb parameter of equation III.4 is not a constant anymore but becomes a
function describing the local evolution of the relative solvent pressure above the solution
meniscus. Performing dip-coating without paying attention to the meniscus position can
lead to huge thickness non-uniformity.
Plotting the thickness of a film deposited a constant speed versus the position ∆z of the
liquid level within the container, it is evident that a small variation in the solution height
leads to huge differences in the amount of material deposited, up to a decrease of 80 90%,
in capillarity regime. We performed experiments at constant temperature, humidity and
withdrawal speed, changing the starting level of solution within the reservoir. Lowering
the liquid level we obtained thinner films for every studied system, as reported in figure
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Figure III.7 – Evolution of h/h0 with the difference in liquid level ∆z for different speeds for (a) ethanol-
based sol gel SiO2 solution, (b) water-based colloidal SiO2 solution, and (c) THF-based PS PEO block
copolymer solution. The h/h0 is the ratio between the thickness of a film dip-coated with a liquid level
within the reservoir lowered by 1, 2, or 3 cm and a sample dip-coated at the same speed but with the
liquid level reaching the top edge of the container (level 0).
III.7.
In order to compare different solutions, the final film thickness h was normalized on h0,
which is the thickness of a film deposited in the same conditions but with a completely full
container (level 0). In the latter conditions, the liquid is up to the edge of the container
and, when substrate is immersed, the meniscus is above the container.
Below a given ∆z value, we observe that lowering further the liquid level does not bring
any additional thickness variation. We assume this is due to the fact that within the
solution reservoir the atmosphere is nearly saturated; thus, that evaporation speed is
the minimum. How steep the initial thickness decreases (in other words, how high Pamb
value increases) with solution lowering depends experimentally on the solvent volatility,
on the withdrawal speed, and on the reservoir dimensions and shape. It can be determined
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experimentally in figure III.7 by assuming that h/hO is proportional to Pamb(∆z)/Pamb(0).
This effect is visible even at high withdrawal speed and can be very strong when a highly
volatile solvent, such as THF, is used. This is exemplified with the polymeric system
polystyrene-block-poly(ethylene oxide) in figure III.7, which reveals a thickness variation
of 70-75% even at a withdrawal speed of 5 mm · s1 that is usually considered in a “pure”
LL regime. Thus, in this case, even for a high withdrawal speed, the evaporation process
is faster than the liquid layer deposition.
One could argue that passing from outside the container to within it, meniscus change
its shape and this could be the explanation of the thickness difference observed along the
sample. Anyway, we verified that the meniscus shape changes noticeably only in the first
0.1 cm (the experiment is illustrated in figure III.8 and III.9 and results are reported in
table III.2), but we can observe thickness variations during the first 2-3 cm on the film
(figure III.7), meaning that the solvent vapor pressure variation is mainly responsible for
the described behavior.
From these results, we can infer that, to gain reproducibility, it is better to keep the liquid
level some centimeters below the top of the reservoir to be on the plateau of vapor pressure
profile. In such a case, obtaining the targeted thickness of 80 nm for an anti-reflective
layer, implies re-adaption of the concentration of the solution, as shown in figure III.10.
Moreover, it is better to use a large reservoir with respect to the volume of the substrate;
in this way, the dragging will impact less the level of the solution within the container
than in the case of a smaller reservoir, but this may demand a large volume of solution
for large substrates.
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Figure III.8 – Setup used to observe meniscus shape variations: with a camera perpendicular to the
meniscus plane we observe its shape evolution while slowly lowering the liquid level inside the tank
employing a peristaltic pump (not shown in the pictures). We build a tank with two PTFE walls spaced
0.5 cm. We attached a Si wafer at one of the PTFE walls (white in the pictures) making it exceed the
height of the opposite wall. We submerged everything in a transparent glass container and filled it with
water. We observed the meniscus of water on the Si surface; at the starting point the liquid reached the
top of the PTFE wall, and the meniscus is higher than the tank top, as sketched in the figure.
Figure III.9 – Evolution of the meniscus shape. a) h = 0 mm b) h = 0.42 mm c) h = 0.84 mm d) h =
3.57 mm. Angles have been drawn and measured with ImageJ software.
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Table III.2 – Angle Θ variation with distance from the top of the reservoir.
Distance from the top h (mm) Angle θ(±1)◦
0 27.0
0.21 25.5
0.42 24.9
0.63 21.5
0.84 20.6
1.26 19.7
1.68 20.4
1.89 22.2
2.1 20.9
2.52 21.3
3.57 20.7
4.41 19.9
5.04 20.5
7.98 20.7
10.08 20.8
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Figure III.10 – Dip-coating of an anti-reflective layer on a sodalime glass (u = 0.3 mm s1). (Left) Film
thickness profile obtained at different positions of the substrate. (Right) UV vis transmission spectra
at similar positions of the substrates. The films are obtained by dip-coating a mesoporous silica sol
gel solution (TEOS/MTEOS 0.5:0.5); (a c) Lowering the liquid level within the container leads to more
uniform film deposition, but the layer becomes too thin to have good anti-reflective properties with the
original solution. (d) By readapting the solution concentration and dip-coating with the meniscus inside
the reservoir, we obtain quasi-homogeneous film thickness and good anti-reflective properties along the
whole sample. ∆z = 0.5, 2 and 2 cm for figure b, c, d respectively.
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III.4 Towards controlled gradients
In the previous section, we observed the variation of the solvent relative vapor pressure
in the atmosphere during the dip-coating process, verifying that it may cause a huge
thickness gradient on the deposited films. We proposed some solutions to compensate it
when the thickness uniformity of the layer is required. Nevertheless, considering that in
some processing conditions the thickness decrease can be as important as 90%, it would be
very interesting to exploit this effect to fabricate graded films with a controlled thickness
profile. The huge potential of thin films exhibiting functionality gradients obtained from
films thickness gradient is well illustrated in the work of Faustini et al. [172]. In this study,
thickness gradients were produced by employing the dip-coating technique with increasing
withdrawal speeds. However, with this procedure, the maximum thickness obtained is
about two times the value of the initial thickness. In contrast, partial vapor pressure
gradient can promote much larger relative thickness variations. Moreover, exploiting the
effect described in this work to produce controlled thickness gradient allows preparation
of graded films at a constant withdrawal speed in a very simple process that does not
require elaborate dip-coating equipment.
As highlighted in equation III.4, the factor that has to be controlled is the relative solvent
vapor pressure in the atmosphere Pamb. If one target is building a linear film thickness
profile, we are facing the fact that a linear evolution of ∆z caused by the substrate
dragging induces at the solvent/air interface a Pamb(∆z), which does not have a linear
evolution inside the container. Hence, ideally, one should find a way to promote a linear
solvent relative pressure within the reservoir.
A simpler method consists of playing on the ratio between the substrate volume and
the solution volume Vsample/Vl. The goal is to maintain the total solution lowering ∆z
(promoted by substrate dragging) within the range in which the surrounding atmosphere
is far from saturation (the first centimeter of ∆z in figure III.7 experiments for exam-
ple). In this ∆z range, the diffusion profile of Pamb can be considered as a reasonable
linear approximation. This could lead to the preparation of graded layers exhibiting large
thickness gradient along the specimen.
We tested this method (cf. figure III.11) by varying the solvent to substrate volume
ratio in order to vary the solution total lowering ∆z. For a small volume ratio of 0.21,
resulting in a small ∆z, the deposited layer has a thickness gradient which is perfectly
linear but of moderate amplitude. A too high volume ratio of 0.43 does not allow a linear
thickness gradient to be obtained. With an intermediate volume ratio of 0.32 however,
one obtains an almost regular thickness gradient decreasing from 74 to 16 nm on 5 cm
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length. Thus, controlled thickness gradients can be obtained with a very simple constant
speed dip-coating process by knowing and compensating the solvent vapor pressure vari-
ations around the meniscus. Remarkably, the thickness variation observed here (4.6-fold
between smaller and larger thicknesses) is larger than that previously obtained by using
an accelerating dip-coating process (2.5-fold) [169].
Figure III.11 – Plot of the thickness of graded mesoporous SiO2 films for different volume ratios
between the sample and the solution. The ethanol-based solution was dip-coated at a withdrawal speed
of 0.1 mm · s−1. Black lines are given as guides for the eyes.
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Ellipsometry as a tool to study
thin films dynamics in biological
fluids
IV.1 Spectroscopic ellipsometry
Ellipsometry is a non-destructive measurement technique to obtain optical properties of
a sample material through the reflected light waves. The technique measures a relative
change in polarization and is therefore not dependent on absolute light intensity, which
makes ellipsometric measurement very accurate and reproducible. An ellipsometer sends
linearly polarized light at an oblique incidence on a surface, this light changes its polariza-
tion state when it is reflected, becoming elliptically polarized. In some cases the incident
light can be circularly or elliptically polarized. A general scheme of ellipsometry is given
in figure IV.1.
When a plane light wave is directed at a surface at oblique incidence, there is a vector
which points in the direction of propagation of the light wave, called the wavevector kin.
This vector is contained in a plane perpendicular to the surface defined as the plane of
incidence. Perpendicular to kin is the E-vector for the electric field E of the light wave,
which can be decomposed into two components, which are mutually perpendicular and
perpendicular to kin. The two components of E are parallel and perpendicular to the
plane of incidence and are named p and s respectively.
When a light wave is linearly polarized it means that the p- and s-component of E oscillate
with an amplitude and mutual phase causing the endpoint of E to move in a straight line
in the plane of p- and s-components (see figure IV.2). When the light wave reflects off the
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Figure IV.1 – The general principle of ellipsometry. A linearly polarized light beam is reflected by a
surface, changing its state of polarization to an elliptical one.
surface, the polarization changes to elliptical polarization. This means that the amplitude
and mutual phase of p- and s-component of E have been modified, causing the endpoint
of E to move describing an ellipse. Elliptic polarization can be rather right-handed or
left-handed, if, observing from a point towards which the wave is advancing, the vector
E moves in clockwise or counter-clockwise direction, respectively.
Figure IV.2 – General representation of polarized light waves: when plane light propagates along z
direction, the electric field vector E (represented in red) oscillates in the plane xy, perpendicular to the
wave propagation direction, describing a line (linear polarization), a circle (circular polarization) or, in
the most generic case, an ellipse (elliptical polarization). In the case of an incident beam on a surface,
x and y are the directions of the two components of the electric field p and s, respectively parallel and
perpendicular to the plane of incidence.
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Between the p- and s-components of the electric field there is a relative phase shift ∆
which is ∆ = 0 for linearly polarized light, ∆ = pi/2 for circularly polarized light and
can span from 0 to 2pi in elliptic polarization. In ellipsometry, the ∆ phase shift of the
reflected beam is directly measured. The other parameter measured by ellipsometry is
the angle Ψ, which is defined to satisfy the following:
tan Ψ = X/Y (IV.1)
This is illustrated in figure IV.3.
Figure IV.3 – Polarization ellipse, described by the ellipsometric angles Ψ and ∆. The polarized wave
propagates on z axis, which points towards the reader.
Only relative amplitude X/Y is relevant in ellipsometric analysis, this makes the measure
independent from intensity (bigger or smaller ellipse as beam spot), assuring a very precise
and reproducible measurement.
The measured values Ψ and ∆ are related to the ratio of Fresnel reflection coefficients Rp
and Rs for p- and s- polarized light, through what is called the fundamental equation of
ellipsometry IV.2:
ρ = Rp
Rs
= tan(Ψ)ei∆ (IV.2)
The ratio of the reflection coefficients Rp and Rs is maximized at a specific angle of
incidence, called Brewster’s angle θB for which Rp is minimal. The value of this angle
depends on the refractive indexes of the media in which light is traveling (n1) and of the
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material which reflects it (n2) and can be calculated with the formula IV.3:
θB = arctan
n2
n1
(IV.3)
Because the sensitivity of ellipsometry is higher at this particular angle of incidence,
measurements are usually performed at angles close to Brewster’s angle.
An ellipsometer is generally made of the following main parts:
-The light source, emitting unpolarized light
-The linear polarizer, converting the light in linearly polarized light.
-The compensator, not always present, which delays the two perpendicular components
of the electrical vector by different amounts. This delay occurs because of the optical
anisotropy of the element acting as a retarder. Basically, each of the orthogonal electric
fields of the incident light experience a different refractive index and so they have different
phase velocity. A compensator is a retarder element that introduces a 90◦ phase change.
Therefore, linearly polarized light becomes circularly polarized when passes through it.
-The analyzer, which is a linear polarizer collecting the light beam reflected by the
sample.
-The detector, measuring the intensity of the light passed through the analyzer.
Polarizer, compensator and analyzer can be either fixed or rotating depending on the
configurations. The most employed are the rotating polarizer ellipsometer (RPE), the
rotating analyzer ellipsometer (RAE) and the rotating compensator ellipsometer (RCE).
Ellipsometers can be generally classified in two families: null ellipsometers and photomet-
ric ellipsometers. In null ellipsometers the components settings are adjusted to extinguish
the light collected by the detector. So, polarizer and compensator are rotated to obtain
linearly polarized light after reflection, extinguished by rotating the analyzer to a suitable
angle. Anyway this procedure, usually performed manually, is pretty slow and not very
suitable for spectroscopic studies across broad spectral ranges. Photometric ellipsometers
on the contrary, measures light intensities for several properly chosen conditions, which
can be rotational azimuths angles of the polarizer, compensator or analyzer or angle of
incidence. The general principle behind a photometric ellipsometer is thus to measure
the intensity at different analyzer (or polarizer or compensator) rotational angles, and
from these measurements calculate the ellipsometric parameters Ψ and ∆. These systems
don’t necessarily need a retarder but they are not very sensitive when ∆ approaches to
0 or pi values. This issue can be solved adding a variable retarder (compensator) after
the polarizer and before the sample. In this configuration any input polarization can be
generated before the reflection on the sample, adjusting it to obtain a reflected beam with
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∆ close to pi/2 where the sensitivity of the system is maximized. Light intensity can be
measured at predetermined fixed azimuthal positions or while periodically varying the
azimuth angle of either or both the analyzer and polarizer with time.
IV.2 Light and materials
Figure IV.4 – Reflection and transmission of an incident light wave at a surface boundary between a
medium (1) with refractive index n1 and another material (2) with refractive index n2. θi = θr.
Physical properties of materials such as refractive index and thickness can be obtained by
ellipsometry on thin films. This section describes the relation between the ellipsometric
function Ψ and ∆, directly measured, and the complex index of refraction n˜2 of the
material analyzed.
The fundamental equation of ellipsometry (eq.IV.2) contains Fresnel reflection coefficients
R˜p and R˜s which can be given as function of refractive indexes, angle of incidence θi and
angle of refraction θt. In fact, R˜p and R˜s are expressed as the ratio between the amplitude
of the reflected electric field Er and the amplitude of incident electric field Ei, for the p-
and s- component, respectively (eq. IV.4). Using the notation employed in figure IV.4
the Fresnel coefficients for reflection are defined as follows:
R˜s =
Ers
Eis
= n˜1 cos(θi)− n˜2 cos(θt)
n˜1 cos(θi) + n˜2 cos(θt)
R˜p =
Erp
Eip
= n˜2 cos(θi)− n˜1 cos(θt)
n˜2 cos(θi) + n˜1 cos(θt)
(IV.4)
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where n˜1 and n˜2 are the complex refractive indexes of the media and the reflecting mate-
rial, respectively. Thus, inserting the expressions for R˜p and R˜s in the equation IV.2 we
obtain the relation between Ψ and ∆ and the complex refractive index of the analyzed
material n˜2. The data from spectroscopic ellipsometry are values of Ψ and ∆ as a function
of wavelength. These data can be used to calculate the complex index of refraction as a
function of wavelength, which is defined as n˜ = n − ik where n is the real part and k is
the extinction coefficient.
Figure IV.5 – Multiple reflected and transmitted beams for a single film on a substrate.The incident
wave is partially reflected and partially transmitted at each boundary, between the ambient and the film
and between the film and the substrate.
In a three phase optical system as the one represented in figure IV.5 (ambient-film-
substrate structure), it is possible to determine the thickness of the thin film by ellip-
sometry, if the refractive indexes of the three materials are known. In fact, the incident
wave is partially reflected at the first interface and partially transmitted. The transmitted
wave travels through material 1 until the boundary with the substrate where it is again
partially reflected through the film until the interface with ambient. At this point one
wave is reflected back inside the film and one wave is transmitted in the ambient medium.
Thus, in such a system there are several reflected beams with a phase difference between
them which depends on the film thickness. The quantity measured in ellipsometry is in
this case the ratio between the total reflection coefficients Pp and Ps, which contains the
contributions of all the reflected beams and their phase difference factor β. Knowing the
refractive indexes and the angle of incidence, β can be calculated and, from it, the value
of thickness can be determined.
So, how do we get layer thickness and optical constants of the material analyzed from
the measured ellipsometric parameters Ψ and ∆? Ellipsometry is a model-dependent
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technique, meaning that a numerical analysis of the experimental data, based on mathe-
matical models, is required to obtain the physical properties of the studied sample. The
ellipsometric data as function of wavelength and angle of incidence are measured, then
an optical model representing the studied system is built, with several layers, each one
with its own refractive index and thickness. Some parameters of this model are adjusted
such that the experimental data match the data calculated from the model as closely as
possible.
The quality of the match between the data calculated from the model and the experimental
data can be evaluated through the mean-squared error (MSE), which should be as close
as possible to zero when the model fit well with experimental data:
MSE = 12N −M
N∑
i=1
[(
Ψmodi −Ψexpi
σexpΨ,i
)2
+
(
∆modi −∆expi
σexp∆,i
)2]
(IV.5)
where N is the number of Ψ and ∆ pairs (the number of wavelengths in spectroscopic
mode) and M is the number of variable parameters and σ is the standard deviation of
experimental data points. To analyze data we used CompleteEASE software, where some
multiplicative factors are included to the MSE formula, thus an ideal model fit should
have an MSE of ≈ 1. This could be achieved on single thin films with good optical quality
on Si substrate, while with more complex samples such as multilayers the MSE is usually
larger and a MSE around 10 is still considered acceptable.
The refractive index of transparent films in the visible range can be modeled using the
Cauchy dispersion relation:
n = A+ B
λ2
+ C
λ4
(IV.6)
where the A parameter defines the amplitude of the material index and B and C param-
eters provide the shape of the index curve versus wavelength, λ values in equation IV.6
are expressed in µm. For this materials extinction coefficient k is very close to zero in the
considered spectral range.
For absorbing materials other models are employed, including classical Lorentz oscillator
and Drude expressions for the real and imaginary parts of the complex dielectric functions
(˜1, ˜2), or the real and imaginary parts of the complex index of refraction (n, k) [173].
Often one would like to model the optical functions of thin films using an average of
two or more other sets of optical functions, because the material is a non-homogeneous
mixture of other materials. It exists some theories, called effective medium approximation
theories (EMA) which calculate the dielectric function for the composite film based on the
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dielectric functions of two or more other materials. One of the most known and employed
EMA theories has been developed by Bruggemann and for a two-component system it
calculates the effective dielectric function ˜ from the following:
fA
˜A − ˜
˜A + 2˜
+ fB
˜B − ˜
˜A + 2˜
(IV.7)
being fA and fB the volume fraction of the two components and ˜A and ˜B their dielectric
functions.
The silica films studied during this thesis were modeled through a Bruggeman-EMA layer
constituted by dense silica and air or dense silica and PBS. The refractive index of the
dense silica and the PBS had been previously measured and modeled through a Cauchy
dispersion.
IV.3 Total Internal Reflection Ellipsometry
Several biological fluids are opaque and will not allow ellipsometric studies at a solid/liquid
interface in external reflection mode. However, if the substrate is transparent the inter-
face can be probed by internal reflection. Internal reflection setups in combination with
spectroscopic ellipsometry (total internal reflection ellipsometry, TIRE) [174, 175] have
been used to study protein adsorption and other biological processes in situ [176–178],
displaying high sensitivity. The technique is similar to the most known surface plasmon
resonance (SPR) in which a p-polarized light beam is used to excite a surface plasmon in
a metal layer and reflectivity is monitored.
Surface plasmon polaritons (SPPs) are charge density oscillations caused by coherent
oscillations of free electrons in the metal conduction band. SPPs are excited by an elec-
tromagnetic field at the interface between the metal layer and a dielectric layer, often
through a prism coupler. The SPPs form an electric field that exponentially decays into
its surrounding medium, with a penetration depth of hundreds of nanometers. This
evanescent field is highly sensitive towards the refractive-index change of the surrounding
environment. Thus, when the refractive index of the sensing medium changes, the inci-
dent light which excites SPR will have different characteristics (a different angle if we are
looking at a fixed wavelength, or a different wavelength if we fixed the angle). In practical
terms, this means that we will observe a shift in the peak of plasmon resonance, for every
change in the refractive index of the medium surrounding the metal/dielectric interface.
In the most common Kretschmann configuration of SPR [179] a thin film (30-50 nm) of
metal (usually Au, Ag or Cu) is deposited on the base of the prism, which provides the
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conditions of total internal reflection. Alternatively, the metal layer is deposited on a
glass substrate, which is put in optical contact with the prism through an index matching
fluid (see figure IV.6).
A polarized light beam passes through the prism and the in-plane component kx of its
wave-vector can be varied by changing the angle of incidence (see figure IV.6).
When the angle of incidence exceeds the critical value θr for total internal reflection of
the glass/air interface, the light is almost completely reflected (reflectivity ≈ 100%). The
value of θr can be calculated from equation IV.8 for the interface between two materials
with different refractive index, in which n0 is the refractive index of the medium in which
light propagates (the prism, in Kretschmann configuration). Employing a BK7 prism the
θr value is 41◦ for the interface with air and 61◦ for the interface with water.
θr = arcsin
n1
n0
n0 > n1 (IV.8)
If the in-plane wave vector kx of incident light matches the value of the wave vector ksp of
electron plasmon oscillations in the metal layer, the energy of the light beam is partially
transferred to surface plasmons (reflectivity drops in a sharp peak), as sketched in figure
IV.6. Light beam in this special conditions excites the SPPs on the prism/metal interface
but if the metal film is thin enough (less than 100 nm for visible and near-infrared light),
the evanescent wave penetrates through the metal film and couples with a surface plasmon
at the outer boundary (metal/air or metal/water interface).
Figure IV.6 – Kretschmann configuration of surface plasmon resonance. With a monochromatic light
source, SPPs can be excited when the in-plane wave vector of the incident light kx matches the value
of ksp (B) and in this case the energy of the incident beam is partially transferred to plasmons causing
a drop in reflectivity, as showed on the right. This plasmon resonance peak can shift depending on the
refractive index of the surrounding medium.
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When ellipsometry is performed in internal reflection mode, the ellipsometric function Ψ
exhibits a peak similar to the one seen in surface plasmon resonance (SPR) experiments
(figure IV.7). At the corresponding resonance conditions ∆ displays a very large drop –
from 10 to 20 degrees when a dielectric layer is deposed on gold and until 90◦ analyzing
bare gold surface. This is a remarkable change when compared to the change in external
reflection which at maximum is a few degrees. Conventional SPR is based on monitoring
the intensity of reflected p-polarized light, while TIRE measures two parameters, Ψ and ∆
carrying informations on the intensity and the phase of reflected polarized light. The two
ellipsometric parameters in fact, are linked to Fresnel coefficients for p- and s-polarized
light, as explained previously (equation IV.2). Several authors have pointed out that
TIRE enhances sensitivity with respect to external reflection ellipsometry and also with
respect to SPR technique. In fact, it has been reported that the phase function ∆ (absent
in SPR) is more sensitive than intensity function Ψ [175,180].
Figure IV.7 – Ellipsometric functions Ψ and ∆ in TIRE technique employing a Kretschmann config-
uration and measuring at a fixed angle. The Psi function exhibits a peak at the wavelenght of surface
plasmon resonance, while the Delta function displays a sharp drop.
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IV.4 Development of TIRE setup including a microfluidic
device
An experimental setup to perform TIRE requires an ellipsometer, a prism and a flow cell
designed to be attached to the prism (or to the glass slide coupled with it). Employing a
glass slide as a support for the metal layer is usually preferred because it avoids compli-
cated regeneration of the metal layer for repeated use. When using metal covered glass
slides, the substrate is simply replaced for each experiment.
The prism should be chosen with an opening angle assuring perpendicular incident light
beam. Once settled the total internal reflection condition for the probed interface, the
opening angle can be calculated. If the incident polarized light beam isn’t perpendicular
to the prism face, refraction phenomena will modify the incident angle on the metal layer
and this angle offset needs to be considered when modeling the surface plasmon resonance
position.
We decided to build a TIRE setup in which the flow cell was constituted by a microfluidic
channel, to study mesoporous silica dissolution in biological, non-transparent fluids under
controlled flow conditions. In the last years, coupling plasmonics with microfluidics has
been indicated as a very promising path for biosensing and point-of-care diagnostics [181,
182]. The microfluidic cell allows the controlled reproduction of in vivo flow conditions
employing small volumes of liquids, which is ideal when working with biological fluids
such as blood, being the available amounts usually very limited.
We designed a setup to work at fixed angle (70◦) in a spectroscopic mode, at the interface
with aqueous media. We employed a BK7 triangular prism with an opening angle of
45◦. This means that the incident light beam was not perpendicular to the prism face
and a correction to calculate the real angle of incidence was made, because of refraction
phenomena at the air/prism interface. We deposited a 50 nm gold layer on a glass
slide which we coupled with the prism through an index matching liquid (Cargille BK7
matching liquid). A chromium layer of 1 nm between glass and gold was necessary to
assure adhesion. The surface to probe is a sol-gel mesoporous silica layer which we deposed
directly on gold through dip-coating. The setup is displayed in figure V.41 and was used
with a UV-IR (193 1690 nm) variable angle spectroscopic ellipsometer (VASE) M2000DI
from Woollam.
We also needed a syringe-pump to manage the flow in the microfluidic device, and a
heating element (Kapton flexible heater by Omicron) to bring the system at 37 ◦C along
with a thermocouple placed on the PDMS cell to check the temperature (showed in figure
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Figure IV.8 – Setup to perform total internal reflection ellipsometry under flow conditions employing
a microfluidic channel. The mesoporous silica film is deposited onto a glass substrate previously covered
with a gold layer, the liquid is flowed through the microfluidic cell.
IV.9). To hold the sample we built a support in aluminum, sealed with PTFE windows
which had a hole for the microfluidic tubes, and the heating element connections (figure
IV.9). The temperature controller displayed a stable temperature of 37 ◦C on the PDMS
cell (figure IV.10). The complete setup mounted on the ellipsometer platform is showed
in figure IV.10.
Figure IV.9 – The aluminum support for the sample is heated at the desired temperature through a
heating thin film and it is sealed with PTFE windows to assure uniform temperature, which is controlled
through a thermocouple on the PDMS microfluidic device. The PTFE windows had an opening to pass
microfluidic and heating system connections.
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Figure IV.10 – Setup for TIRE mode mounted on the ellipsometer platform, including the syringe pump
for the liquid flow control and the temperature controller.
We tried to study silica dissolution kinetics through an SPR commercial system (Bionavis,
SPR Navi 210A), performing experiments in collaboration with Dr. Omar Azzaroni at
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Universidad
Nacional de La Plata – CONICET, La Plata, Argentina. Nevertheless, we faced some
difficulties in studying long kinetics with media more complex than PBS. In fact, the
volume of the injected fluid is limited and to have a fast flow it is necessary to re-load the
loop many times. Unfortunately, every time that the loop is re-loaded, a buffer solution is
flushed on the sample, removing eventually adsorbed proteins and changing the interfacial
dynamics. Moreover, this system could only give kinetic informations while we wanted to
model the refractive index variation of the silica layer. Thus, we came back to the more
versatile TIRE technique coupled with a microfluidic channel.
Nevertheless, being a home-made system, it suffered of many problems due to a lack of
calibration. In fact, nor the support for the sample, the microfluidic cell or the prism were
in a fixed position and alignment should be found for every experiment. The presence
of the prism induced some shifts in Ψ and ∆ functions which can be corrected setting
some offsets, but since the positions were not fixed, offsets needed to be defined every
time. Moreover, if it happened to move the setup during the experiment (to solve a liquid
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leakage for example) the offset were not valid anymore. Ψ and ∆ shifts along with incident
angle correction introduced many parameters to adjust when fitting experimental data
with optical models. For this reason, often the refractive index evolution was difficult to
model, considering that in our system nor thickness or refractive index stayed constant
in time. We thus decided to analyze in priority the raw data of plasmon resonance shift
to evaluate kinetics.
In order to fully exploit this kind of system it would be necessary to build a fixed, cali-
brated setup including prism and liquid cell, leaving layer optical constants and thickness
as the only variable parameters in the measurements.
IV.4.1 Microfluidics
Microfluidics is the manipulation of liquids in channels with cross-section of 10-100 µm and
has been greatly developed in recent years for many miniaturized systems for chemical,
analytical and biomedical applications. Microfluidics allows the reduction of samples and
reagents volumes, reducing the global fees of analysis. Because of their compact, small
size microfluidic devices can integrate many following operations, shortening the time of
experiment, on platforms now called lab-on-a-chip [183–186]. Microfluidics is particularly
important in biomedical studies, in fact, microfluidic channels have sizes in the range of
blood capillaries and flow patterns can approximate in vivo conditions [187].
Figure IV.11 – Example of a microfluidic device in PDMS.
IV.4.2 Microfluidic cell fabrication
The simplest microfluidic device is constituted by micro-channels molded in a material
that is bonded to a flat surface (such as a glass slide). Several materials, such as glass,
silicon and polymers, have been employed to manufacture microfluidic devices. Conven-
tional methods rely on etching in glass and silicon the micro-channels but fabrication of
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polydimethylsiloxane (PDMS) devices by lithography and replica molding is faster and
cheaper and it became the most employed technique to realize microfluidic chips.
PDMS is a biocompatible, mineral-organic polymer of the siloxane family, it is deformable
and cheaper compared to glass or silicon. Moreover, it is transparent in the visible region
so that micro-channels can be observed directly and their content analyzed with optical
techniques. It is a linear polymer with a structure reported in figure IV.12 which can
have different viscosity depending on the chain length and can be poured into a mold.
PDMS can also form cross-linked elastomer materials. Typically, linear PDMS polymers
containing two vinyl end groups react with a multifunctional cross-linker leading to a
three-dimensional cross-linked network [188].
Figure IV.12 – General structure of PDMS linear polymer. Terminal groups can be substituted with
hydroxyl or vinyl groups to allow further functionalization and cross-linking to obtain an elastomer.
It is often employed for microfluidic applications employing water but can’t be used with
some organic solvents. In fact, PDMS swells in organic solvents changing the cross-
sectional area of the channel and, therefore, the rate and profile of flow [189]. Sometimes
swelling can cause a detachment of the device from its substrate. For this reason, appli-
cations involving organic solvents usually employ microfluidic platforms made of glass.
The fabrication of microfluidic chips in PDMS requires several steps and starts with
designing the microfluidic channels with a dedicated software (AUTOCAD, Illustrator,
etc..) and then transfer the scheme on a photomask. The channels pattern is then
transfered on a photo-sensible SU-8 resin, supported on Si, by photo-lithography. The
thickness of the resin determines the height of the final channels. Once removed the non-
cured resin, a mold is obtained from which microfluidic channels can be reproduced in
PDMS many times. A scheme of the process is reported in figure IV.13. Once obtained
the mold, a mixture of PDMS and cross-linking agent is poured into the mold and heated
to accelerate the cross-linking reaction. Once the polymer is hardened, it can be taken off
the mold and it will show a replica of the mold pattern carved in the PDMS. We employed
PDMS polymer and cross-linker from Momentive (RTV 615 kit) mixing them in a ratio
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of 10:1 w/w. After the mixing the material needed to be degassed under vacuum to avoid
air bubbles to remain trapped in the crosslinked structure. Then we poured the PDMS
mixture in the mold and cured it for one night at 60◦C. When removed, we punched holes
(diameter 0.75 mm) to allow the injection of fluids, being careful not to crack the polymer
in any point (cracks in the drilling holes can cause liquid leaks). Our microfluidic pattern
was a single channel of 4.8 x 4.8 mm and 30 µm of thickness.
Figure IV.13 – Scheme of microfluidic chips fabrication. First, a master mold is realized in SU-8 resin
supported on silicon through photo-lithography (left). Then, PDMS is poured on the master mold and
crosslinked to reproduce the channel pattern of the mold. Once removed from the mold, the PDMS device
is bonded with substrate through a plasma treatment.
IV.4.3 Sample fabrication
Glass slides (RS, 26x76 mm) were cleaned in water and ultrasonic bath for 5 min, then
cleaned with acetone. A bonding layer of 1 nm of metallic chromium have been de-
posited (deposition rate 0.1 nm/s) on the glass slides by an electron-beam physical vapor
deposition Plassys 550 SL, followed by a 50 nm gold layer (deposition rate 1 nm/s).
A silica sol constituted by TEOS, CTAB, H2O in ethanol has been dip-coated on the
metal layer. Silica solution has molar ratio of 1:0.14:5 for TEOS:CTAB:H2O and 1:40
TEOS:EtOH, it is acidified by HCl 37% (0.09 molar ratio with respect to TEOS). Samples
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have been dip-coated at 21◦C and 30%RH and stabilized at 130◦C for one night, to obtain
a final thickness value around 120 nm. Silica deposited on gold can’t be heated to higher
temperature than 200◦C, because the gold layer modifies its optical properties when
heated and the optical quality of the film is compromised.
Samples were then washed with ethanol to remove CTAB surfactant from the pores
(3x5min).
IV.4.4 Bonding
The PDMS microfluidic device needed to be bonded to the silica surface to allow the
analysis of the latter in moving fluids. Usually both surfaces (PDMS and glass to bond)
undergo a plasma treatment before the sticking, to introduce silanols on the surface,
allowing a permanent bond between the PDMS device and the substrate. In our case
the bonding step was more delicate because the surface to bond was also the surface to
analyze and we didn’t want to modify it with a plasma treatment, especially thinking
about silica functionalized with organic groups. We tried to treat with plasma an hybrid
silica film carrying aminopropyl moieties and just after the treatment they emanate the
typical smell of amines, meaning that organic moieties had been cleaved by the plasma
treatment.
Thus, we tried some mechanical pressing methods to bond the PDMS and the silica
surface without plasma treatment, but this kind of method wasn’t effective. We found
that performing the plasma only on PDMS surface (80 s, 1000 mTorr) was enough to
assure a perfect bonding when sticking on silica surface. We used an air plasma cleaner
from Harrick (Expanded Plasma Cleaner PDC-001). After the sticking the samples were
kept at 60 ◦C for 1 hour.
However, while flowing liquids through the microfluidic devices we encountered some
problems. Sometimes, due to some channel blocking or air bubble, or even some blockage
of the microfluidic tubes the pressure in the channels reached high values and the PDMS
cell quickly detaches from the sample, making it not employable anymore. We noticed
that the fragile interface wasn’t the one between silica and PDMS but the one between
gold and silica, as evident from figure IV.14.
The adhesion between gold and silica is not very good, and to solve this problem we
added a second layer of 1 nm of chromium between the gold and the sol-gel layer. The
glass substrates were then covered with Cr/Au/Cr and then dip-coated with the sol-gel
silica. This didn’t solve the problem, so we decided to depose the metal layers only on
the center of the micro-channel (where TIRE analysis will be performed) covering the
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Figure IV.14 – Picture of a PDMS microfluidic device which detached from the silica sample because
of a sudden pressure jump in the channels. It can be seen that the interface which give way is the one
between sol-gel silica and gold.
sample with a mask during metal deposition. In this way, metal will be where it is needed
for surface plasmon resonance but PDMS will stick on silica deposited on glass, avoiding
fragile interfaces. This design,displayed in figure IV.15, avoids detachment with sudden
pressure peaks.
Figure IV.15 – Samples employed with TIRE technique: Cr/Au/Cr layer was deposed on a glass
substrate through a mask, then the sol-gel silica layer was deposed on all the substrate and then the
PDMS microfluidic device was bonded to the silica surface. The sample is analyzed from the back side,
thus is mounted on the support with microfluidic cell towards the bottom, while light beam comes from
the top and passes through a prism before hitting the sample. The prism will be positioned on the top of
the sample while it is disposed as in the picture on the right.
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IV.4.5 Oligomers release
PDMS is hydrophobic and it easily adsorbs hydrophobic molecules, which has been iden-
tified as a problem for some biological sensing applications. Moreover, it can release
oligomers into the channels [190, 191]. This was a major problem for us, because PDMS
oligomers contaminated the silica surface affecting the analysis. We verified that the
static water contact angle on silica surface was around 15-28◦ before the microfluidic de-
vice bonding, while it passed to 86-90◦ after (figure IV.16 a,b). To check this change we
bonded a microfluidic PDMS cell to the silica sample and then removed it with the help
of a razor blade.
We tried to flow some ethanol and water after the sticking of the device, but solvents
didn’t remove the oligomers. We tried also to cure PDMS for longer times before sticking
(24hours) but it wasn’t effective. We deposited a surfactant layer only in the channels
before bonding, making it act as a sacrificial layer on which the oligomers would adsorb.
After bonding, we washed out the surfactant and the oligomers adsorbed on it flushing
water in the channels. This method reduced the oligomers on the silica surface but the
static contact angle still passes from 15-22◦ to 35◦. If heated at 60◦C after bonding, the
surfactant started to decompose and sticked to the surface, causing contact angle to be
90◦ (figure IV.16 c-e).
We finally found that solvent extraction of the PDMS devices after curing removed the
oligomers in an efficient way before the bonding. We used the following protocol: after
curing PDMS cells one night at 60◦C we swelled them in diethyl ether for 24 hours, then
replace diethyl ether with toluene for 24 hours and finally replace toluene with 1-propanol
for further 24 hours, changing the last solvent with fresh one after 6 and 16 hours. The
passage in three solvents of decreasing swelling ability for PDMS is done to avoid cracks
in the material which happen when dried too fast from a highly swollen state. The devices
were then dried in oven at 70◦C for 1 hour and then at 130 ◦ for 1 hour. Bonding on
silica leaved the static contact angle unchanged as displayed in figure IV.16 f,g.
Generally, once optimized every step of fabrication, it took from 5 to 8 days to realize a
complete sample.
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Figure IV.16 – Static contact angle of water on silica surface: (a-b) before and after bonding of PDMS
device + 1 hour at 60◦C; (c-e) before and after the bonding with PDMS using a sacrificial layer of sur-
factant, without heating (d) and with heating treatment after bonding (e); (f-g) before and after bonding
with PDMS, employing solvent-extracted PDMS devices from which oligomers have been removed. The
angles after bonding have been measured in the channels, after removal of the PDMS device.
IV.4.6 Setup issues
Once found a robust protocol to prepare samples, we tested the setup. The main issues
encountered involved air bubbles and temperature control. In fact, the plasmon resonance
for our samples was placed at a wavelength of 720-760 nm in air and it shifts at 1180-1240
nm in PBS and at 1260-1312 nm in serum. When the microfluidic channel was full of
liquid, the plasmon resonance was clearly visible over 1100 nm. Its shift towards smaller
wavelengths due to silica dissolution could be followed. However, if air bubbles entered in
the channel the plasmon resonance lost intensity and in some cases completely disappeared
because of the energy transfer to the plasmon resonance at gold/air interface (see figure
IV.17). Until the air bubbles were removed, the TIRE was blind and we couldn’t have
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uniform kinetic data. Air bubbles were a regular issue, in particular when high flow rates
required to load the syringe several times. Moreover, the hydrophobic surface of PDMS
retained them, making it complicated to flush them away.
Figure IV.17 – Surface plasmon resonance of a 50 nm gold layer coated with 120 nm of mesoporous
silica in serum, without air bubbles (black line) and with air bubbles in the microfluidic channel (red line).
The red line shows two plasmon resonance peaks: the one corresponding to the gold/air interface (smaller
wavelength) and to the gold/serum interface (bigger wavelength).
Anyway, the biggest issue of the setup was the temperature control. If heating the sample
and microfluidic cell at 37◦C was simple and quick, it was very difficult to maintain the
temperature constant during dissolution. In fact, the liquid injected in the microfluidic
device couldn’t be heated up, and when it flowed in the channel, it cooled the channel
down (a temperature decrease of several degrees was revealed by the thermocouple on
the PDMS, the channel should be even colder). We passed the microfluidic wires in
water at 40, 60 or 80 ◦C before entering the device but it didn’t solve the problem. The
heating transfer with the ambient was very efficient also because the laboratory was at a
particularly low temperature when we performed the experiments (12 ◦C).
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We solved this problem by passing the wires through a metal tube, heated to have an
internal temperature of 42-44◦C (depending on the flow rates). The metal tube finished
just before the sample leaving a very short path between itself and the space heated at
37◦C, not sufficient to cool down the fluid (figure IV.18). The temperature was measured
at the exit of the microfluidic channel and was found to be 37 ±0.5◦C. Unfortunately,
we didn’t have time to repeat the experiments with this new configuration and they are
scheduled in the next months. Only the dissolution experiments in serum and blood were
performed without temperature fluctuations.
Figure IV.18 – Heating system for the microfluidic tube bringing the fluid to the PDMS device. The
tube is passed inside a metal tube heated at 42-44◦C from the syringe to the sample.
IV.4.7 Concluding remarks
Total internal reflection ellipsometry is a non-destructive technique very promising for in
vitro studies of biological system. It can be performed in real time and in opaque media,
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allowing analysis of real biological fluids. It has a high sensitivity due to the us of phase
information in the reflected light. Nevertheless, it is technically more complex than other
techniques such as SPR analysis, and it requires a very good knowledge of the sample to
build the correct optical model and a very well calibrated experimental system.
Coupling TIRE with microfluidics is extremely interesting to probe in vivo-like dynamics
and it brought important results during this thesis work, on the silica degradation dynam-
ics under controlled flow conditions. Anyway, it added some complexity to the system, in
particular regarding sample fabrication and temperature control.
An optimization of system and sample parameters should be performed for future techni-
cal developments, in order to make TIRE more competitive for biomedical applications.
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Chapter V
Mesoporous silica dissolution in
physiological conditions
V.1 State of the art
The last decade has seen the fast development of mesoporous silica nanoparticles as a
platform for drug delivery and along with the increasing employment of these engineered
nanomaterials, their toxicity on human health has become of concern. A good understand-
ing of silica nanoparticles biodegradability is required not only for their risk assessment
but also to control their drug release properties and design efficient nanocarriers. The
degradation of mesoporous silica under physiological conditions has been studied in vitro
using simulated body fluids, nevertheless results are sometimes conflicting and difficult
to compare. On the other hand, in vivo tests are expensive and it’s usually complicated
to follow the dynamics taking place in this kind of experiments. Determining the key
parameters which influence the dissolution kinetics of mesopourous silica nanoparticles
is of high interest and could mark a decisive step towards their employ as drug delivery
vectors.
This research work wants to determine the dissolution rate of mesoporous silica under
physiological conditions and identify some of the factors affecting silica behavior in bi-
ological media. The conducted study leads to results which, if they can’t be directly
extrapolated towards in vivo conditions, can anyway provide useful informations about
trends and can be used to design in vivo tests.
Silica is not chemically stable in water media, it undergoes hydrolysis forming silicic acid,
the breaking of Si-O bonds being the rate-limiting step of the reaction. Anyway its solu-
bility strongly depends on its structure, surface area and on the properties of surrounding
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media. The stability of mesoporous silica particles and films has been tested in several
simulated body fluids and physiological buffers [98, 117, 119, 192–194] finding dissolution
rates going from several hours to several days depending on experiment conditions and
silica structure.
Thermal treatments can increase silica stability in aqueous media, as reported by Bass
et al. [195] and modifying the inorganic network introducing heteroatoms such as Zr or
Al, also results in an effective way to increase silica hydrolytic stability [98, 195]. The
bulk composition influences dissolution kinetics and so does the material structure, since
the Si-O bond length and energy vary in different silica materials causing hydrolysis to
happen at different rates [196].
Moreover, the structural organization of silica at a small scale can influence its surface
reactivity, as discovered by Zhang et al. [123] and, consequently, its dissolution rate.
This can explain some of the conflicting data found in literature about silica dissolution,
in fact different methods of synthesis can produce silicas with different bulk structures
(e.g. presence or absence of strained cyclic species or predominance of highly connected
species [197]), which don’t react with the same kinetics.
The surrounding medium characteristics determine dissolution as well, in particular pH
is known to be an important parameter to tune silica solubility, which starts to increase
abruptly above pH 9 [198]. Moreover, if silica is grafted with polymers or ligands, or
presents adsorbed molecules on the surface, its dissolution kinetics is altered.
This is the reason why dissolution behavior can be significantly different in different me-
dia, for example He et al. showed that in presence of Ca and Mg ions, calcium/magnesium
silicates are formed at the silica surface, protecting underneath silica from further dis-
solution [117]. Icenhower showed that the presence of NaCl in solution can increase
dissolution rates up to a factor of 20x [196]. In the case of particles, another factor that
has to be considered is aggregation, which reduces the exposed surface area, slowing down
dissolution.
The driving force of dissolution is the undersaturation in silicon species of the medium
in contact with the surface: when silicic acid saturation is reached, silica can randomly
nucleate and precipitate, getting to an equilibrium in which silica dissolution and pre-
cipitation happen at the same rate and hindering the complete dissolution of solid silica
particles. In porous materials this behavior can lead to pores occlusion due to precipita-
tion, further inhibiting dissolution by reduction of accessible reactive surface [199]. The
presence of ions or molecules able to form soluble complexes with the released ions alters
the saturation level, enhancing dissolution.
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The saturation level of biodegraded silicon species is a very important issue and causes
some problems in evaluating dissolution rates: in fact, depending on the experiment con-
ditions, an equilibrium of dissolution-precipitation can be reached more or less quickly,
blocking dissolution. This leads to easy misunderstanding on the degradation of meso-
porous silica in biological environments, since some works reported hour-scale dissolution
while other studies showed stability over many days. As pointed out by He et al. [117]
and also verified during this thesis work, in a undersaturated medium mesoporous silica
is degraded within few hours. Nevertheless, in previous literature reports, degradation
is investigated with a silica concentration between 0.2 and 1 mg/mL (or even higher),
conditions for which the saturation limit is reached soon or later, while monitoring silica
concentrations below 0.1 mg/mL leads to complete dissolution within few hours. This
hour-scale degradation is observed in all the studies conducted on mesoporous silica thin
films [98,195,200], where the small amount of matter involved avoids silica saturation in
the medium, the same kinetics have also been observed during the studies which will be
presented here, carried out on mesoporous silica thin films.
V.2 Dissolution of mesoporous silica thin films
The main goal of this work is to investigate mesoporous silica dissolution in situ under
physiological relevant conditions. Because the biological fluids are complex media, to
have a reference in simplest conditions the first experiments have been performed in a
phosphate buffered saline solution (PBS) containing 0.01 M phosphate buffer, 0.0027 M
potassium chloride and 0.137 M sodium chloride, at 37 ◦C and pH=7.4. Amorphous
silica solubility can reach 145 mg/L at 37 ◦C in pure water, according to the equation
V.1, elaborated by Fournier and Rowe [201] and valid between 0 and 250 ◦C:
logC = −731
T
+ 4.52 (V.1)
where C is silica concentration in mg/L and T is temperature in Kelvin. This value can
be alterated by the presence of salts in solution and by the variations of pH, but can be a
good starting point to settle the saturation value and design the experiments conditions
accordingly.
As previously pointed out, silica saturation in solution stops dissolution and, if it is
interesting to understand the behavior of silica material in saturated conditions, it is
also necessary to assess the silica dissolution kinetics in a non-saturated media. In fact,
concerning biomedical applications, silica nanoparticles can be confined in small compart-
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ments such as cells and vesicles, where high local silica concentration in the surrounding
media can be attended, finding themselves in a saturated environment. On the other
hand, before being uptaken, nanoparticles travel in the blood stream and undergo degra-
dation in an undersaturated media. This first stage of their permanence in the body
is crucial, because they need to reach their target intact, delivering encapsulated drugs
where is needed and not releasing them previously, in an uncontrolled process.
Thus, we decide to perform our experiments in non-saturated conditions, working on thin
mesoporous silica films of 100-120 nm thickness, looking more deeply into the dynamics
involved during dissolution in this regime. We analyzed the film degradation in PBS
solution at 37 ◦C in a liquid cell of 5 mL volume, in static condition or with a weak flow.
In any case, we are far below the saturation limit calculated from eq. V.1, being the silica
mass involved in every experiment around 0.015 mg/mL.
Figure V.1 – Schematic representation of experimental setup to investigate mesoporous silica thin film
dissolution in PBS, through ellipsometric in situ measurement. Both the liquid cell and the liquid reservoir
are kept to a constant temperature of 37 ◦C during analysis.
Thin layers of mesoporous silica were obtained by dip-coating at u= 2mm · s−1, 26 ◦C and
30% RH from sols whose compositions are given in table V.1. Tetraethyl orthosilicate
(TEOS) was used as precursor and hexadecyltrimethylammonium bromide (CTAB) and
Pluronic F127 as templating agents. Sols have been stirred at room temperature for 72 h
before use. After deposition the films were stabilized 1 night at 130 ◦C and, in the case
of F450 and CT450, further calcined at 450 ◦C for 15 minutes. In films stabilized at 130
◦C the templating surfactant was removed by cold extraction in ethanol. As reported in
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section II.5.3 the silica films templated with CTAB have a Pm3n cubic mesostructure,
while the films templated with Pluronic F-127 showed a p6m 2D-hexagonal structure
V.2. Their porous volume, specific surface area and pore sizes distribution have been
obtained through Environmental Ellipsometric Porosimetry (EEP) and are reported in
table V.2. From GI-SAXS experiments we obtained the cell parameters of both materials
and, comparing them with pore sizes acquired trough EEP, we calculated the silica wall
thickness wt.
Table V.1 – Composition of mesoporous silica sols (molar ratios).
Molar ratio TEOS Ethanol HCl H2O F127 CTAB
CT SiO2 1 40 0.09 5 - 0.14
F SiO2 1 40 0.09 5 0.005 -
Table V.2 – Structure parameters such as semi-major axis (rl) and semi-minor axis (rs)
of the elliptical pores, thickness of silica walls wt, specific surface area and porous volume
for the investigated silica mesostructured films.
sample rl (nm) rs (nm) wt (nm) S (m2/cm3) Vp (%) Structure Surfactant
CT130 1.61 1.55 1.2 700 0.455 Pm3n CTAB
CT450 1.63 1.44 1.0 750 0.510 Pm3n CTAB
CT450 800 0.562 wormlike CTAB
CT450 1.62 1.44 1.1 850 0.620 Pm3n CTAB
F450 2.91 1.98 5.7 370 0.554 p6m Pluronic F-127
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Figure V.2 – GI-SAXS pattern of the CTAB templated (left) and Pluronic F-127 templated (right)
silica films, showing peaks of Pm3n cubic structure (left) and (11) and (02) peaks of the 2D-hexagonal
structure (right).
V.3 Dissolution in PBS
Monitoring the refractive index of mesoporous silica thin films during dissolution we
observe a linear decrease which ends up on a plateau approaching the medium refractive
index, as reported in figure V.3. In fact, silica refractive index is higher than PBS one,
and the optical properties of the porous layer are proportional to its PBS content (which
is equal to the porous volume of the film in air) following equation V.2. Thus, during
dissolution porous volume is increased and refractive index diminishes progressively (see
figure V.3).
Thermal treatment doesn’t influence much the dissolution kinetics, as can be seen com-
paring the data of CT450 and CT130, films obtained from the same sol and thermally
treated at 450 ◦C and 130 ◦C, respectively. The dissolution of silica calcined at 450 ◦C is
slightly slower than the one of silica stabilized at 130 ◦C, very probably because highest
temperatures allow for further silica condensation, building a more cross-linked network,
as already reported by Bass et al. [195] in previous studies. Anyway the high temperature
treatment doesn’t seems to improve silica stability towards hydrolysis to a great extent.
The film thickness remains constant at early times while refractive index decreases, con-
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Figure V.3 – Refractive index and thickness variation during dissolution in PBS at 37 ◦C, static condi-
tions. In yellow is reported the refractive index value of PBS in the same conditions, previously measured.
Thickness is normalized on the thickness value at t=0. In early times dissolution enlarge the pores while
thickness remains constant, causing a decrease in the refractive index of the mesoporous layer. Two
mechanisms are possible for the advanced stages of dissolution: either thickness starts to diminish homo-
geneously or a highly swollen silica gel is formed and later degraded. The data seemed to confirm the
latter hypothesis, showing a remarkable thickness increase.
firming the mechanism in which dissolution starts in the pores, leading to a progressive
increase of pore volume in a so-called bulk dissolution mechanism [98, 195]. Refractive
index of the silica layer reaches the value of PBS after only 50 minutes in the case of
CTAB-templated silica, meaning that almost all its volume is replaced by PBS. In the
case of F-127 templated silica this point is reached after 100 minutes, doubling the disso-
lution time.
At the moment in which the refractive index of the silica layer matches the one of the
medium, the ellipsometer showed limitations in measuring layer thickness accurately, find-
ing a huge swelling as the best fitting solution. We can’t verify the in-situ thickness with
independent experiments, so it is not possible to know if at a certain value of porous
volume the silica layer becomes an highly swollen gel of if it is just an artifact due to the
very small optical contrast between the mesoporous film and the surrounding medium.
The formation of a porous gel layer at the surface is possible and it has been proved in
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the case of dissolution of nuclear glass [202,203], anyway the material and the conditions
of dissolution in the latter case are pretty different from ours, thus the material behavior
could differ sensibly. When retired from liquid media, samples showed no visible silica
layer and by ellipsometry we measured a residual layer of 1-5 nm. We can thus assume
that mesoporous silica dissolution is complete in these conditions and saturation of the
liquid medium is never reached, as expected.
The volume fraction of silica in each film was calculated from ellipsometric data using a
Bruggeman effective medium approximation, considering the layer optical constants as a
two-phase mix of the optical constants of silica walls and optical constants of PBS.
Bruggemann effective medium approximation (BEMA) model allows determining the rel-
ative volumetric fractions fa and fb of two materials A and B of known dielectric constants
εa and εb within a volume unit of measured dielectric constant ε (eq. V.2). In our case ε
is the dielectric constant of the porous film, measured by ellipsometry, εa and εb are the
dielectric constants of PBS and dense silica, respectively. Both the optical properties of
silica and PBS have been measured previously by spectroscopic ellipsometry (the ones of
silica have been evaluated on a dense film of similar composition). Thus the volumetric
fraction of PBS (fa) and silica (fb) can be obtained by fitting the experimental data. Re-
maining silica mass was calculated from the silica volumetric fraction and the thickness
of the film, assuming the walls as chemically homogeneous with a density of 2.2 g · cm−2,
usually accepted for amorphous silica.
fa
εa − ε
εa + 2ε
+ (fb)
εb − ε
εb + 2ε
= 0 fa + fb = 1 (V.2)
V.3.1 The Noyes-Whitney model of dissolution
The evolution of the dissolved silica amount versus time is reported in figure V.4. We ob-
served that more than 85% of silica was dissolved in the first 40 minutes for some films and
in about 2 hours for more stable materials. From figure V.4 we can also notice that films
templated with pluronic F127 dissolve slower than films templated with CTAB, suggest-
ing that porous volume and surface area play an important role in dissolution kinetics. To
address this aspect deeply we investigated samples presenting different structure, surface
area and porous volume. In fact, dissolution is proportional to the surface area exposed
to the solvent, according to Brunner modification of the Noyes-Whitney equation, which
describes the dissolution of a solid in a liquid:
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Figure V.4 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution in PBS
at 37 ◦C.
dC
dt
= kS(Cs − C)
with k = D
V h
(V.3)
where the concentration of the dissolved species in solution C follows a first order kinetics,
being S the surface area of the solid, Cs the solubility at equilibrium and k a constant
factor gathering the diffusion coefficient of the dissolved species D, the volume of the
solution V and the width of the diffusion layer h. Practically, dissolution is driven by
the concentration gradient between the surface of the solid material (where C is assumed
equal to Cs) and concentration in the bulk solution, with a rate which depends on the
exposed surface. The concentration gradient is controlled by the diffusion process between
the surface and the bulk solution, which, in this model, is the rate limiting step.
After integration, eq. V.3 gives the value of concentration at any given time t ≥ 0:
C(t) = Cs(1− e−Kt) (V.4)
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where K = kS and from which we can develop the expression for the amount of dissolved
silica Mt, normalized on initial silica mass M0:
Mt
M0
= CsV
M0
(1− e−Kt) (V.5)
Anyway, it has to be pointed out that equation V.3 is derived from Fick’s laws assuming
special boundary conditions: the solution concentration in the bulk is assumed to be zero
(perfect sink condition) at t=0, and the surface and the diffusion coefficient are considered
constant with time. This model assumes that saturation is rapidly achieved at the solid-
liquid interface and then diffusion takes place across a layer of stagnant solution, called
diffusion layer, towards the bulk solution. This concept of a stagnant diffusion layer is not
perfectly realistic but it allows easier calculations [204], in reality the boundaries of the
diffusion layer are not sharp and it exists a region where concentration decreases gently
towards the bulk one (see figure V.5).
Figure V.5 – Scheme showing the model concentration–distance-profile through the unstirred liquid
boundary layer surrounding a solid substance, which dissolves in its own solution, by Nernst-Brunner.
The theoretical trend is represented by the solid line, while the dotted curve represents a more realistic
trend in which concentration decreases less abruptly towards the bulk value, through a zone in which
convection gains more and more importance on diffusion as transport mechanism.
In our system dissolution happens fast, following Noyes-Whitney kinetics, nevertheless,
the boundary conditions of this model are not valid in our conditions. Indeed, in our
system we will never reach saturation, while the Noyes-Whitney model assumes that the
dissolving solid constitutes an amount of material equal or greater than the saturation
limit. Thus, it is reasonable to think that the silica dissolution kinetics will follow equation
V.3 as long as the amount of solid material will be enough to sustain the kinetics.
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Moreover, mesoporous films surface area evolves with time due to the bulk dissolution of
the material and D may not be considered constant. In fact, inside the porous network,
diffusion is limited by the accessible volume and its tortuosity, which means that a diffus-
ing molecule in a porous solid will have a diffusion coefficient Deff ≤ D, where D is the
diffusion coefficient in the selected medium when diffusion is not hindered. A model for
molecular diffusion in porous matrices was developed by Higuchi in 1963 [205] for drug
release devices, where Deff is defined as follows:
Deff =

τ
D (V.6)
where  is the porous volume of the solid and τ is the tortuosity of the porous network.
Higuchi assumed tortuosity and porosity to stay constant, because he developed his model
for porous matrices which don’t evolve with time. This may not occur when the porous
solid undergoes bulk degradation. In fact during the dissolution/erosion of the matrix the
porous volume increases and the morphology of the pores changes, along with their surface
curvature and the number of open connections with contiguous pores, until it reaches a
configuration in which the channels can be considered completely interconnected. It is
very difficult to follow the evolution of the tortuosity factor τ but it is reasonable to
assume that it is decreasing during dissolution. At the same time the porous volume 
increases continuously, and we can follow its trend fitting the ellipsometric data with a
Bruggerman-EMA model.
The differences between conditions of our experiments and the Noyes-Whitney dissolution
model mean that mesoporous silica layer dissolutions can deviate from Noyes-Whitney
kinetics.
If we fit the silica concentration data with the corresponding equation V.4, we can see
a good agreement between the model and the experimental data in the first part of the
experiments, while after the 50% of silica is dissolved, the kinetics of release starts to slow
down (figure V.6). Considering the first half of the dissolution experiments and a value of
Cs = 145 µg/mL, we found K = 2.5 · 10−3 s−1 for CT450, K = 2.78 · 10−3 s−1 for CT130
and K = 9.6 · 10−4 s−1 for F450.
Because of the difference in boundary conditions between our systems and the theoretical
model, the description of the constant K needs some further considerations. We know
that K gathers the surface factor S and the coefficient of diffusion D, which are treated
as constants in the model but in our system this assumption may not be true. In fact,
surface is evolving with time during dissolution, and towards the end its value will surely
drop. Concerning the diffusion coefficient D we don’t know if the porous network limits
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(a) (b)
Figure V.6 – Silica concentration growth during dissolution process is reported for mesoporous silica
films templated with CTAB (CT130 and CT450) and with Pluronic F-127 (F450). The three samples
have equivalent porous volume (61-62%). Dashed lines are the theoretical trends according to equation
V.4.
the diffusion causing Deff to be smaller than D or if it is permeable enough to consider
Deff ≈ D. If the diffusion is limited at the beginning, Deff will increase gradually during
dissolution (because porosity  will increase and network tortuosity τ will decrease) until
it will reach the value of D. Thus there will be 3 scenarios for K evolution during
dissolution, summarized in figure V.7:
1- S stays constant at the beginning and starts to diminish in advanced phases of dis-
solution, D stays constant throughout the process. Thus, K is directly proportional to
the exposed surface and it will decrease in the last part of the dissolution experiments,
shaping an inverse exponential release curve.
2- S stays constant at the beginning and then increases, due to the modified morphology
of the porous network after the initial stages of dissolution, towards the end of dissolution
it decreases. D stays constant. Another scenario could consider S constant in the first
part of dissolution and Deff increasing due to an evolution of the porous network towards
a more open and interconnected system. In both these cases, K increases after the first
phases of dissolution (due to an increase of S or of Deff , or both) and decreases in the
end, due to a decrease of the surface involved, shaping a sigmoid release curve.
3- Deff increases and S decreases but they compensate each other, giving a K which
stays constant for the majority of dissolution process, before slowing down at the end,
when surface factor S drops. In this case the release plot is linear and the concentration
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Figure V.7 – Possible scenarios of silica release considering the evolution of surface and diffusion co-
efficient with time. 1- Diffusion is never hindered and D is constant throughout the process. Surface
stays constant for the first 50% of dissolution, then starts to diminish. 2- Reactive surface or D (or both)
increase shortly after the beginning and decrease towards the end of dissolution. 3- Changes of S and D
compensate and dissolution happens at a constant rate. In any case, towards the end, when almost all
silica is dissolved, surface value drops and so does the rate of dissolution. The release curve always ends
on a plateau when silica concentration reached its maximum value.
in solution increases at a constant rate until it reaches a plateau when all the silica is
dissolved.
Influence of the mesostructure
Surface area and porous volume, which are interconnected, are crucial parameters to tune
the rate of dissolution. The structure of the porous network can play a role, but if the
values of porosity and surface area are similar, the difference in dissolution rate are very
small as showed in figure V.8 for two similar silica layer templated with CTAB, one having
a Pm3n cubic mesostructure and the other having a disordered wormlike porous network.
The CTAB-templated silica presenting a Pm3n structure (sample CT450-1) dissolves at
the very same rate than the wormlike structure (sample CT450-3) for more than 70% of
the dissolution process (for similar values of Vp and S). Towards the end of the dissolution
process the wormlike structure dissolved faster than the Pm3n, probably because of the
very interconnected geometry of the porous network, which causes faster diffusion and
surface evolution.
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Figure V.8 – Dissolved silica mass Mt normalized on initial silica mass M0 during dissolution in PBS at
37 ◦C. Both samples are mesoporous silica layer templated with CTAB and exposed to the same thermal
treatment (450◦C, 15 min). They have similar porosity (0.56 for the wormlike structure and 0.62 for the
Pm3n) and surface area (800-850 m2/cm3).
Influence of specific surface and porous volume
On the contrary, Pluronic F-127-templated films dissolve two times slower than CTAB-
templated ones, for similar values of Vp (figure V.9). This happens because they present a
much lower surface area (370 vs 850 m2/cm3). Moreover, not only their starting exposed
surfaces are significantly different but also their evolutions don’t happen at the same
rate. In fact, Pluronic F-127 templated films presented thicker silica walls than CTAB-
templated ones, so their porous volume and surface evolve at a slower rate. Anyway this
structural contribution is someway included in the surface factor and we can say that
dissolution rate of mesoporous silica depends linearly on specific surface area of films
(figure V.10).
Analyzing two equivalent films (CTAB templated, calcined at 450 ◦C, Pm3n cubic mesostru-
cure) with different porous volume we notice a different shape in the release curve (figure
V.11). The sample CT450-1 has a porous volume of 62% while CT450-2 has a porous
volume of 43%. The CT450-1 silica release curve belongs to case 1, where K follows the
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Figure V.9 – Dissolved silica mass Mt normalized on initial silica mass M0 during dissolution in PBS at
37 ◦C for mesoporous silica films treated at 450◦C for 15 min. CT450 is templated with CTAB and F450
with Pluronic F-127. They have similar porosity (0.62 for CT450 and 0.61 for F450) but very different
surface area (850 vs 370 m2/cm3 for CT450 and F450, respectively).
evolution of the surface which stays constant for a while and diminishes in the second
part of dissolution. It is reasonable to assume D as constant, given that the porosity is
already high when dissolution began.
Starting from a lower porosity value, the curve of silica release assumes a sigmoid shape,
as described in case 2. We can attribute this behavior to a starting rate which increases
shortly after the beginning and decreases again towards the end of dissolution. This could
be due to an initial increment of surface or to a raise in the value of Deff , or both. In
fact, for lower porosity values, the porous network may hinders molecules diffusion, in this
case when Vp increases Deff rises, accelerating the release. Another possibility is that not
all the surface is available to react with water at the beginning of dissolution, because of
pore blocking. In the latter case, the increment of Vp due to dissolution can trigger an
acceleration of the release rate, due to an increase of reactive surface. This effects can
also combine. Towards the end of dissolution the surface value drops inevitably and the
release rate slows down.
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Figure V.10 – Rate of dissolution K derived from equation V.4 vs surface area for mesoporous silica
thin films. All the samples have been obtained in the same conditions (deposition speed = 2mm · s−1,
26 ◦C and 30% RH) and treated at 450◦C for 15 min. The point at the lowest surface value refers to
dense silica while the porous samples have porosity values ranging from 0.43 to 0.62. The surface has
been evaluated from porosimetry measurements with t-plot method, the error bars reported corresponds
to an error on the surface value of 20%.
Figure V.11 – Dissolved silica mass Mt normalized on initial silica mass M0 during dissolution in PBS
at 37 ◦C for mesoporous silica films (CTAB templated, Pm3n structure) treated at 450◦C for 15 min.
The sample CT450-1 has a porous volume of 62% and a surface area of 850 m2/cm3, while CT450-2 has
a porous volume of 43% and surface area of 600 m2/cm3.
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V.3.2 Alternative models of dissolution
There are some other models which concern molecular release process from a solid device,
and they are usually employed in pharmaceutical studies. Nevertheless, the most of them
only consider the diffusion process of a soluble drug encapsulated in a matrix (dense or
porous). This situation doesn’t correspond to our case of study, in fact, mesoporous
silica dissolution implies the hydrolysis of silica network and then the diffusion of the
dissolved species. The models used in pharmaceutics only accounts for the second step of
the process so, most likely, they will not fit with the silica dissolution kinetics. We tried
some of them, verifying the mismatch between our data and the models.
Figure V.12 – Dissolved silica massMt during dissolution in PBS at 37 ◦C. CT450-1 and CT450-2 have
different values of surface and porous volume. Data have been fitted with Higuchi equation V.7 (dashed
lines).
The already cited Higuchi model [205] describes a square-root dependence of the released
amount with time (V.7):
Mt =
√
Deff (2C − Cs)(Cst) (V.7)
This kind of kinetics can’t describe satisfactorily our systems, as evident from figure V.12.
The silica mass release of mesoporous films seems rather to follow a zero-order kinetics
where Mt increases at a constant rate (eq. V.8), as showed in figure V.13.
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Mt
M0
= βt (V.8)
where β includes the surface parameter S and the diffusion coefficient Deff , which is
dependent on porous volume and morphology. Thus, β gathers some parameters which
aren’t constant during dissolution, but their combined evolutions account for a constant
rate of silica release. Zero-order release kinetics have already been observed for swellable
polymeric devices [206–209]. Ritger and Peppas presented an empirical equation, valid
for MtM0 ≤ 0.60, useful to analyze data from Fickian and non-Fickian diffusional release for
this kind of systems [206,207]:
Mt
M0
= βtn (V.9)
where n describes the transport mechanism involved, being equal to 0.5 for Fickian dif-
fusion and to 1 for the so-called case II transport, which provokes a zero-order release
kinetics. If n assumes values between 0.5 and 1 the transport mechanism is a combination
of Fickian and non Fickian behavior, with the latter dominating. Fitting our release data
with equation V.9 we find for all the systems a dominance of non-Fickian transport, with
values of n close to 1, indicating a condition in which silica release is almost linear with
time (zero-order kinetics), as showed in figure V.14.
Nevertheless, we can notice that there is a case in which n is higher than 1, which is
not possible. This is an indication of a discrepancy between the model assumptions and
our system conditions: in fact, also in this case the only part of the dissolution process
considered by the model is the transport outside the matrix of a species which is already
dissolved, without taking into account the hydrolysis of silica.
Moreover, for polymeric swellable matrices it was pertinent to imagine a non-Fickian
transport mechanism, due to chains relaxation processes which modify molecules diffusion,
but for mesoporous silica there’s no reason to assume this kind of transport mechanism.
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Figure V.13 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution in
PBS at 37 ◦C. Data are reported for the first 60% of dissolution process (Mt
M0
≤ 0.6) and have been fitted
with linear equation V.8 (dashed lines).
Figure V.14 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution in
PBS at 37 ◦C. Data are reported for the first 60% of dissolution process (Mt/M0 ≤ 0.6) and have been
fitted with equation V.9 (red lines) finding n values of 0.78 for CT130 (not reported), 0.89 for CT450-1,
1.09 for CT450-2 and 0.94 for F450.
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V.3.3 Mesoporous Silica Nanoparticles film
All the informations gathered on mesoporous silica thin film dissolution are meant to
provide knowledge about this process in order to gain control upon mesoporous nanopar-
ticles use in biomedical applications. Thus, we wanted to check if the results obtained on
mesoporous films could be applied in case of equivalent mesoporous nanoparticles.
To do so, we deposed mesoporous silica nanoparticles on a silicium wafer and analyzed
their dissolution in PBS at 37 ◦ by in situ ellipsometry, employing the same experimental
setup used for thin films.
The nanoparticles were synthesized adding 3 mL of a solution 0.88 M of TEOS in EtOH
to a solution of CTAB (0.29 g) in water (125mL) and ammonia 0.512 M (25mL). The
water/ammonia solution is kept at 50 ◦C under stirring (750 rpm) during the addition of
TEOS solution. The nucleation happens in the first 3 minutes at 50 ◦C and the solution
is then kept under stirring at r.t. for 2 hours.
Nanoparticles have diameters around 40 nm, 2D-hexagonal mesostructure and their mor-
phology is shown in SEM pictures V.15.
Figure V.15 – SEM images on mesoporous silica nanoparticles, synthesized using CTAB as templating
agent.
The sol containing the silica particles has been dip-coated on a silicium substrate at
0.01 mm · s−1 and 50◦C to obtain a layer of nanoparticles. The high temperature and
slow withdrawal speed are necessary when dip-coating from aqueous solution, to avoid
dewetting phenomena. The film has then been heated at 130 ◦C for 1 night and washed in
EtOH to remove CTAB. The film refractive index at 632 nm was 1.102 meaning that the
layer had a very high porosity, as expected for packed mesoporous nanoparticles. SEM
images on the colloid layer (figure V.16) showed a dense packing of the nanoparticles.
We performed environmental ellipsometric porosimetry (EEP) on the nanoparticles film,
136
V.3. Dissolution in PBS
Figure V.16 – SEM images on mesoporous silica nanoparticles film, dip-coated at 0.01 mm · s−1 and
50◦C. The bottom left picture has a higher resolution.
observing two adsorptions which corresponds to the capillary condensation in the meso-
pores (lower P/P0) and to the filling of inter-particles pores (higherP/P0). The water
adsorption curve is reported in figure V.17. Anyway, it was not possible to calculate the
specific surface area with the t-plot method, because of the huge incertitude on external
surface. In fact, on a flat film, the external surface can be easily evaluated knowing the
film volume, while in this case the layer has a huge surface roughness (≈ 45 nm from ellip-
sometric measurements) and a complicated, irregular surface morphology, as can be seen
from SEM images (figure V.16). These nanoparticles have usually surface area ranging
from 900 to 1200 m2/cm3 but when packed in a multilayer film they will most probably
lose some accessible surface due to the compact spatial arrangement.
Fitting the dissolution data with Noyes equation, considering a saturation limit of 145
µg/mL, we found aK value of 3·10−3 s−1 for the first part of the release curve, very similar
to the value found for silica mesoporous films with surface values of 800-850 m2/cm3
(K = 2.5− 2.55 · 10−3 s−1). The silica release is slightly slower than for mesoporous films
after the 50% of dissolution, this is most probably due to a different surface evolution
between a layer of nanoparticles and an homogeneous silica layer. Anyway, the 80%
of silica is dissolved within 50 minutes, and the very similar dissolution rate observed is
encouraging: it confirms the relevance of data obtained on mesoporous films for predicting
nanoparticles behavior.
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Figure V.17 – Evolution of refractive index vs P/P0 of a layer of mesoporous silica nanoparticles (40
nm of diameter, pore size = 2.5-3 nm) during water adsorption. We can notice the capillary condensation
in the mesopores at P/P0 = 0.60 and the adsorption of water in the pores between nanoparticles at a
P/P0 value of 0.87. In the box is reported the evolution of film thickness vs P/P0.
Since the starting rate of dissolution fit perfectly with the one of silica mesoporous films
having a surface of 800-850 m2/cm3 we can assume a similar value of available surface for
this nanoparticles film.
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Figure V.18 – Silica concentration during dissolution in PBS at 37 ◦C of a film of mesoporous silica
nanoparticles. Theoretical trend according to Noyes equation V.4 is reported with a dashed line and has
a K = 3 · 10−3 s−1.
V.4 Role of surface adsorbed biomolecules
It is nowadays established that a layer of proteins (corona) forms on the surface of
nanoparticles when they are in contact with biological fluids. The protein corona mediates
the interactions of nanomaterials with cells and it determines nanoparticles biocompati-
bility and biodistribution.
We want to investigate the influence of protein corona on silica dissolution rate, to be
able to predict silica nanoparticles behavior in a more realistic environment. To do so, we
started performing dissolution experiments in a bovine serum albumin (BSA) solution in
PBS, to pass later to more complex biological fluids such as serum and blood.
BSA is widely used as a model protein because it has similar properties and molecular
weight to its human variant, human serum albumin, while being easily available and less
expensive. Albumin is found in all bodily fluids, being very often a major component of
the corona. BSA has a molecular weight of approximately 66 kDa, an isoelectric point of
4.7 and it exists in multiple forms depending on the pH of its environment. The common
forms of BSA are the normal form (N form, pH 9.0–4.5), the fast form (F form, pH
4.0–3.5), and the extended form (E form, pH below 3.5). The sizes of N, F, and E forms
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of BSA are: 8.0 x 8.0 x 3.0 nm, 4.0 x 4.0 x 12.9 nm, and 2.1 x 2.1 x 25.0 nm, respectively.
It has been proved that BSA can undergo conformational changes upon adsorption onto
a surface. In particular, onto silica particles it showed a loss of α-helix structures because
of strong interactions with hydroxyl groups on the surface, causing the protein secondary
structure modification [210]. In fact, even if BSA and silica are both negatively charged
(for example at pH = 7.4) strong hydrogen bonding interactions exist between the amino
acid chain and the silica hydroxyl groups. Moreover, NH3+ groups present on the protein
can participate in electrostatic interactions with deprotonated silanols.
In literature are reported values around 4.5− 5 · 1011molecules · cm−2 for BSA adsorption
onto SiO2 surface at neutral pH [210] and concentrations of 3-10 g/L, which describes a
multi layer surface coverage (a monolayer should be around 2− 4 · 105molecules · cm−2
depending on the adsorption conformation).
We perform dissolution experiments of mesoporous silica layers in a solution of BSA in
PBS (37 g/L, pH = 7.4). The chosen concentration is in the range of albumin concen-
tration in human blood. In these conditions, BSA will be in its N form and will bring a
negative surface charge. At such concentration, we assume an uniform adsorbed layer on
the silica surface which reaches its equilibrium before the start of dissolution experiments.
Depending on its mobility, the protein surface layer should hinder diffusion (and so, dis-
solution) more or less, thus, we expect dissolution to happen at a slower rate compared
to PBS.
Figure V.19 – Refractive index of mesoporous silica film CT130 (CTAB templated, stabilized at 130
◦C) during dissolution in BSA solution (37 g/L) at 37 ◦C in static conditions.
In such protein rich environment, the refractive index of the silica layer showed a very
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different evolution compared to the dissolution in phosphate buffer, as reported in figure
V.19. The decrease of refractive index n is much slower and it is interrupted after 40
minutes of dissolution. At this point, the refractive index value starts to increase sensibly,
until it reaches the value of the beginning in about 40 min, then it decreases constantly.
This peculiar behavior could be interpreted as a change in protein adsorption. In fact,
adsorbed BSA may change its conformation when the silica surface evolves and proteins
may pack differently on the surface, restoring a more compact surface coverage (which
causes the rise of n).
However, this behavior was not observed on calcined silica samples CT450, of any porosity
and structure. The evolution of their refractive index is an almost linear decrease, with no
sign of modified adsorption on the surface, as showed in figure V.20. The only difference
between CT130 and CT450 films (being equal surface and porous volume) is the method
of removal of the surfactant. In CT450 the surfactant is decomposed by thermal treatment
at 450 ◦C, while in CT130 it is extracted through ethanol washing. We started to think
that the behavior observed for CT130 in a BSA solution could be due to the presence of
some residual CTAB molecules.
Figure V.20 – Refractive index of mesoporous silica film CT450 (CTAB templated, calcined at 450 ◦C)
during dissolution in BSA solution (37 g/L) at 37 ◦C in static conditions.
An investigation of the literature on this subject showed that CTAB forms a protein-
surfactant complex with BSA, not soluble in water, unfolding the protein and inducing
its aggregation with other BSA molecules [211,212]. The positively charged head group of
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CTAB interacts electrostatically with carboxylic groups of aspartic acid and glutammic
acid on BSA, which are deprotonated at pH = 7.4. This process reduces the ζ-potential
of BSA, triggering aggregation after an initial lag phase which was found to last around
20 minutes [211]. The presence of this CTAB-BSA complex and/or the BSA aggregates
on the surface of mesoporous silica films could explain the optical response of the CT130
layers.
The refractive index of the mesoporous silica layers after the washing step is 1.2-1.23 at
632 nm, equal to the values measured for CT450, meaning that the residual amount of
CTAB after ethanol extraction has to be very weak, because it is not influencing the
optical properties of the layer (a porous layer before the washing step has a refractive
index equal to 1.38-1.4) and could not be detected by ellipsometry.
We performed XPS experiments on ethanol-extracted samples, looking for bromine peaks
(binding energy of 70 eV), without detecting any residual bromine presence (figure V.21).
Figure V.21 – XPS survey spectra of CT130 sample after ethanol extraction of CTAB. No peak is
detected in the typical bromine area, around 70 eV of binding energy. Data above 250 eV are not showed.
Yet, even if XPS analysis could not detect any residual bromine in the extracted samples,
this doesn’t mean that there aren’t CTAB molecules inside the porous film. In fact, if
it is true that the detection limit of XPS is very low (≤ 0.5 atomic percent) it has to
be considered that XPS is a surface technique and does not analyze the sample bulk. It
is reasonable to imagine that if there are some few molecules of CTAB still embedded
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in the silica layer, they will be placed deeper in the sample, because solvent extraction
rely on diffusion. Even if there are only few CTAB molecules left, it is enough to form
some CTAB-BSA complex and adsorb it on the surface of the film. The amount of these
aggregates is probably very low and doesn’t seem to influence the overall dissolution
kinetics (considering the residual silica after 3h, measured ex-situ) but it is enough to be
detected by in situ ellipsometry because it modifies sensibly the optical response of the
sample.
When a weak flow (5 mL/min) was applied we noticed the shift of the perturbation to
earliest times but the behavior is similar. In order to confirm the role of the surfactant
in this process, we reloaded a calcined film CT450 with CTAB and analyzed it. So, in
the silica film after calcination there is no surfactant left and it doesn’t show any visible
change in surface adsorbed layer (figure V.20). When CTAB is reintroduced in this layer
(by soaking it in a CTAB-ethanol solution) we can see the same variation of refractive
index as the one reported for CT130.
Thus, we can infer that this peculiar behavior is due to the residual presence of CTAB
molecules in the mesopores. Even if their quantity is very low they influence the interac-
tions with BSA and reshape the interface. The formed CTAB-BSA complex unfolds the
protein and triggers its association in big aggregates which adsorb on the silica surface.
A liquid flow isn’t useful to remove them.
The observation of this phenomenon points out how important it is the washing step in
the synthesis protocol of nanoparticles made for drug delivery. In fact, if the conformation
of adsorbed protein may be not a main issue for dissolution experiments, it is indeed very
important in a biological environment. CTAB promotes aggregation of BSA molecules
which compromises their biological function. Actually, protein aggregation is linked with
several disease such as Alzheimer’s disease, Parkinson’s disease, Down’s syndrome and
Cataract and Sickle cell diseases [213]. The origin of aggregation is often unclear but
most of the times it involves partially unfolded native proteins. The formation of com-
plexes protein-ligand provokes the unfolding of the native structure of proteins and can be
a starting point for aggregation. It has been demonstrated in the case of CTAB, in which
the reduced ζ-potential of the complex CTAB-BSA promotes aggregation [211]. Com-
plexes with BSA have also been observed for other surfactants such as anionic sodium
dodecyl sulfate (SDS) and nonionic polyoxyethylene 8 lauryl ether [212] so, it is evident
to which extent washing protocols of nanoparticles need to be optimized to assure the
complete removal of the templating surfactant. In fact, usually solvent extraction is the
chosen method to eliminate the surfactants from nanocarriers, because nanoparticles of-
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ten aggregate during thermal treatments and if they contain some organic ligand they
can’t be heated to high temperatures or all the organics will decompose.
In the case of nanocarriers, the protein corona mediates every interaction between cells and
nanoparticles and if the proteins structure is altered their function will also be affected,
impacting the biological activity of NPs. For example, it has been reported that the
conformation of BSA induced by the CTAB-BSA complex has higher affinity for hematine
hydrochloride than the N form of BSA [211].
Because of the interference of residual surfactant in the measurements, we decided to
evaluate the influence of surface adsorbed proteins on silica dissolution on CT450 samples,
in which the CTAB is completely removed by thermal treatment. These samples are dip-
coated (speed 2mm · s−1, 26◦C,RH = 30%) from a solution of TEOS/EtOH/CTAB/H2O
with molar ratio 1:40:0.14:5. The solution is acidified by adding HCl 37% (0.09 molar
ratio with TEOS) and stirred at r.t. for 72h before use. Samples are then stabilized at
130 ◦C for one night and heated at 450 ◦C for 15 minutes.
From their dissolution experiments, we see that the presence of proteins slowed down
silica dissolution by a 5x factor, as reported in figure V.22. Fitting data with equation
V.4 we found a value for K = 3.4 ·10−6 s−1 when dissolution is performed in BSA solution
and K= 1.58·10−3s−1 for dissolution in PBS of samples with equivalent porous volume
(0.42-0.43) and surface (650 m2/cm3). We removed samples after 3 hours of soaking at
37◦C and after a quick rinsing in water we measured them by ellipsometry, finding almost
no silica residual layer (1-5 nm) for samples soaked in PBS, while samples soaked in BSA
solution still presented a thick layer of silica (about 70% of the starting thickness), as
showed in figure V.23.
The observed slowdown in silica dissolution rate is due to the proteins adsorbed on the
surface, which act as a barrier to diffusion and is consistent with the retarded drug release
observed by Shahabi [70] for porous silica nanoparticles in the presence of proteins. The
effect of protein surface layer on the dissolution rate has been observed for every sample
analyzed, independently from its porosity, structure, composition and thermal treatment.
The experiments have been repeated at least two times for each kind of samples, showing
very good reproducibility, with a difference in calculated dissolution rates K always ≤ 6%
for samples of the same series.
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Figure V.22 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution at 37
◦C in PBS (dashed line) and BSA solution in PBS (solid line), for CT450 samples with porosity values
Vp = 0.42-0.43. BSA concentration in solution is 37 g/L.
Figure V.23 – Mesoporous silica layers after 3 hours of dissolution at 37 ◦C in PBS (left) and BSA
solution in PBS (right), for CT450 samples with porosity values Vp = 0.42-0.43. BSA concentration in
solution is 37 g/L.
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V.5 Hybrid silica films
In practical applications silica is often employed as hybrid silica, containing functions such
as methyl or amine in a given percentage. Particularly, silica carrying amine moieties
is usually employed because of its easy functionalization chemistry which allows to bind
proteins, dyes or antibodies to the surface. Thus, we decided to investigate the dissolution
kinetics of hybrid aminated silica in physiological conditions.
V.5.1 Synthesis and characterization
We perform the experiment as described above, dip-coating from a sol of similar composi-
tion to CT SiO2 using TEOS and (3-Aminopropyl)triethoxysilane (APTES) as precursors
in a molar ratio of 0.85:0.15 and CTAB as templating agent. Hybrid silica is formed
through a co-condensation process, thus the organic moieties are anchored to the silica
matrix. The obtained films have a so-called wormlike disordered mesostructure with in-
terconnected pores, as revealed by GI-SAXS experiments (figure V.24). Hybrid films have
been treated at 130 ◦C for one night, then washed in ethanol to remove CTAB. This kind
of layers can’t be heated at higher temperatures or their organic groups will decompose.
Figure V.24 – (a) ellipso porosimetry (b) TEM image and (c) GI-SAXS pattern of an hybrid mesoporous
silica layer obtained through co-condensation of TEOS and APTES (0.85:0.15 molar ratio)
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V.5.2 Dissolution in PBS
Following the dissolution of hybrid mesoporous films in PBS at 37◦C, we noticed a much
slower dissolution rate than pure silica layers. Actually, comparing silica and hybrid silica
with similar porosity (0.42-0.45) and surface area (600 m2/cm3) we saw a very similar
dissolution rate in the first 25 minutes, then hybrid silica slowed down sensibly and after
60 minutes of dissolution (≈ 0.5% of total mass released) changed its rate to a much slower
one. Setting the experiment time to 16 hours we observed no acceleration: after the first
hour, silica dissolution followed a slow linear rate. Fitting the concentration data with
Noyes equation we found a starting rate of dissolution K=1.6·10−3 s−1, very similar to
the one of the equivalent pure silica films having the same Vp and surface (K=1.58·10−3
s−1).
Figure V.25 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution at 37
◦C in PBS for mesoporous silica (dashed line) and hybrid silica carrying amine moieties (solid line). Both
samples have porosity values Vp = 0.42-0.45.
We performed XPS analysis on samples before and after dissolution, finding an increase
in N/Si ratio which passes from 0.13 to 0.38. Observing the nitrogen peak we noticed a
decrease in the peak of protonated/hydrogen-bonded amine, which is usually attributed
to amines interacting through hydrogen bonding with silanols on the silica surface (figure
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V.26). This peak diminished after dissolution, probably because there are less close
silanols onto the silica surface for amines to interact with . In fact, given these data,
we propose a dissolution mechanism for which at the beginning the hydrolysis concerns
those Si-O bonds which are far enough from the amine moieties to be not influenced from
the functional group. This is supported by the fact that the starting dissolution rate is
coherent with the one of pure silica layers having the same characteristics.
(a) (b)
Figure V.26 – Nitrogen peak of XPS spectra of hybrid aminated silica (a) before dissolution, (b) after
dissolution in PBS at 37 ◦C for 3 hours. The atomic ratio N/Si calculated from the survey spectra (not
showed) passes from 0.13 before dissolution to 0.38 after 3h in PBS.
The propyl-amine group deactivates by inductive effect the near Si atoms towards nucle-
ophilic attack by water molecules, causing the material to be much more stable towards
hydrolysis. Thus, the starting dissolution rate is due to the hydrolysis of Si-O bonds
which aren’t affected by the presence of the organic group, once they have all reacted the
dissolution changes rate, slowing down. This means that playing on the composition of
the initial solution it is possible to tune the dissolution easily, even if an excess in amine
functions may produce a more fragile silica network, making the overall material less
stable towards hydrolysis than a composition with a smaller organic percent, as already
observed by Fontecave [98].
This is also interesting considering drug delivery applications because the amine group can
interact with drugs loaded in the mesopores, retaining them and releasing them slowly. At
the same time, any interaction with other molecules (electrostatic or hydrogen bonding)
could modify the inductive effect on Si atoms. Indeed, the behavior of drug-loaded hybrid
nanoparticles will strongly depend on the matrix/drug interaction and solubility of the
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drug [214]. Thus, experiments with encapsulated or grafted drugs should be carried out,
employing different ratio of silica functionalization and different drugs (cationic, anionic.
hydrophobic, hydrophilic).
V.5.3 Role of surface adsorbed proteins
We performed the dissolution experiments on hybrid silica in presence of proteins, as
previously described for pure silica films. We used the same experimental apparatus and
the same protein solution (BSA in PBS 37 g/L, 37◦C).
Figure V.27 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution at 37
◦C for mesoporous silica (dotted line) and hybrid silica carrying amine moieties (solid line). Both samples
have porosity values Vp = 0.42-0.45. For comparison, it is reported also the release of a similar hybrid
mesoporous silica film in PBS at 37 ◦C (dashed line).
As can be seen in figure V.27 the presence of surface adsorbed proteins slows down the
dissolution kinetics, in a similar way than observed on pure silica films. The diffusion
barrier constituted by BSA molecules hinders the release of dissolved species, keeping the
overall dissolution rate low. We didn’t observe the formation of CTAB-BSA complexes
onto the surface of hybrid films, although they have been washed in ethanol to remove
the surfactant with the same protocol used for pure silica films. The washing proved itself
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more efficient in the case of hybrid silica, probably because of the electrostatic repulsions
between the cationic head of CTAB and the protonated amines on the silica surface. The
values of dissolution rate K calculated from Noyes-Whitney equation V.4 for silica and
hybrid silica dissolution in PBS and in BSA concentrated solution are reported in table
V.3. We can notice that dissolution rate in protein solution is smaller for both materials
but the protein effect on dissolution is more pronounced for pure silica than for hybrid
silica.
Table V.3 – Dissolution rate K of silica and hybrid silica films with equivalent porous
volume and surface area (Vp= 0.42-0.45 and S= 600 m2/cm3).
SiO2 PBS SiO2 BSA NH-SiO2 PBS NH-SiO2 BSA
K (s−1) 1.58 · 10−3 3.4 · 10−6 1.6 · 10−3 2.4 · 10−4
V.5.4 Surface chemistry
Before their use as drug delivery devices, mesoporous silica nanoparticles are usually
functionalized with a surface layer of PEG, to minimize protein adsorption and recognition
by the immune system. Thus, the material exposed to biological environment is an hybrid
material formed by a silica (or, most often, hybrid silica carrying organic functions) core
and a polymer outer shell.
We wanted to reproduce this structure and test its dissolution kinetics in physiological
conditions. To do so, we prepared PEGylated hybrid silica films as described in Chapter
II, section II.4. Unfortunately, we were not able to obtain the desired core-shell structure
preserving the free access to the porous network. We successfully grafted pegylated poly-
mer brushes on silica surface but from porosimetry data seems that the pores are blocked
by polymer brushes and are not accessible to water vapors. This would make comparisons
very difficult because, as we previously demonstrated, silica dissolution rates depend on
surface area and pores tortuosity, two factors deeply modified from brushes growth inside
pores.
We performed anyway dissolution experiments on these PEG-grafted films in PBS and
in BSA solution in PBS (37 g/L) at 37◦C. The ellipsometric modeling of the layers as
a mesoporous silica layer and a surface polymer layer was not possible. The refractive
index found for the silica layer was way too high (1.47 at λ = 632 nm), indicating that the
material is an hybrid containing polymer brushes in the pores throughout its thickness.
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Thus, without knowing the optical properties of this silica/polymer layer we couldn’t
calculate either the porous volume or the silica content.
For this reason, we will only comment the evolutions of layer refractive index and thick-
ness.
Figure V.28 – Thickness and refractive index evolutions of an hybrid silica layer functionalized with
PEGMA (500) brushes. Results are reported for dissolution in PBS and in concentrated BSA solution
(37 g/L in PBS) at 37 ◦.
Observing the refractive index in PBS we can see a slow decrease for the first 150 minutes,
which then accelerates, to stabilize itself reaching a plateau around 300 minutes. Thick-
ness decreased slowly in the beginning, then reached a plateau around 160 minutes to
start diminishing again after 250 minutes, faster than at the beginning. What is evident,
is that the dissolution kinetics of this polymer-hybrid silica are much slower than the
one of the substrate silica before polymer grafting. These PEGMA-grafted samples were
obtained from hybrid silica layers carrying amine moieties, after an ATRP reaction which
grafted polymer brushes on amine groups, as reported in chapter II, section II.4.
Hybrid silica carrying amines dissolved the first 50% of the total mass within 75 minutes,
then started a slower dissolution process concerning silica directly linked with the organic
moieties. After the polymer grafting, the latter process seemed to happen after 300
minutes, meaning that the first step of dissolution is 4 times slower. This is likely to
be due to a very hindered diffusion process caused by the presence of the brushes in the
pores. Because the brushes are grafted on the amine moieties, it is reasonable to imagine
that when the first step of dissolution process is finished the material will contain more
PEGMA in percentage, as it happens with amine moieties. The acceleration in refractive
index decrease is most probably due to an opening of the porous structure after a certain
time and to a less hindered diffusion, which also allowed the polymer brushes located
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in the pores to swell. This swelling would explain the simultaneous decrease of n and
increase of thickness (thickness stopped to diminish).
In protein solution, we saw an increase in refractive index of 0.02 compared to the material
in PBS, which is in the same range as the one observed for hybrid silica without brushes.
The thickness also increased slightly. These behaviors indicates a surface adsorption of
the proteins, which is not completely avoided by the PEGylated polymers. Nevertheless,
it is not possible to quantify the amount of protein adsorbed and if it is smaller than onto
silica without PEG. In fact, through ellipsometry in liquid medium in static conditions,
the ellipsometer "sees" not only the irreversibly adsorbed layer but also the proteins weakly
bonded to the surface layer.
Thus, to conclude, in situ ellipsometry is not the better analysis technique to study this
kind of hybrid films and we would need parallel measurements with other methods such
as neutron reflection, which could provide valuable informations on material density. In
this way we could be able to study the evolutions of both silica and organic part of the
material.
The grafting of poly(oligo(ethylene glycol) methacrylate brushes (p(OEGMA)) could be
a powerful tool to obtain PEGylated silica surfaces in a controlled way but it is necessary
to optimize the protocol for porous substrates, avoiding the reaction to take place also
inside the pores and limiting the grafting to the surface moieties. This could be done
performing the initiator grafting with pores occupied by surfactant or drug molecules, in
solvents and pH conditions which avoid cargo diffusion outside the pores and which allow
grafting reaction in the same time.
V.6 Monitoring Gold clusters embedded in mesoporous sil-
ica
Gold nanoparticles smaller than 2 nm (often also called gold clusters or gold quantum
dots) have peculiar optical and magnetic behaviors, different from the ones exhibited by
bigger particles, and are very promising for many applications including catalysis and
health care [215–217]. As the size of gold nanoparticles decreases below 2 nm, their
plasmonic properties are lost and their conduction band shows discrete energy levels,
originating a molecule-like behavior. The gold clusters are interesting for biomedical ap-
plication because they absorb light in the near-infrared (NIR) biological window (650–900
nm) and convert it into photons and heat, having great potential for imaging purposes
and photothermal therapies. Some of them also showed magnetic properties. However,
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they suffer a lack of stability in aqueous solvents and tend to aggregate quickly to form
bigger nanoparticles, losing their peculiar properties.
Recently, they have been successfully integrated in a mesoporous silica shell to form an
hybrid platform which preserves the properties of gold quantum dots in biological envi-
ronments and which has demonstrated good efficacy in photothermal treatment against
tumors in vivo [218]. The authors synthesized structures named "quantum rattles" which
are hollow spherical particles ( ≈ 150 nm total diameter) with mesoporous silica shells
( ≈ 25 nm thickness), hosting both gold clusters (<2 nm diameter) and AuNPs (aver-
age diameter 7.3 nm). The NPs are hosted in the cavity while the gold quantum dots
(AuQDs) are embedded in the mesoporous silica shell, as showed in figure V.29.
Figure V.29 – (A) Schematic structure of a silica quantum rattle. QRs hosts AuQDs (red) inside their
mesopores and gold nanoparticles AuNPs (yellow) inside their macrocavity. (B) Bright field TEM image
of an ultrathin section of resin-embedded QRs, showing AuNPs within the mesoporous silica shells. (Scale
bar, 0.2 µm.) (C) Bright field TEM image of a QR showing AuNPs within the cavity of the mesoporous
silica shell. (Scale bar, 20 nm.) (D) Higher-magnification bright field TEM image of the silica shell
showing the AuQDs (red arrows). (Scale bar, 20 nm.) Adapted from [218]
The QRs displayed a NIR extinction peak at 672 nm, typical of AuQDs, which excited a
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fluorescent emission mode at 827 nm and also exhibited T1 contrasting agent properties.
They have been tested in vitro without showing cytotoxicity over several days, they were
internalized by cells and accumulated in the perinuclear area within vesicles, as observed
through fluorescent images. They have been proved excellent multimodal imaging agents,
to be exploited in fluorescence, magnetic and photoacustic imaging. They have also
proved themselves effective in tumor burden reduction through photothermal treatment.
The QR-injected areas reached temperatures above 51 ◦C after less than 1 min irradiation
with a 671 nm laser, causing necrosis of cancer cells. Moreover, the QRs prolonged the
release of the drug payload when compared with hollow silica spheres filled with the same
drug (Doxorubicine, DOX). In fact, the presence of gold clusters in the mesopores hindered
the release of DOX forming a more tortuous pore structure and enhanced the affinity for
DOX. Consequently, the release of DOX was extended to 12 h from 4 h observed for the
silica particles free from AuQDs.
Similar structures, made of mesoporous silica nanoparticles with embedded gold quantum
dots, have been monitored in vivo through fast micro-X-ray fluorescence and micro-X-ray
absorption spectroscopy [219]. The theranostic vectors have been detected in the spleen,
in the liver and in the kidneys, and their presence seems not inducing any inflammatory
processes. The study reported no oxidation for the gold centers during their metabolism
but could not establish whether the AuQDs are still confined in the silica particles or not.
For their great potential as theranostic vectors, we decided to reproduce the structure of
quantum rattles and follow their evolution during dissolution of the silica shell. We syn-
thesized gold clusters and confined them inside a mesoporous hybrid silica layer, then we
monitored the optical properties of this hybrid layer in PBS through in situ ellipsometry.
We employed the setup previously described for mesoporous silica thin films dissolution
in PBS (figure V.1).
V.6.1 Gold QDs synthesis and characterization
Small gold clusters are not stable in their bare configurations and need ligand protection
to avoid aggregation. We prepared gold clusters stabilized by 4-aminothiophenol (4ATP)
which present 25 gold atoms and 17/18 ligands.
The Au25(4ATP)18 gold clusters were synthesized according to Demessence’s methodology
[220], employing gold (III) chloride trihydrate (HAuCl4 · 3H2O) as metal precursor and
lithium borohydride (LiBH4) as reducing agent in tetrahydrofuran (THF). Three solutions
need to be prepared as follows:
-Solution A: Dissolve 60 mg of LiBH4 in 25 mL of THF and let under stirring for 1h.
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Pay attention to the complete dissolution of the lithium borohydride, heat with a water
bath if needed.
-Solution B: In a 100 mL flask, dissolve 128 mg of ATP in 20 mL of THF. Put the flask
in an ice bath and let it under stirring at 500 rpm.
-Solution C: Dissolve 260 mg of HAuCl4 · 3H2O in 25 mL of THF.
Employing syringe pumps, add 20 mL of both solutions A (precursor) and C (reducing
agent) to the solution B (ligand), at a rate of 1 mL/min. Solution B is kept under stirring
at a temperature ≤ 25 ◦C for 5 hours. The reaction mixture have a brown/black color.
For the purification, eliminate the THF under reduced pressure at 40 ◦C and 300 mbar,
then centrifugate the obtained black solid 3 times washing with ethanol (8000 rpm, 15
minutes). Dry the solid.
Transmission electron microscopy (TEM) characterisation was carried out, TEM samples
were prepared by dispersing the gold clusters in tetrahydrofuran (THF), and then placing
a drop of the suspension on a carbon coated Cu grid. After solvent evaporation the
samples were ready. Figure V.30 shows the TEMmicrograph of the Au25(4ATP)18 clusters
synthesized. We can see the formation of large aggregates but also many well dispersed
clusters. Particle diameter ranges from 0.53 to 3.5 nm, with an average diameter of 1.78
± 0.62 nm.
Figure V.30 – Transmission electron microscopy image of gold clusters. The cluster size distribution is
shown on the right. The average diameter is 1.78 ± 0.62 nm.
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Optical properties of gold clusters are different from the ones of gold nanoparticles, in
fact, they don’t show a surface plasmon resonance band but discrete energy levels. This is
a consequence of the restricted size of the gold core and accounts for a molecular behavior
of the clusters. Thus, their UV-visible spectra have absorption bands corresponding to
specific electronic transitions.
The optical spectrum in THF was measured, it is shown in figure V.31 and has band
absorptions at 382, 520 and 672 nm. If peaks at 382 and 672 are typical of gold clusters,
the large peak at 520 indicates the presence of bigger NPs in solution, which have a plas-
mon resonance usually around 520 nm. These results are coherent with some previously
reported [220].
Figure V.31 – UV-visible spectrum of Au25(4ATP)18 clusters in THF.
Photoluminescent emission spectrum of AuQDs in solution was measured, showing an
excitation peak centered at 763 nm and an emission peak centered at 823 nm.
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Figure V.32 – Fluorescence spectrum of Au25(4ATP)18 clusters in THF.
V.6.2 Gold QDs confined in mesoporous silica
We prepared thin mesoporous films of hybrid silica through co-condensation of TEOS
and APTES, as already described in section V.24. These layers were immersed in a
solution of AuQDs in ethanol for 1 and 10 minutes and then analyzed by ellipsometry
and ellipsometric porosimetry. The two samples showed very similar results, indicating
that the loading of QDs in the mesopores is very fast and reaches saturation level after one
minute. To avoid misinterpretation due to little variations between samples we registered
data before AuQDs loading and after it for every film, comparing only data taken on
the same sample. From porosimetry results we observed a decrease in porous volume of
4-7% after the loading of gold clusters compared to the layers with empty mesopores. We
also registered an increase in refractive index values around 0.03 unities, as evident from
isotherms displayed in figure V.33.
These data suggested the presence of AuQDs in the pores, TEM micrographs confirmed
the loading of mesopores with gold clusters, as showed in figure V.37. We measured
the optical properties of thin films before and after dissolution through ellipsometry but
we were not able to register an increment of extinction coefficient k. In fact, employing
models for absorbing layers (which can account for absorption) the values of k obtained
were always close to the sensitivity limit of the technique (k = 0.002). Most probably,
the amount of gold embedded in the silica is too low to detect its absorption with this
method. For this reason, we didn’t discuss the k variations and we only evaluated the
evolution of refractive index n.
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Figure V.33 – Refractive index n vs P/P0 for mesoporous silica hybrid layers before (red line) and after
(blue line) soaking in a solution containing AuQDs. The refractive index of the layer increased sensibly,
indicating the loading of AuQDs inside the pores.
Figure V.34 – TEM images of (a-b) mesoporous hybrid silica and (c-d) quantum rattle structure, with
gold QDs embedded in a mesoporous hybrid silica layer. (e) Blow-up of a mesoporous hybrid silica film,
scale bar = 10 nm. (d) Blow-up of a mesoporous silica film loaded with AuQDs. Gold clusters are
indicated with red arrows.
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V.6.3 Dissolution of a quantum rattle structure in PBS
We dissolved the mesoporous hybrid silica films containing AuQDs in PBS at 37 ◦C. We
observed a slowing down of dissolution compared to the empty layer, which is not sur-
prising considering the decrease of porous volume due to the presence of gold clusters.
For sure, AuQDs reduced the reactive surface available and could also increase the hy-
drophobicity of the pores because of the phenolic ligands, leading to a decreased rate of
dissolution. The shape of the release curve drew a sigmoid, with a dissolution rate which
increased after the first 20-25 minutes, stays constant for half an hour and then started
to decrease to reach a linear slower rate corresponding to an higher amount of amine
moieties in the material (see section V.24). We previously proposed an explanation to
sigmoid release curves relying on a diffusion limitation in the beginning of the dissolution
process, either due to non accessible pore surface or to a porous network with high tortu-
osity. Hosting gold clusters in the pores could cause both, decreasing the available pore
surface and increasing the tortuosity of the diffusional path. When dissolution proceeds
the tortuosity decreases and some clusters are released in the medium, making more sur-
face available. At this point, when diffusion is not hindered anymore, the dissolution rate
increases.
The observed behavior confirmed our hypothesis on hindered diffusion and dissolution
due to a reduced surface and porous volume. In fact, when the rate increases after a
slower starting period, its value is comparable to the one obtained for hybrid silica and
mesoporous silica with equivalent surface area. In fact, fitting the silica concentration
growth with Noyes equation (V.4) we found a K value of 7.1 · 10−4 s−1 for the first 15
minutes, which then switched towards a value of 1.53·10−3 s−1 (17-60 min), consistent with
the rates previously observed for silica having the same Vp and surface (K = 1.58−1.6·10−3
s−1).
Comparing the amount of silica released normalized on starting amountMt/M0 of hybrid
silica and hybrid silica with embedded AuQDs we noticed an increase in the latter case.
Before reaching the slower kinetic regime due to a concentration of organic groups in the
matrix, the amount of dissolved silica is higher than for the empty matrix ( ≈ 70% vs ≈
50%). We proposed a dissolution mechanism in which in a first step is dissolved the silica
which is not affected by the inductive effect of the organic moieties and in a second time
the hybrid matrix, now with increased percentage of organics, which has much slower
dissolution rate. This hypothesis is supported by the fact that the first dissolution rate
is almost identical to the one of mesoporous silica with equivalent surface area and that
XPS analysis showed a concentration in N content (the organic functionality carries an
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Figure V.35 – Concentration of dissolved silica in solution vs time for a dissolution experiment at 37
◦C of a mesoporous hybrid silica layer containing AuQDs. The silica release curve has a sigmoid shape
with a lower rate k1 at the beginning an a higher rate k2 after 15 minutes.
amine group) after the first step.
In the case of the quantum rattle structure, there is no reason for the gold clusters to
modify the inductive effect of the organic moieties on the silica, making more Si centers
"free" from the influence of the alkyl chain. The most probable hypothesis is that the
observed increase in the amount of silica dissolved derived from an important decrease in
refractive index. In fact, since the amount of silica is calculated from optical properties
of the mesoporous layer, a huge drop in the refractive index results in a pronounced
increase in dissolved silica amount. Dissolving the silica porous matrix some AuQDs are
released and the refractive index variation associated with this process is larger than the
one associated with substitution of silica with PBS. Thus, the behavior of the matrix
doesn’t change overall and the observed increase in dissolved material amount is due to
an artifact due to the experimental method.
The measured kinetics suggests that the gold clusters stay confined in the silica matrix
until its dissolution and don’t diffuse outside in short times. If this was the case, we
should see no influence of the presence of AuQDs throughout the dissolution. To verify
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Figure V.36 – Dissolved silica mass normalized on initial silica mass (Mt/M0) during dissolution at
37 ◦C in PBS for mesoporous hybrid silica carrying amine moieties (dashed line) and mesoporous hybrid
silica with embedded AuQDs (solid line) . The porosity values of the two samples are similar before the
loading of AuQDs (Vp = 0.40-0.43.), after the adsorption of the clusters into the pores Vp = 0.33 for the
sample NHSiO2 + AuQDs.
whether or not the gold clusters remained in the porous matrix during the dissolution
process, we performed TEM on the films after 75 minutes of soaking in PBS at 37 ◦C and
we noticed the presence of numerous gold clusters still embedded in the matrix (image
V.37). This is not surprising because the amine group on the 4ATP ligands of the AuQDs
is deprotonated at pH=7.4 and interacts strongly with silica surface silanols, anchoring
the clusters to the pore walls. Some of the clusters aggregate when the matrix dissolves
but they kept size smaller than 6 nm, which will assure their clearance through kidneys
when employed as theranostic devices. The majority of them still had a diameter ≤ 2 nm
after dissolution, which allows the preservation of clusters peculiar optical and magnetic
characteristics (figure V.38).
Through in situ ellipsometry it wasn’t possible to follow the evolution of extinction co-
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Figure V.37 – TEM images of mesoporous hybrid silica layers with embedded AuQDs after 75 minutes
of dissolution in PBS at 37 ◦C. The gold clusters remained confined in the matrix and some of them
aggregate but they kept dimensions ≤ 10 nm overall.
Figure V.38 – Size distribution of gold clusters observed in the silica matrix after dissolution. The sizes
have been measured with ImageJ software on TEM micrographs, considering 280 clusters.
efficient k because of the very low amount of gold in the films, which furnished k values
in the range of instrument sensitivity. To monitor the absorption and the appearance or
not of a surface plasmon (meaning clusters aggregation inside the pores to form NPs) we
should load more gold in the mesoporous layer, employing a film with higher porosity or
using a thicker layer.
Otherwise, the absorption could be monitored through fluorescence experiments in liquid.
We were able to load AuQDs in a mesoporous hybrid silica layer carrying amine moieties
and we verified that the clusters stay confined in the silica matrix during the dissolution
process in PBS at 37 ◦C, being released when the wall dissolved themselves. We observed
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some aggregation between the clusters while the porous network became more intercon-
nected, nevertheless the average diameter of AuQDs stays lower than 2 nm, retaining the
peculiar properties of gold clusters and being in the size range of NPs renal clearance.
V.7 Considerations about in vivo conditions: shear stress
and particle flow dynamics
The purpose of targeted drug delivery devices is to reach the target site, anchor to it
and release the encapsulated drug spontaneously or upon an external stimulus. Various
vector administration methods exist depending on the localization of the target. For non-
organ-specific administration of antitumoral drugs, the usual method is injection. The
injected nanoparticles travel in the bloodstream, experiencing a fluid flow which depends
on the environment (big arteries or small capillaries). In a second time, nanoparticles will
be immobilized, either adsorbed at the surface of a target cell, removed by macrophages,
or, if they are small enough, cleared out by the kidney. For any situation in which
the nanoparticles anchor to some fixed surface, they are immobilized and must thus
experience a different shear stress due to the blood flow. The knowledge about degradation
of nanoparticles under a fluid flow is essential if we want to design efficient targeted
nanocarriers which ideally would not dissolve and release their cargo before reaching
their target site.
There are some applications for which controlling the dependence of particles degrada-
tion on flow is of major importance. For example to target kidney diseases, nanoparticles
arrive quickly in the kidneys and there, they are exposed to a very important flow rate
during the blood filtration. In this context, a drug carrier which accelerates its disso-
lution and drug release with the flow would be very efficient. We wanted to place our
silica dissolution results in a more realistic context, performing some experiments under
physiologically relevant flow conditions. To do so, we built a special setup coupling a
microfluidic channel with total internal reflection ellipsometry, and to compare flow con-
ditions between the experimental apparatus and the bloodstream we considered shear
stress values experienced by the surface.
In the body, the wall of blood vessels is constantly exposed to hemodynamic shear stress
because of blood circulation. The shear stress value can be calculated by Poiseuille’s law
which defines it as proportional to blood viscosity η and inversely proportional to the
third power of the vessel’s radius R (eq.V.10), considering vessels as uniform tubes with
laminar and steady flow Q. The velocity profile in these conditions is parabolic, with
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maximum speed umax on the tube axis, u=0 at the walls surface (no slip condition) and
average velocity V = umax/2.
τs =
4µQ
piR3
(V.10)
umax =
2Q
piR2
(V.11)
Figure V.39 – A) Scheme illustrating hemodynamic shear stress, dependent on the flow Q, on the walls
of a blood vessel. B) Diagram showing the range of shear stress magnitudes in the vasculature and in
cases of low-shear and high-shear pathologies. Reproduced from [221]
These equations can give a good approximation of the shear stress on the vessels walls,
even if the blood is not properly a newtonian fluid (it contains cells which tend to con-
centrate at the center of the vessels leaving a depletion zone close to the walls) and its
flow is not steady but pulsatile. Anyway, the Pouiseuille’s law is an easier model which
gives good estimations of the fluidodynamic of human circulatory system. This equation
is valid only if the flow is laminar, that is if the Reynolds number Re is < 2300. The Re
represents the balance between inertial forces and viscous forces within a moving fluid and
it is used to predict flow patterns (laminar or turbulent flow). In most of blood vessels Re
value is much lower than 1, assuring laminar flow, with the exception of aorta and vena
cava in which the high Re (3000-4000) indicates a turbulent flow.
Re =
2RρV
µ
(V.12)
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The Reynolds number can be calculated from equation V.12 where ρ is the fluid density,
V is the average speed of the fluid, µ is the viscosity and R is the vessel radius.
Physiological shear stress values range from 1-6 Dyne/cm−2 in veins and aorta to 10-
50 Dyne/cm−2 for arteries. Capillaries walls are usually exposed to shear stress values
around 35-40 Dyne/cm−2. There are some pathologic vascular conditions in which the
shear stress can reach 70 Dyne/cm−2 and beyond or, on the contrary, drop to values close
to zero [221]. The shear rate at the vessel axis, r = 0, is zero, so the blood cells and
every circulating nanoparticle encounter a range of shear stresses and shear rates over the
vessel’s cross-section.
The mentioned values are shear stress values at the vessels walls, thus a nanoparticle
traveling in bloodstream will experience such stress on its surface when it adheres to the
cells forming the wall. Nevertheless, while it is moving in the blood flow, the shear stress
on its surface will be much lower. In fact, for a sphere with radius r moving in a creeping
flow (Reł1)the surface shear stress is given by the following expression V.13 [222]:
τ = 3µV sin θ2r (V.13)
where θ is the angle between the point considered on the sphere surface and the flow
direction (see figure V.40). The surface shear stress is zero for points lying in the flow
direction and is maximum for points on the perpendicular direction. For this reason the
sphere rolls while it is dragged by the fluid.
Calculating surface shear stress for a nanoparticle with radius r= 50 nm and considering
blood viscosity as 3.5 mPa · s, we obtained values ranging from 5 · 10−12 to 1.1 · 10−9
Dyne/cm2 (depending on blood velocity, which changes from arteries to capillaries). Thus,
while traveling in the bloodstream, before adhesion to their target cells, nanoparticles
undergo a very low surface shear stress, which allows to consider static measurements in
undersaturated conditions as a good approximation for NPs behavior while injected in
the circulatory system. On the other hand, as soon as a nanoparticle adsorbs onto a fixed
surface, it will undergoes a shear stress several orders of magnitude higher.
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Figure V.40 – Distribution of shear stress on the surface of a sphere in a creeping flow.
V.8 Flow influence on dissolution rate
Nanoparticles employed as drug delivery carriers encounter several environments in the
human body which differ for pH, biomolecules compositions and fluid dynamic conditions.
The latter could play an important role on degradation process of NPs strongly influencing
diffusion dynamics.
For these reasons we developed a special setup in which we coupled total internal reflection
ellipsometry and microfluidics to study the dissolution of mesoporous silica under different
flow conditions (V.41).
In this ellipsometric technique the shift of a plasmonic resonance peak is followed, and
the value of refractive index of the material in contact with the fluid flow is extracted
using a Cauchy dispersion as optical model for the mesoporous silica layer. As previously
explained, the volume fraction of silica is calculated through a Bruggermann EMA model
and the mass of dissolved silica Mt is obtained. The plasmon peak shifts towards shorter
wavelengths during the dissolution process, due to a decrease in the refractive index of
the layer probed by the evanescent wave.
To compare flow conditions applied with those of bloodstream we chose flow values to
have physiological relevant shear stress values on the silica surface (1-35 Dyne/cm2). To
calculate the shear stress we used the following equation, derived from Stokes law in the
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Figure V.41 – Setup to perform total internal reflection ellipsometry under flow conditions. The
mesoporous silica film is deposited onto a glass substrate previously covered with a gold layer, the liquid
is flowed through the microfluidic cell.
case of a laminar flow between two parallel plates:
τ = 6µQ
h2w
(V.14)
where h is the height of the microfluidic channel (30 µm) and w is the width (4.8 mm).
However, we faced many problems of fabrication in the realization and optimization of
the setup, as reported in Chapter 4.
Finally we found a robust protocol for sample preparation, but some difficulties persisted
because the setup is pretty complicated and would need a calibrated stage and liquid
cell to eliminate all the incertitudes due to the position and alignment of the different
components.
The measurements in TIRE mode need a correction of ellipsometric function ∆ and Ψ
because of the prism presence. In fact, their value will be slightly shifted. Thus, it is
important to set these offset for every experiment, otherwise the fitting of the data will
not be possible. Moreover, the angle has also an offset, due to refraction inside the prism.
These are fitting parameters to add to the layer parameters we want to find (refractive
index, thickness), making the fitting process delicate. An offset has to be fixed at the
beginning of the experiments and then only layer parameters should be fitted.
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Figure V.42 – Ψ(λ) and ∆(λ) spectra acquired in total internal reflection ellipsometry (TIRE). At the
plasmon resonance wavelength the reflected intensity Ψ reaches its minimum value and the phase ∆ shows
a marked drop.
However, sometimes it is necessary to move the setup during experiments (because of a
liquid leak for example) and than the offset won’t be correct anymore.
Another important issue is air bubbles. If air bubbles enter in the microfluidic channel
and stick to the surface the plasmon peak loses its intensity and sharpness until bubbles
are removed. This happened very often and sometimes it took some minutes to remove
the bubbles. For this reason following a dynamic experiment, fitting refractive index and
thickness vs time, was sometimes complicated.
For all these reasons, we will comment only raw data from TIRE (∆ shift vs time) without
extrapolating optical properties nor silica dissolved amount.
In TIRE Ψ(λ) spectra resembles typical SPR curve, with the reflected intensity reaching
the minimum at the plasmon resonance conditions, while the ∆(λ) spectra showed a drop
in the phase near the resonance. The wavelenght of the minimum Ψ value will shift during
the dissolution and so will do the ∆ drop. This gives a possibility of kinetics study by
following the spectral shifts of Ψ and ∆ during the dissolution process. Usually the shift
in ∆ is higher that in Ψ, for this reason it is often the one selected to monitor the kinetics.
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Figure V.43 – Series of TIRE ∆(λ) spectra corresponding to the dissolution of mesoporous silica in
horse serum, with a flow rate of 600 µL/min and a surface shear stress of 17 Dyne/cm2.
Plotting the λ value of the minimum in ∆ function versus time we could evaluate the
dissolution kinetics looking at the time needed to reach a plateau. In fact, when Delta
doesn’t shift anymore it means that there are no more changes in the layer probed by the
evanescent wave, thus the dissolution is complete.
Comparing the ∆ shift of mesoporous silica samples, exposed to a PBS flow producing
shear stress equivalent to 9.5 and 18 Dyne/cm2, we didn’t observe a difference in the
kinetics, at least for the first 100 minutes (figure V.44). Nevertheless, paying attention to
the curve concerning the higher value of shear stress, we noticed that the plateau started
after 180 minutes, which is 3 times slower than equivalent experiments in static condition.
There is only one possible explanation for this behavior and it concerns a temperature bias
between TIRE experiments and static dissolution experiments. Indeed, we verified that
our system was not well thermostatted, also because of the particularly low temperature
(12◦C) experienced in the laboratory at the moment of the experiments. Moreover, the
temperature in the microfluidic channel changed with the flow rate, making difficult to
compare different experiments.
We finally found a method to keep the temperature at the desired value, passing the
microfluidic tubes inside a thermostatted metallic tube before entering the microfluidic
device. Unfortunately, we didn’t have enough time to repeat experiments in PBS and we
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Figure V.44 – Wavelength of the minimum value of ∆ vs time for mesoporous silica films exposed to a
PBS flow, causing a surface shear stress of 9.5 and 18 Dyne/cm2.
directly passed to experiments in real biological fluids such as serum and blood.
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V.9 Dissolution in real biological fluids
We developed a special setup for TIRE because we wanted to perform dissolution exper-
iments in real biological fluids, which usually are not transparent and can’t be employed
in standard reflection ellipsometry.
V.9.1 Serum
Thus, we tested mesoporous silica degradation when in contact to horse blood serum at
three different shear stress values: 4, 17 and 35 Dyne/cm2, corresponding to the shear
stress on the wall of veins, arteries and capillaries, respectively.
Serum is blood plasma from which clotting proteins have been removed, it contains all
the other blood proteins plus electrolytes, antibodies, antigens, and hormones. It doesn’t
contain cells.
Plotting the ∆ shift versus time we can see an important influence of the flow rate, as
reported in figure V.45. In fact, for the lower shear stress value, the plateau was reached
after 60 min, for a shear stress of 17 Dyne/cm2 after 30 minutes and for the higher value
of shear stress (35 Dyne/cm2) the ∆ minimum is stable after only 20 minutes.
The collected data showed a strong influence of the flow rate on the dissolution rate
of mesoporous silica. Indeed, considering the model of Noyes-Whitney (section V.3.1),
increasing the flow means decreasing the thickness of diffusion layer h which is inversely
proportional to k (see figure V.46). It is reasonable to think that when h has reached its
minimum value, further flow increase will bring no acceleration to the dissolution rate.
In the performed experiments, the increase of shear stress between 4 and 17 Dyne/cm2
caused a bigger decrease in dissolution rate than the change between 17 and 35 Dyne/cm2.
These results suggested that an high surface shear stress can increase the dissolution rate
of mesoporous silica of more than 10 times (compared to a static case where shear stress
is zero or close to zero), even in presence of surface adsorbed biomolecules.
Fixing the layer thickness at 150 nm, we fitted the variation of refractive index δn during
dissolution. The absolute value of refractive index doesn’t represent the effective n of the
mesoporous silica layer, because in the TIRE configuration the surface plasmon resonance
responds to the total variation within its sensibility range, being not able to distinguish
the silica layer from the adsorbed proteins. Anyway the variation in refractive index
between the starting point and the end of dissolution reflects the kinetics of the process,
even if it is not possible to extrapolate a dissolved silica amount.
Plotting the refractive index variation δn/δt versus the average flow speed V , we found
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Figure V.45 – Wavelength of the minimum value of ∆ vs time for mesoporous silica films exposed to
horse serum, with a surface shear stress of 4, 17 and 35 Dyne/cm2. Dashed lines are reported as guide
for the eyes.
a square root dependence (figure V.47). This agrees with the model developed by Levich
[204], which found a dissolution rate proportional to the square root of average fluid
velocity, in the case of a planar surface dissolution with a liquid flow parallel to the
surface.
Extrapolating the δn/δt in static condition (V = 0) for mesoporous silica dissolution
in serum (red dot in figure V.47, we found a value of 1.72 · 10−4 min−1. The static
measurement in standard reflection ellipsometry employing the liquid cell (not TIRE
mode) is not possible using serum as medium, because the light absorption from the
liquid is high and the intensity of the reflected beam is too low when it comes to the
detector. Nevertheless, the δn/δt of the silica static dissolution in the presence of BSA
protein is 2 · 10−4 min−1, a value very close to the one extrapolated for serum employing
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Figure V.46 – Concentration profiles vs distance of a dissolving solid substance exposed to different
liquid flow rates, with f1 < f2 < f3, representing the model of Noyes-Whitney in which an unstirred liquid
boundary layer of thickness h is in contact with the solid surface. Through this boundary layer concen-
tration decreases linearly from saturation value Cs to the bulk value Cb. If the bulk fluid is stirred by a
flow, the thickness of the boundary layer diminishes.
the fitting equation. If we assume that serum and concentrated BSA solution will behave
in a similar way respect to silica dissolution, with proteins acting as a diffusional barrier,
the good agreement with BSA data from static measurements means that the obtained
results may have some errors, due to setup differences, but the overall trend is correct.
This result has important consequences for drug delivery vectors, in fact, when the
nanoparticles are traveling in the bloodstream they undergo a very low surface shear
stress (equation V.13) and we can consider their dissolution rate almost equal to the one
measured in static conditions. When they adhere to the membrane of target cells they
are part of the vessel wall and they will experience the wall shear stress (≈ 10 order of
magnitude higher), dissolving much faster. This is ideal in drug delivery applications, be-
cause it means that any vector for which the drug release is related to matrix dissolution
will have enough time to reach its target without degrading itself and when it arrives in
the diseased area it will release its cargo quickly.
The registered kinetics for dissolution in serum were 6-12 times faster than the one mea-
sured in BSA solution and static condition. These experiments suggested that mesoporous
silica dissolution in vivo could be much faster than usually reported in literature. The
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Figure V.47 – Refractive index variation δn/δt versus the average flow speed V for mesoporous silica
dissolution in horse serum. Experimental points (black dots) have been fitted with a power law y = a+bxc
with c=0.5. From the fitting equation has been extrapolated the δn/δt for V = 0 (red dot). The black
and white diamond dot is the value of δn/δt for mesoporous silica dissolution in a concentrated solution
of BSA (37 g/L in PBS), reported for comparison.
relation between surface shear stress and dissolution rate could be used to predict the
delivery kinetics accurately for each application, depending on the nanoparticle path in
the body.
V.9.2 Blood
The interesting results obtained with serum pushed us to try a dissolution experiment in
blood. We could obtain some pig blood stabilized with citrate-glucose anticoagulant from
Dr. Serge Pin (LIONS, IRAMIS, DRF, CEA, CNRS, Université Paris-Saclay, France).
The blood needed to be centrifuged (2000 rpm, 5min, 15 ◦C) to remove the leukocytes.
In fact, these cells have diameters of 10-30 µm and block the microfluidic channel (which
height is 30 µm), causing a huge increase of pressure which eventually detaches the cell
from the sample. Centrifugation separates plasma (on the top) and erythrocytes (on the
bottom). Between these two phases there is a thin white layer called "buffy coat" which
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Figure V.48 – Photos of the TIRE setup to analyze silica samples in pig blood.
contains platelets and leukocytes. After removal of buffy coat the blood could be injected
in the microfluidic channel and flowed at different speed for some hours without causing
any blockage.
However, the TIRE spectra showed a plasmon resonance shifting towards longer wave-
lengths during dissolution and diminishing its intensity (figure V.49). This is due to the
adsorption of red cells on the silica surface which balances the effect of dissolution on
the refractive index of the probed layer. In fact, bulk dissolution of the mesoporous film
decreases the refractive index of the layer in contact with the gold but molecules and
cell adsorption increase n. If the contribution of proteins didn’t mask the evolution due
to the dissolution process, this seemed to happen for blood cells adsorption. Blood red
cells are disc-shaped with a diameter of 6-8 µm and thickness of 2-2.5 µm and, in the
real situation it will be most probably the nanoparticles to adsorb on their surface, given
their relative dimensions. On the contrary, on our samples (flat thin films of some mm2)
the red cells saw a kind of infinite surface to adhere. The dimensions of the erythrocytes
along with their high refractive index (1.4) shifted the plasmon resonance from 1148 to
1319 nm, masking all the successive evolutions due to silica dissolution. Throughout the
experiment the plasmon resonance peak shifted back and forward, as reported in figure
V.50, responding to adsorption and desorption (due to an high liquid flow rate) of red
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Figure V.49 – Series of TIRE Ψ(λ) spectra of mesoporous silica dissolution in pig blood at 0, 40 and 50
minutes with a flow rate of 500 µL/min and a surface shear stress of 40 Dyne/cm2. The minimum value
of Ψ corresponding to the plasmon resonance shifted towards longer wavelength during dissolution, to
return towards shorter wavelength later. Only three spectra are presented here for clarity but monitoring
the plasmon shift during 120 minutes we observed several oscillations in both directions.
blood cells on the silica surface. After rinsing the surface with water flow, we still noticed
red cells adsorbed on the surface, visible because of the red color of hemoglobin (figure
V.51).
The experiments in blood displayed one limit of TIRE technique: when two effects in-
fluences the plasmon resonance shift in opposites direction it’s not possible to separate
them and thus, it is not possible to rely on this kind of analysis to follow the refractive
index evolutions and reaction kinetics.
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Figure V.50 – Wavelength of the minimum value of ∆ vs time for mesoporous silica films exposed to
pig blood, with a surface shear stress of 40 Dyne/cm2. Any defined trend is visible.
Figure V.51 – Photos of the silica sample analyzed with a blood flow of 500 µL/min and shear stress
40 Dyne/cm2. (a) before microfluidic cell removal (b) after the cell removal (c) after rinsing with water
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V.10 Conclusions
We monitored mesoporous silica thin films dissolution kinetics in physiologically relevant
conditions through in situ ellipsometry employing two different setup. We used a liquid
cell in standard reflection ellipsometry to soak the samples in transparent liquids such as
PBS and a concentrated protein solution (BSA 37 g/L in PBS). We also designed and
realized a setup to perform total internal reflection ellipsometry (TIRE) to analyze silica
thin films in non-transparent biological fluids such as serum and blood. We employed a
microfluidic cell to investigate different flow conditions and their influence on dissolution.
The commercial liquid cell setup, employed with simpler media, allowed us to address
deeply the factors playing on porous silica dissolution.
In undersaturated conditions, the dissolution process showed a very fast kinetics, in which
more than 85 % of the starting material is degraded within 2 hours. The dissolution rate
was found to be linearly dependent on surface, but the porous structure can cause a
diffusion lag time if it exists some pore blocking.
The mesoporous structure seems not to influence dramatically the kinetics, when surface
areas are equivalent, even if there are some little differences. In particular, a structure
with high tortuosity can dissolve slower because the dissolution obeys the Noyes-Whitney
law, which relies on diffusion, and if diffusion is hindered dissolution will be slower. At
the same time this could be a factor which inserts a lag time in the matrix dissolution
(and in the embedded drug release, consequently). Playing on the mesoporous structure
and porous volume one could obtain a phase of slow degradation until the porous network
becomes interconnected enough to allow free diffusion.
When designing porous particles as nanocarriers it has to be remembered that a high
porous volume allows for elevated drug charge but it also implies faster degradation ki-
netics in liquids, as presented results confirmed. To thermally treat silica porous materials
is not a very efficient way to improve their stability and, in the case of nanoparticles, it can
be a tricky step which favors aggregation. On the other hand, to play on their accessible
surface and volume allows to tune their dissolution kinetics.
We verified that the observed kinetics are respected even in the case of films made of
nanoparticles and so the surface curvature should not be critical when evaluating degra-
dation kinetics.
Analyzing hybrid silica carrying aminopropyl groups we found two different regimes of
dissolution. In the first one, the dissolution rate is equivalent to the pure silica one, while
after the 50% of silica mass is dissolved the rate slowed down and XPS analysis found an
enrichment in N content. Thus, we inferred that in a first phase was dissolved the part
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of silica which is not affected by the inductive effect of the organic groups and later the
remained material which has a much slower dissolution kinetics.
In order to study a mesoporous silica matrix hosting a cargo, we choose to reproduce
a quantum rattle structure in which a mesoporous silica layer hosted gold clusters of
size < 2 nm, a system successfully employed as a theranostic platform for cancer. We
had interesting results that denied a fast release of the clusters, which stayed embedded
in the matrix during dissolution. We observed some aggregation phenomena during the
dissolution process but most gold particles maintained sizes ≤ 5 nm, which should allow
their excretion by renal clearance.
Performing experiments in protein solution we noticed a very efficient diffusional barrier
constituted by surface adsorbed protein which slowed down the silica dissolution by a 5x
factor. This behavior was confirmed also for hybrid silica carrying aminopropyl groups.
The silica layers where templating surfactant was removed by solvent extraction displayed
protein aggregates on their surface. This behavior was due to the strong interaction
between CTAB and BSA, which leads to protein unfolding and aggregation even if the
CTAB is present in small amount. It pointed out the extreme importance of employing
a washing protocol able to completely remove the surfactant from mesoporous silica NPs
employed as drug carriers, to avoid damage to biomolecules. Hybrid silica films didn’t
show this behavior, demonstrating a more efficient CTAB extraction due to the repulsive
electrostatic interactions between CTAB and protonated amine groups on silica.
With the TIRE setup, even if we encountered many experimental problems, we could
observe an important effect of the flow rate in dissolution kinetics in real biological me-
dia. This could be of major importance when designing a carrier to predict its release
and degradation time considering its path inside the body, where it is exposed to many
different flow conditions.
The experiment conducted in blood showed a limit of the TIRE technique employed,
because red blood cell adsorption on the silica surface masked the plasmon shift used to
monitor dissolution. Total internal reflection ellipsometry is thus a powerful tool to study
kinetics in all biological media which don’t contain cells, but it can’t be employed with
blood as liquid medium.
V.11 Future perspectives
The conducted work allowed to obtain many interesting informations on mesoporous silica
dissolution in biological relevant media. The investigation should be continued to address
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deeply some aspects.
For example, it would be interesting to synthesize some pegylated silica surface and look
at the influence of surface chemistry on dissolution. Unfortunately, we were not able to
functionalized the mesoporous silica only on the surface and what we obtained was an
hybrid material containing polymer brushes on the surface and in the pores. For future
perspective, some efforts to optimize the grafting process to obtain the desired material
are necessary.
The TIRE technique showed great potential to perform kinetics studies in real biological
media and under controlled flow conditions. Nevertheless, a calibrated setup is neces-
sary to assure reproducibility and limit errors in the fit process. Temperature control
is mandatory, unfortunately, once found the method to guarantee a stable temperature
we didn’t have enough time to perform large series of experiments with different surface
chemistry and different biological media. This will be done in the future, to extrapolate
general trends able to predict porous nanoparticles in vivo degradation.
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General Conclusions
The main objective of this thesis was to investigate the dissolution processes of mesoporous
silica in biological environment, since the employ of silica mesoporous nanoparticles as
theranostic platforms is very promising and attracts many attentions in drug-delivery
research.
In particular, we wanted to determine the influence of protein surface adsorption on the
silica degradation, because often the data reported in literature on NPs dissolution are
taken in buffered solutions which don’t contain biomolecules. Thus, the behavior of silica
nanoparticles in vivo can diverge sensibly from kinetics registered in buffer solutions,
because the interface interactions are very different. Another goal of this project was to
reproduce flow conditions which mimic the bloodstream and evaluate the impact of the
flow on protein adsorption and on the overall material dissolution rate.
To investigated the silica-bio interfacial structure and its dynamics was chosen to work
on thin films, which can be analyzed and modeled through in situ ellipsometry, to obtain
detailed information on their structural evolution in time.
We carried out a detailed study on dip-coating deposition technique to obtain perfectly
reproducible sol-gel silica mesoporous films. This study brought additional knowledge on
this widely employed deposition method and allowed mastering an important fabrication
step.
Since the drug delivery vectors constituted by nanoparticles have often a PEG-surface
layer on the surface to minimize protein adsorption, we tried to obtain the same core-
shell structure on films, grafting PEGylated polymer brushes on hybrid silica surface.
Nevertheless, we couldn’t obtain the desired outer polymer shell but we got an hybrid
material in which polymers grew in the pores. This kind of material was difficult to
analyzed through ellipsometry and, as a future perspective, efforts should be made to
elaborate a better grafting protocol and to identify complementary analysis techniques,
such as neutron reflectivity or quartz microbalance.
We performed dissolution experiments in PBS at 37◦ through a liquid cell, finding that
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mesoporous silica dissolution follows the theory elaborated by Noyes and Whitney and
expanded by Nernst and Brunner, in which dissolution is limited by saturation and its
rate is proportional to the specific surface of the material. Diffusion processes have a
central role in this dissolution mechanism and we verified that the porous structure can
influence the dissolution rate by hindering diffusion.
We observed a huge decrease in silica dissolution rate in presence of proteins, which form
a barrier to diffusion on the silica surface.
In order to mimic more closely in vivo environments, we wanted to perform dissolution
experiments in complex, real biological fluids. This introduced a challenge because that
sort of liquids (serum,blood) absorb and scatter light and ellipsometry can’t be performed
through them. Thus, we designed and developed a setup to employ ellipsometry in to-
tal internal reflection mode which allows working with opaque liquids. We proposed an
innovative coupling of TIRE technique with microfluidics, which revealed itself very com-
plicated in terms of fabrication. We spent a huge amount of time to optimize the sample
preparation and the measurements, but finally we could perform dissolution experiments
in real biological fluids under flow conditions. Even if we didn’t have time to deeply ex-
ploit this kind of setup we obtained valuable informations on mesoporous silica behavior
in flow, which can be employed to predict in vivo fate of nanoparticles and their cargo.
In fact, we displayed that dissolution rate increases with the root-square of flow average
velocity, as theorized by Levich. Nanoparticles undergo a relatively weak shear stress due
to the flow when they are traveling in the bloodstream but once they adhere to their
target they experience a flow shear stress from 5 to 40 times higher. Being able to predict
their dissolution rate with different surface shear stress conditions will allow the design
of more efficient nanocarriers once known their biodistribution.
This kind of setup, to the best of our knowledge, was never employed before and proved
itself very powerful. To fully exploit it and make it a routine tool, it is still necessary to
perform some experimental optimization on fabrication and calibration processes. How-
ever, employing this alternative and innovative system we could unify in a single model
theory the dissolution behavior of mesoporous silica, in saturated or undersaturated me-
dia, in absence or presence of biomolecules and liquid flow and we could work in conditions
as close as possible to real biological environment.
We believe that this approach can provide extensive informations on nanomaterials be-
havior in in vivo-like conditions, coupling the sensitivity of total internal reflection ellip-
sometry for interfaces to the flow conditions control of microfluidics.
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